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ABSTRACT 
The purpose of this investigation was to determine the 
effects of the culture environment on antibody production by 
hybridomas. Several observations made during" this Investigation 
suggest that antibody production by the 321 hybridoma was 
favoured at low growth rates. 
1) Antibody production by the 321 hybridoma continued throughout 
the growth and decline phases of batch cultures but the specific 
rate of antibody production was highest when cell growth had 
ceased. 
2) In proliferating cells, the antibody production rate was higher 
at pH 6.8 or with 1% newborn calf serum than at pH 7.2 and with 
1094 serum, conditions which were more favourable for cell growth. 
3) Antibody production rates were higher in cultures where cell 
division had been arrested by excess thymidine. 
4) Specific antibody production rates and the yield of antibody from 
glutamine were higher at low growth rates In chemostat culture. 
Studies on the metabolism of the 321 hybrldoma provided 
evidence for an increased demand on metabolite and energy pools 
at high growth rates suggesting that the cell's metabolic capacity 
may be diverted towards cell growth at the expense of antibody 
synthesis. 
Alternatively, antibody production may be cell cycle-related. 
In synchronised cultures of the 321 hybridoma there was a 
reproducible decline in the antibody production rate during mitosis 
and evidence of a further decline during the S phase. Higher rates 
of antibody synthesis during the Gx and G2 phases suggest that an 
increase in the proportion of cells residing in one or other of those 
phases would result in an increase in the rate of antibody 
production. Observations made on the effect of pH on the cell cycle 
were consistent with the hypothesis that unfavourable 
environmental conditions increase the duration of the Gi phase and 
hence the proportion of cells residing in that phase. 
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ABBREVIATIONS 
APR antibody production rate 
ATP adenosine triphosphate 
BSA bovine serum albumin 
cpm counts per minute 
D dilution rate 
DEAE diethylaminoethyl 
DMSO dimethyl sulphoxide 
ELISA enzyme-linked immunosorbent assay 
g gravity constant 
Gi phase period following mitosis and preceding DNA synthesis 
G2 phase period following DNA synthesis and preceding mitosis 
h hours 
HPLC high performance liquid chromatography 
HPRT hypoxanthine phosphoribosyl transferase 
IgG immunoglobulin G 
KL a volumetric mass transfer coefficient 
M phase period of mitosis 
NAD nicotinamide adenine dinucleotide 
NADH reduced form of NAD 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
S phase period of DNA synthesis 
SDS sodium dodecyl sulphate 
TCA trichloracetic acid 
Tris tris(hydroxymethyl)aminomethane 
Tween 20 non ionic detergent 
11 specific growth rate 
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Chapter 1 
Introduction 
1.1 Animal cell culture. 
The earliest reports of explanted tissue being maintained and 
studied in vitro date back to the late 19th century when Wilhelm Roux 
(1885) maintained chick embryo tissue for several days in warm saline 
and Arnold (1887) studied the movements of isolated frog leukocytes 
maintained in lymph-soaked elder pith over a period of 4-5 days. 
However the work that stimulated most interest in tissue culture was 
a study on growth of nerve cells in lymph clots carried out by 
Harrison in 1907. Subsequent work by Carrel and colleagues (Carrel 
and Burrows, 1911; Burrows, 1912; Lewis and Lewis, 1912) led to 
refinements in salt and amino acid composition in culture media 
containing plasma or clotted lymph as growth promoting supplements. 
The first report of serial propagation followed in 1916 when Rous and 
Jones dispersed chick embryo cells from tissue and grew them in a 
plasma clot. They were able to redisperse the cells using trypsin and 
there was subsequent regrowth. These early studies demonstrated that 
the structural organisation and physiology of tissues could be 
investigated by in vitro culture techniques and in the next decade 
studies on cell metabolism established that the energy requirements of 
cell were provided by glucose (Lewis, 1922; Warburg, 1930) and/or the 
deamination of amino acids (Holmes and Watchorn, 1927; Warburg and 
Kubowitz, 1927). The quantitative oxygen requirements of cells were 
also examined at this time (Warburg and Kubowitz, 1927). 
In the 1930s and 1940s there were many studies concerned with 
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the identification of the essential amino acid, vitamin and inorganic 
components in plasma, lymph or serum which were the principle media 
for tissue culture at that time. This resulted in the development of 
media with defined components (Fisher et al., 1948; White, 1949; 
Morgan et al., 1950; Earle et al., 1951) and culminated in Eagles 
painstaking determination of the essential amino acid and vitamin 
requirements for several mammalian cell lines (Eagle, 1955a; Eagle, 
1955b). Modifications of these early media are still extensively used 
today. 
Since those initial studies tissue culture has proved to be a 
valuable tool for the study of animal cell physiology. Following the 
discovery by Enders in 1949 that poliomyelitis virus could be grown In 
primary cell cultures, cell culture has also been used in virus 
propagation and vaccine production. Indeed the large scale use of 
animal cell cultures for the production of biological material was 
largely confined to virus vaccine production until relatively recently 
despite the obvious therapeutic potential of many mammalian proteins 
which have been discovered In tissues. However the production of large 
quantities of proteins from normal tissues Is often limited by the 
availability of the appropriate tissue. the low concentrations present in 
tissues and loss of protein during purification. The large scale 
production of proteins from cultured normal cells is limited by the finite 
lifespan of normal cells in vitro. It was therefore considered that the 
future of large scale production of human proteins lay with genetically 
engineered bacteria and while biologically active proteins such as 
insulin (Johnson, 1983) and human growth hormone (Hsuing et al., 1986) 
have been produced in large quantities from Escherichla cola, there are 
many problems associated with the expression of mammalian proteins in 
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bacteria. For example bacteria are unable to carry out post translational 
modifications such as glycosylation, phosphorylation and signal peptide 
cleavage which may affect the activity or solubility of the product. The 
proteins may also be Incorrectly folded or present in a denatured form 
(Williams et al., 1982; Marston, 1986; Kenealy et al., 1987). While lower 
eukaryotes such as yeast can glycosylate and secrete proteins, the 
glycosylation pattern and protein folding may be Incorrect (Ballou, 1982; 
Kingsman et al., 1987) and low product activities have been reported 
(Wood et al., 1985). It has therefore become apparent that while a 
number of biologically active proteins have been produced in yeast and 
bacteria (Berman and Lasky, 1985; Kingsman et al., 1987). proteins such 
as erythropoietin, which rely on correct post translational modification 
for their activity (Dube et al., '1988), may only be effectively expressed 
in mammalian cells. Furthermore the potential for large scale protein 
production by animal cells has been advanced by a number of recent 
developments in mammalian cell technology. 
The first of these was the development of the hybridoma by 
Kohler and Milstein in 1975. The potential of monoclonal antibodies as 
therapeutic and diagnostic agents was quickly realised and led to the 
development of large scale culture processes to provide. sufficient 
material for clinical -testing. Secondly the finding that a number of 
continuous cell lines constitutively express useful therapeutic proteins 
has led to the development of large scale culture processes for the 
production of proteins such as tPA from human melanoma cells (Kluft et 
al., 1983) and a-interferon from Namalwa cells (Phillips et al., 1985; 
Lazar et al., 1987). More recently the development of techniques for the 
expression of recombinant human protein in -mammalian cell lines 
(Ringold et al., 1981; Lubiniecki, 1987; Bebbington and Hentschel, 1987) 
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has greatly increased the potential for the production of proteins from 
mammalian cell cultures. 
The main concern with the use of continuous cell lines is the 
perceived risk of the transfer of material with tumorigenic potential to 
the recipient since some transforming viral genes and activated 
oncogenes can transform cells in. vitro (Bishop. 1983; Diderholm et al.. 
1965) and cause tumours in vivo (Fung et al.. 1983; Israel et al.. 1979). 
However improved techniques for the detection of residual nucleic acids 
(Van Wezel et al.. 1982) and favourable assessments of the risks 
involved (Petricianni. 1987; Ramabhadran. 1987) have led to an 
increasing acceptance of products derived from continuous cell lines for 
human therapy. The market value of such products is high and animal 
cell products also have potential applications In research, diagnostics 
and biochemical purification. Comprehensive reviews of current and 
potential applications of mammalian cell technology may be found in the 
reports of Spier and Horaud (1985), Lubiniecki (1987), Mizrahl (1988) 
and Spier (1988) and some examples of these applications are presented 
in table 1.1. 
This investigation however concentrates on the production of 
monoclonal antibodies by hybridoma cell cultures. This system was 
chosen for study for several reasons. 
1) Monoclonal antibodies have potential in a number of fields 
including therapeutic medicine. There is therefore a requirement for the 
large scale production of antibodies by hybridomas. The design and 
optimisation of such processes will be facilitated by an analysis of the 
factors which influence antibody production by hybridomas. 
ii) Hybridomas grow readily in homogeneous suspension culture which 
is amenable to conventional fermentation techniques. 
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Table 1.1. Current and potential products fron cultured animal cells. 
Viral vaccines Spier 1983 
Spier and Horaud, 1985 
Mizrahi, 1988 
Recombinant viral antigens 
hepatitis B surface antigen 
Crowley et a1., 1983 
herpes simplex g1ya)protein D Berman et al. 1985 
Immunoregulatory proteins 
interferans, interleukins 
Monoclonal antibodies 
Polypeptide growth factors 
Enzymes 
tPA 
factor ü 
factor VIII 
Shoham, 1983 
Phillips et al., 1985 
Klein et al., 1983 
Kris et al., 1985 
Kadouri and Bohak, 1985 
Kaufman et al. 1985 
Anson et al., 1985 
Toole et al. 1984 
Wood et al. 1984 
Hormones 
erythropoietin Jacobs et al. 1985 
Katinger and Bliem, 1983 
Viral insecticides 
baculoviruses Miltenberger and Krieg, 1984 
71iatr specific antigens 
carcinoembryic antigen 
Animal cells as products 
reconstitution of skin 
Kim et a1., 1985 
Reuveny et a1., 1987 
Green et al. 1979 
Bell et al. 1983 
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ill) Hybridomas secrete a product that is readily detected and 
characterised by existing assay techniques. 
1.2 The B-cell hybridoma. 
The B-cell hybridoma is the result of a cell -fusion between a 
B-lymphocyte which secretes antibody and a myeloma cell line which 
confers immortality to the resulting fusion product. In accordance with 
Burnet's clonal selection theory for antibody production by 
B-lymphocytes (Burnet, 1957). It is possible to select a single hybridoma 
clone producing antibodies of uniform specificity. The hybridisation 
technique was developed by Kohler and Milstein in 1975 and has since 
become a widely used technique in research. Detailed descriptions of the 
technique may be found in several reviews and books (Milstein, 1980; 
Fazekas de St Groth and Scheidegger, 1980; Goding, 1983; Campbell, 
1984; Epstein and Epstein, 1986) therefore only the basic principles will 
be outlined below (see figure 1.1). 
To produce a hybridoma secreting an antibody of the desired 
specificity an animal (usually a mouse) is Immunised with the antigen 
of interest although in vitro immunisation techniques are also used 
(James and Bell, 1987; Borrebaeck. 1987). B-lymphocytes, a proportion 
of which will be secreting antibody to the antigen, are harvested from 
the spleen, and fused with a cultured myeloma cell line. Kohler and 
Milstein used Sendai virus to promote cell fusion but the use of 
polyethylene glycol (Davidson et al., 1976) is more convenient and Is 
more commonly used today. Improved fusion efficiencies have been 
claimed for electrofusion (Zimmerman et al., 1985). 
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Figure 1.1. The principles of hybridoma production 
Mouse immunised 
with antigen 
a 
EýS: 
B-lyrrphocytes harvested 
from spleen 
Cultured myeloma 
HPRT - Cell fusion 
(promoted by PEG) 
oooo0 
0ö 0 08 
Hybridomas selected 
with HAT medium 
Screen for cells producing 
desired antibody 
Select by cloning 
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The fusion partner is a myeloma cell line which is deficient in the 
enzyme hypoxanthine phosphoribosyl transferase (HPRT). This enzyme 
is part of a salvage pathway which utilises hypoxanthine in the absence 
of de novo purine synthesis. Cells lacking HPRT are unable to 
synthesize purines from hypoxanthine and will die in the presence of 
aminopterin (a folate antagonist which blocks the de novo synthesis of 
purines and pyrimidines). Normal B-cells which possess both the 
enzymes thymidine kinase (TK) and HPRT can synthesize both purines 
from hypoxanthine and pyrimidines from thymidine but are unable to 
proliferate in vitro. Successful B-cell myeloma fusions may therefore be 
selected by their ability to proliferate in HAT medium which contains 
hypoxanthine, aminopterin and thymidine (Littlefield, 1964). 
It is then possible to screen the hybridomas for secretion of 
the desired antibody by immunoassay and subsequent selection and 
cloning will result in a single hybridoma clone producing monoclonal 
antibody. 
The monoclonal antibody has a number of advantages over more 
conventional polyvalent antisera. 
I) The antigen binding site Is uniform in its specificity and affinity 
whereas polyvalent antisera contain a population of antibodies from 
several B cell clones which have a variety of antigen affinities and 
specificities. 
ii) It is possible to use relatively Impure antigens In the immunisation 
of animals for monoclonal antibody preparation because cells producing 
the desired antibody can be selected after cloning. The production of 
a polyvalent antiserum requires that the antigen is of the highest 
purity to ensure that the greatest proportion of antibodies are directed 
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towards the desired determinants. 
ill) The monoclonal antibody, which can be produced in unlimited 
quantities, is highly consistent in its properties whereas the quality of 
polyvalent antiserum varies from animal to animal and between 
bleedings of the same animal. 
1.3 Applications for monoclonal antibodies. 
The main use of monoclonal antibodies to date has been in the 
fields of research and diagnostics. The increasing use of 
diagnostic and assay kits in medicine has resulted in a demand for 
highly specific and reproducible reagents. The monoclonal antibody 
fulfils both these criteria. Furthermore the unique specificity of the 
monoclonal antibody has allowed research to progress into areas which 
would prove too rigorous for conventional antisera. Such areas include 
the identification of tumour-specific antigens (Schlom and Weeks, 
1985), the delineation of closely related cell types such as lymphocytes 
(Van Wauwe et al., 1981; Talle et al., 1983), cell receptor studies 
(Goldfine et al., 1985) and studies on the antigenic variation of viruses 
(Wiktor and Koprowski, 1978; Gerhard et al.. 1981). The application of 
monoclonal antibodies in these fields has been reviewed extensively 
(see for example Epstein et al., 1986) and will not be considered further. 
Another growing area is the use of monoclonal antibodies for the 
purification of valuable biologically active substances by 
immunoaffinity chromatography. This enables the highly specific 
separation of a product which may be present In low quantities and 
heavily contaminated by other substances. Industrial processes have 
been described for the separation of hepatitis B surface antigen (as 
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reported by Spier, 1983) and interferon (Secher and Burke, 1980). 
The potential of monoclonal antibodies In therapeutic medicine has 
attracted a considerable amount of attention. The use of monoclonal 
antibodies for passive immunisation is attractive because, at present, 
antibodies have to be fractionated from immune sera from humans or 
animals with the risk of transfer of infectious agents. There are now 
human monoclonal antibodies to bacterial, viral and parasite antigens 
(James and Bell, 1987) with obvious potential in the treatment of 
resistant or highly virulent organisms. The potential for such treatment 
has already been demonstrated in the veterinary field by the use of 
monoclonal antibodies against E. cola K99 antigen to prevent diarrhoea 
in neonatal calves (Sadowski, 1982). 
Target-directed drug therapy has also received considerable 
attention in recent years due primarily to its potential for the 
treatment of cancer. Monoclonal antibodies raised against tumour 
associated antigens may be conjugated to toxins such as abrin or ricin 
which will then selectively destroy cells bearing those antigens (Youle 
and Neville, 1980; Gilliland et al., 1980; Lord et al.. 1985; Vitetta et 
al.. 1987). This technique may be especially useful in autologous bone 
marrow transplants for the removal of tumour cells (Krolick et a!., 
1982; Bast et a!.. 1983) or in allogeneic transplantation to remove 
T-cells from donor marrow so reducing the incidence of graft versus host 
disease (Vallera eta!.. 1982). Successful treatment of acute graft versus 
host disease In humans by the use of ricin conjugated antibody to the 
CD5 antigen on T-lymphocytes has also been reported (Kernan et al., 
1988). Isotopically labelled antibodies to tumour antigens have been 
used to image tumours in vivo (Buchegger et a!., 1983) and studies are 
now in progress to determine the effectiveness of isotope-labelled 
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antibodies in tumour therapy (Byers and Baldwin, 1988). Unmodified 
antibodies may also be useful as therapeutic agents and some success in 
the treatment of B-cell tumours using anti-idlotypic monoclonals has 
been reported (Miller et al., 1982; Lowder et al., 1987). Unmodified 
anti-T-cell receptor antibodies (OKT3) have also been used to prevent 
renal graft rejection presumably by preventing lymphocyte-antigen 
interactions (Goldstein et al., 1985). 
Most clinical trials to date have used murine monoclonal antibodies 
(Byers and Baldwin, 1988) but successful treatment has so far been 
limited by the generation of an immune response to murine antibody 
which often precludes continued treatment (Levy and Miller, 1983; 
Jaffres et al., 1986). The use of human monoclonal antibodies would 
alleviate this problem but is limited by the difficulties in producing 
human antibodies to tumour antigens (James and Bell, 1987). Recent 
development of chimeric antibodies containing either human constant 
and mouse variable regions (Morrison et al., 1984; Boulianne et al., 1984; 
Morrison, 1985) or rat hypervariable regions inserted into a human 
antibody (Riechmann et al., 1988) may soon overcome these problems. 
A further potential application for monoclonal antibodies is in their 
use as anti-idiotype vaccines. Anti-idiotypic antibodies which are 
raised against the antigen binding site of a second antibody, can mimic 
the conformation of the antigen recognised by the second antibody. Such 
antibodies thus have the potential to act as immunogens and could be 
used as vaccines (Reagan et a1., 1983; Kaufmann et al., 1985). 
The realisation of the potential of monoclonal antibodies for 
diagnostic and therapeutic products will require the production of large 
amounts of antibody. Diagnostic assays may' only require microgram 
quantities of antibody for individual tests but could consume gram 
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quantities of antibody if used in large scale screening such as in ABO 
blood typing (Voak and Lennox, 1983). In vivo imaging applications and 
immunotherapy may require tens of kilograms assuming that each 
patient may require several hundred micrograms for imaging (Mach et 
al., 1981) and several hundred milligrams during treatment (Miller et al., 
1982). Furthermore as the economics for large scale production of 
monoclonal antibodies improve then kilogram quantities of antibodies 
could be consumed in biochemical purification processes. It has 
therefore been predicted that the market for monoclonal 
antibodies will increase substantially in the next decade (Ratafia, 1987; 
Spier, 1988) Illustrating a real need for an efficient production system 
to meet such a demand. 
1.4 Production of monoclonal antibodies. 
1.4.1 A scites. 
Hybridomas can be grown as tumours in the peritoneal cavity of 
histologically compatible mice and the antibody harvested from ascitic 
fluid at concentrations of 5-20 mg/ml. A single mouse might produce up 
to 15m1 of ascitic fluid before succumbing to the tumour (Hurrell, 1982). 
There are however several disadvantages in the use of rodents to 
expand monoclonal antibodies production. 
1) Mouse ascites may contain contaminating antibodies from the host. 
Other detrimental proteins such as proteases may also be present. 
ii) Mouse adventitious agents may be present in ascitic fluid. 
iii) Human hybridomas are difficult to propagate in rodents. 
iv) Large scale applications would require large numbers of mice. The 
lack of the economy of scale and process control would have to be 
12 
considered in addition to any ethical objections to such a production 
process. 
For these reasons many workers are investigating the in vitro 
production of monoclonal antibodies and because hybridomas grow 
readily in suspension culture many of the culture techniques used for 
the propagation of microorganisms have been applied to the large scale 
culture of hybridoma cells. 
1.4.2 invitro production methods. 
The stirred tank reactor has already been used extensively for 
both research and production scale cultivation of mammalian cells. the 
largest to date being an 80001 reactor for the production of 
lymphoblastoid interferon (Phillips et al., 1985). As yet the use of large 
scale homogeneous stirred tank systems for the production of monoclonal 
antibodies is limited but Celltech have pioneered the use of a 10001 
airlift reactor for the commercial production of monoclonal antibodies. 
Using this system Birch et al. (1985a) claim to produce an average of 
150g of antibody in a typical run. This fermenter has now been scaled up 
to 20001 and is used for the production of both antibodies and 
recombinant proteins by mammalian cells (Rhodes and Birch, 1988). 
The concentration of product in a homogeneous suspension culture 
is limited by the maximum cell density that can be achieved in such a 
system before either nutrients are exhausted or toxic products become 
inhibitory. This is typically 1-2 x 106 cells/ml for a hybridoma and 
antibody titres ranging from, 20-200 jig/ml can be obtained (see for 
example, Reuveny et al., 1985; Birch et aL. 1985a; Fazekas de St Groth, 
1983). However, increased cell densities may be achieved by perfusing 
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the culture with fresh medium. The increased nutrient supply and the 
removal of toxic metabolites extends the production phase of a culture. 
Himmelfarb and colleagues (1969) showed that higher cell densities 
could be obtained in perfused culture in which cells were retained by 
removing waste medium through a spinning filter device. The high shear 
force generated at the surface of the spinning filter alleviated the 
blocking which occured with static filters. 
Variations on the spinning filter device have been adopted for the 
production of monoclonal antibodies (Tolbert et a)., 1985; Reuveny et 
al., 1986b). These authors have reported hybridoma densities of up to 
3x107/ml and increased antibody titres in the effluent stream (50-500 
fg/ml). However filter blockage still occured after several days of 
culture and it was necessary to replace the filters regularly to maintain 
long term cultures spanning several weeks. 
1.4.2.1 Immobilised cell systems. 
The relative fragility of animal cells and the low product 
densities experienced in homogeneous suspension cultures has led to 
research into the use of immobilised cell systems for high density cell 
culture. Immobilised cells are not exposed to the hydrodynamic stresses 
experienced In agitated systems and are separated from the medium 
which facilitates medium perfusion and downstream processing. 
1) The entrapment of cells within porous matrices. 
A number of techniques have been applied to the immobilisation 
of cells in porous beads using materials such as alginate (Nilsson and 
Mosbach. 1980) or agarose (Nilsson et al.. 1983; Katinger and Sheirer. 
1985). These materials retain cells but nutrients and products may 
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diffuse freely. 
Although hybridoma cells are non-adherent, materials with more 
open pore structures have also been successfully used for hybridoma 
immobilisation. In these systems it appears that cells settle within the 
tortuous network of channels and subsequent outgrowth prevents the 
cell mass becoming dislodged. Hybridoma densities approaching 108 
cells/cm3 of matrix were observed in fibrous collagen beads (Karkare et 
al, 1985). A variety of materials including polymer foams have also been 
investigated for their effectiveness In entrapping hybridoma cells 
(Lazar et a!.. 1987, Murdin et a!.. 1987). Packed beds were used in these 
investigations but problems with mass transfer due to channeling and 
cell outgrowth have been reported in packed beds (Karkare et al, 1985). 
Karkare and colleagues therefore favour a fluidised bed system using 
weighted collagen beads which allow higher medium flow rates and 
improved mass transfer. Bubble columns, air lift and stirred reactors 
have also been used for the cultivation of immobilised cells (Himmler et 
al., 1985). 
A different approach utilises a ceramic matrix perforated by a 
number of uniform square channels (Lydersen et al., 1985). Hybridomas 
proliferate in the porous walls of the ceramic matrix and medium is 
supplied through the channels allowing the system to operated for 
extended periods. 
All the systems described above allow free passage of the product 
into the medium and result in product titres which are often no higher 
than those achieved in homogeneous suspension culture. 
ii) Encapsulation. 
Cellular microencapsulation using poly-l-lysine membranes was 
first described by Lim and Sun (1980), who used encapsulated islets as 
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an artificial pancreas. Microencapsulation has since been used for a 
number of cell lines (Jarvis and Grdina, 1983). 
Damon Biotech Incorporated have adopted this technology for the 
production of monoclonal antibodies (Rupp, 1985). The use of a 
poly-l-lysine capsule with a molecular weight cut off of 8OkD means 
that antibody is retained within the capsule while low molecular weight 
nutrients and waste products can diffuse freely across the membrane. 
The advantages of this system are that cells are protected from 
environmental stress and antibody reaches high concentration (5mg/mi 
capsule volume). As this may represent up to 50% of the total 
Intracapsular protein, product recovery during downstream processing 
is therefore improved. However there are disadvantages to such a 
system, which is essentially a batch process, because the capsules must 
be ruptured to harvest the antibody. The manufacture of microcapsules 
is a complex process and the scale up of such a system would be limited 
by the capacity to manufacture large numbers of microcapsules. 
iii) Hollow fibres. 
The use of capillary systems for the growth of animal cells was 
first described by Knazek et al. (1972) and subsequently developed by 
Amicon. In this configuration cells are grown in the spaces between a 
tightly packed bundle of hollow fibres. Medium is pumped through the 
porous fibres and nutrients diffuse , 
into the, extracapillary space. 
Likewise waste metabolites diffuse into the capillaries and are removed 
by the medium stream. Cells can be grown to high density (> 108 /ml) in 
conditions which are similar to those experienced by tissues in vivo. 
Several cell types have been successfully cultured in these systems 
(see review by Hopkinson, 1985) and since 1981 the hollow fibre sytem 
has been used for both human and mouse monoclonal antibody 
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production (Calabresi et al.. 1981; Wlemann et al., 1983; Altshuler et al.. 
1986; Schonherr et al., 1987). High concentrations of antibody can be 
achieved in the extra-capillary space when low molecular weight cutoff 
(10-100 kDaltons) membranes are used and unlike microcapsules 
antibody can be harvested continuously or intermittently from the 
extra-capillary space. The process is therefore continuous and can be 
operated for several months. 
The hollow fibre systems described above have a closed shell and 
medium and waste products across the membrane by diffusion. An 
important limitation of this configuration is the formation of nutrient 
and metabolite gradients along the length of the fibre bundle due to high 
cell densities (Ku et al., 1981) and due to the pressure gradient which 
exists in such systems (Tharakan and Chau, 1985a). These effects can 
be reduced to some extent by increasing flow rates and, periodically 
reversing the direction of flow (Hopkinson, 1986). Improved mass 
transfer has been reported in cross flow systems where medium is 
delivered from the shell side and exits through the fibre lumen (Ku et 
aL, 1981; Tharakan and Chau, 1985b) while In other systems the_ use of 
pressure cycling ensures that medium passes back and forth across the 
fibre wall and hence give mass transfer rates higher than that of 
diffusion alone. 
Other reactors use ultrafiltration membranes as in hollow fibre 
reactors but the cells are sandwiched between flat membranes (Seaver 
and Gabriels, 1985). Klement et al. (1987) have modified the design 
further to incorporate different porosity membranes which allow the 
separation of cells, medium and product into different compartments. 
Such systems could incorporate several layers of membranes to facilitate 
scale-up. 
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1.4.3 Assessment of bioreactor types. 
The type of bioreactor employed for a particular application 
depends on the properties of the cell and the scale of the process. 
Several authors have reviewed aspects of fermenter design for the scale 
up of animal cell production processes (Glacken et al., 1983; Lambe and 
Walker, 1987; Katinger and Scheirer, 1985; Hu and Dodge, 1985; Merten, 
1988). Merten has assessed reactor design based on the properties of the 
cell line namely. shear sensitivity, production kinetics and genetic 
stability and these parameters will be discussed for hybridoma cells. 
V Shear sensitivity. 
Fazekas de St Groth (1983) found that hybridoma cell doubling 
times in stirred suspension culture increased as agitator speeds 
approached 100 rpm but noted some variation in the sensitivity of 
different hybridoma lines to high stirrer speeds. Other authors have 
found little effect on hybridoma growth at stirrer speeds in excess of 
100rpm (Boraston et al., 1984; Dodge and Hu, 1987). This suggests that 
many hybridoma lines are less sensitive to shear than has been supposed 
and are thus amenable to suspension culture techniques. 
ii) Production kinetics. 
The production kinetics for a particular protein will have a 
profound effect on the design of a production process depending on 
whether the product is growth-associated, non growth-associated or 
subject to feedback regulation. Feedback regulation would preclude the 
use of product retention systems described above. Growth-associated 
production kinetics would be favoured by rapid growth rates precluding 
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the use of immobilised cell systems where growth is restricted. However 
in hybridomas the production of antibody is not growth associated and 
antibody production continues in the absence of cell proliferation (Birch 
et al., 1985b; Miller et al., 1988a). Furthermore, there is no evidence of 
feedback regulation of antibody production in hybridomas (Fazekas de 
St Groth. 1983). These production kinetics would be compatible with high 
cell densities and product retention systems. 
iii) Genetic stability. 
Merten (1988) has suggested that cell retention systems which 
restrict cell growth but allow extended production periods would be 
preferable for genetically unstable cell lines. The loss of genetic 
material during cell replication could be minimised In such systems. 
The stability of hybridoma lines varies considerably but several 
hybridoma lines have been maintained in culture for long periods of time 
without any apparent changes in the production characteristics (see for 
example Low and Harbour, 1985a; Birch et al. 1985b; Bree et al., 1988). 
It would appear that the properties of hybridoma cells do not 
preclude any of the production methods described and the design of the 
process must ultimately be centred upon the economics of the process. 
Stirred suspension culture systems are unit processes and benefit from 
the economy of scale, but low product concentrations increase the 
complexity of downstream processing. The high density product 
retention systems yield a more concentrated product which improves 
product recovery but scale up of such processes is often limited to an 
increase in the number of units and thus economy of scale cannot be 
realised. However cells grown at high density may have a reduced 
requirement for certain medium components such as serum (Hopkinson, 
1985; Reuveny et al., 1987) and thus make a more economical use of 
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medium. The high cost of mammalian cell culture medium suggests that 
any improvement of cell or product yields by process control and/or 
medium design will yield more economical production systems. Such an 
approach requires knowledge of antibody production kinetics and cell 
physiology and some aspects of these are discussed in the following 
section. 
1.5 Hybridoma growth and production kinetics. 
Growth kinetics for hybridomas appear to follow the characteristic 
bacterial growth kinetics because there is a discernable lag phase 
followed by exponential growth and decline phases although cell 
doubling times are generally longer, typically 12-24 hours for mouse 
hybridomas. 
The lag phase may be due in part to the population density 
dependence of cell growth observed in animal cell culture. This was 
shown by Eagle (1962) to be a dependence upon a pool of metabolic 
intermediates which cells must synthesise before they can divide. The 
result is that there is a minimum population which will condition the 
medium sufficiently to support cell growth. Eagle demonstrated that by 
adding various metabolic intermediates the population density 
dependence could be reduced. 
Maximum cell densities achieved in static or stirred batch cultures 
is generally 106 cells/ml (Boraston et al., 1984; Reuveny et al., 1987) 
but this figure can be doubled by batch feeding and improved medium 
design (Rhodes and Birch, 1988). 
Various observations on the production kinetics for monoclonal 
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antibodies suggest that the antibody production rate is independent of 
growth rate. For example a number of authors have observed- that 
antibody production continues into the stationary phase and In a 
number of cases It has been observed that specific antibody production 
rates are maximal during the stationary phase (Fazekas de St Groth, 
1983; Boraston et al., 1984; Reuveny et al., 1985; Birch et al., 1986). In 
contrast some hybridoma lines show a decreasing specific production 
rate as they approach stationary phase (Lavery et al., 1985) and are 
characteristically low producers. The latter production kinetics may be 
due to some inhibition mechanism as postulated by Merten et al. (1985) 
who showed that the addition of spent medium to the culture greatly 
reduces the specific production rate of antibody in these cells. This 
effect seemed to be highly specific in that it could not be reproduced 
using spent media from other cultures or using purified mouse 
monoclonal antibody from other hybridomas. By contrast Fazekas de St 
Groth (1983) has examined a number'of hybridoma lines in continuous 
culture and has found no evidence of feed back Inhibition of antibody 
synthesis because the specific production rate for antibody' was 
essentially the same at cell densities between 105 and 106 /ml. ' 
The underlying mechanism of the former production kinetics has 
posited two possible explanations, firstly that an intracellular pool of 
immunoglobulin builds up in intact cells and is released during the death 
phase as cell membranes are disrupted and secondly that the specific 
production rate increases during the stationary phase. There is 
conflicting evidence in that Emery et al. (1987) claim to have detected 
an increasing intracellular pool of immunoglobulin in some cell lines 
whilst Birch et a!. (1987) found no such evidence in their cell lines. 
Much of the evidence would tend to favour an increased production rate 
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during the decline phase. It has been shown for example in perfused 
culture systems that a stationary cell population is achieved in which 
the specific antibody production rate is sustained at a higher level than 
during the growth phase (Van Wezel et a!., 1985; Reuveny et a!., 1986). 
It has also been shown that the antibody production rate is related to 
the number of viable cells (Velez et al., 1986; Renard et a!.. 1988) with 
an insignificant contribution from dying cells. 
It is evident from the widely ranging antibody productivities seen 
in different hybridoma cell lines, that the production characteristics for 
a hybridoma is ultimately determined by the cell line itself. This results 
from a combination of the parental genotypes (ie myeloma and B-cell), 
the differentiation state of the B-cell and any chromosome 
rearrangement or recombination events which take place after cell 
fusion (Westerwoudt, 1986). Thus it is possible that each hybridoma line 
possesses a unique phenotype which may be manifested as defects in cell 
metabolic pathways or altered production kinetics. In addition defects 
in the metabolism of theýmyeloma parent may be complemented by the 
other fusion partner. Such a phenomenon has been noted for the NS-1 
myeloma which has a requirement for lipids in serum-free medium 
whereas hybridomas derived from the NS-1 parent do not have this 
requirement (Kawamoto et al., 1986). The influence of the parental cell 
phenotype on the growth and productivity of the resulting hybrid has 
not been rigorously examined but it is likely that optimisation of the 
medium and other conditions for the production of antibody will have to 
be undertaken for each hybridoma line. However the effects of the 
environment on the growth and metabolism of cultured cell lines in 
general and hybridomas in particular will be discussed in the next 
section in an attempt to identify those factors which Influence antibody 
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production. 
1.6 The effect of the environment on cell growth and antibody 
production. 
1.6.1 Carbohydrates and cell growth. 
A general review of carbohydrate metabolism may be found in 
the paper by Morgan and Falk (1986) in which they list carbohydrates 
which have been shown to support cell 'growth and discuss the major 
regulatory enzymes of carbohydrate metabolism. 
Rapidly dividing cells exhibit a high rate of glycolysis and a 
substantial proportion of glucose is metabolised to lactate even under 
aerobic conditions (Warburg. 1956; Levintow and Eagle, 1961; Roos and 
Loos, 1973; Reitzer et al.. 1979) and this is also true of hybridoma cells 
(Low and Harbour 1985; Hu et al.. 1987; Luan et al.. 1987). This was 
initially thought to be a characteristic of tumour cells (Warburg, 1926) 
and indeed there is evidence that the regulation of phosphofructokinase 
(a key regulatory enzyme in glycolysis) may be altered in transformed 
cells (Morgan and Falk. 1986) possibly due to a reduced sensitivity to 
feedback inhibition by ATP (Eigenbrodt et al.. 1985). However certain 
rapidly proliferating normal cells and cells with the potential for rapid 
proliferation (e. g. lymphocytes), also exhibit high rates of glycolysis. 
Likewise it has been found that there is no direct correlation between 
glucose uptake and cell yield (Eagle. 1958). This phenomenon is perhaps 
now resolved by recent studies concerning the contribution of other 
carbon sources, in particular glutamine, to energy metabolism and this 
subject is discussed further in a later section. 
It has been suggested that a possible role for the apparently 
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inefficient rate of glycolysis proliferating cells is the maintenance 
of elevated concentrations of glycolytic intermediates, for 
macromolecular synthesis (Hume et al., 1977). Reitzer et al. (1979) 
have gone further and suggested that the primary role of glycolysis In 
HeLa cells was to provide precursors for nucleotide synthesis via 
the pentose phosphate pathway. They subsequently showed that 
several cell lines would grow in the absence of glucose provided uridine 
or cytidine were present (Wice et al.. 1981). 
It has been observed that high glucose concentrations increase 
both the glucose consumption rate and the yield of lactate from glucose 
in several cell types (Graff. et a!., 1966; Renner et al., 1972; Glacken et 
al., 1986) Including hybridomas (Low and Harbour. 1985b; Hu et al., 
1987; Luan et a1., 1987). Renner et al. (1972) found that at glucose 
concentrations less than 60pM, all of the glucose was used for 
macromolecular synthesis and oxidative processes with no net formation 
of lactate. This may be due to a change in the flux of glucose through 
different metabolic pathways as proposed by Reitzer et al., (1979). High 
concentrations of glucose lead to an increased flux through glycolysis 
with the subsequent production of large amounts of lactate whereas at 
low glucose concentrations the flux through glycolysis is greatly 
reduced with a greater proportion of glucose carbon being diverted 
through anabolic pathways. The increased rate of glycolysis at high 
glucose concentrations is accompanied by a decreased oxygen 
consumption rate (Frame and Hu, 1985; Glacken et al., 1986) possibly 
due to the increased production of ATP . 
from , glycolysis inhibiting 
oxidation in Krebs cycle (Miller et a!., 1988a). High growth rates also 
lead to an increased rate of glucose consumption and increased yields 
of lactate from glucose (Hu et al., 1987, Luan et a!., 1987b). 
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The production of large amounts of lactic acid can quickly 
overcome the buffering capacity of cell culture media leading to a drop 
in pH and inhibition of cell growth. Eagle et al. (1958) found that the 
substitution of more slowly metabolised sugars such as fructose or 
galactose for glucose, leads to a greatly reduced lactate yield. Reitzer 
et al. (1979) subsequently demonstrated that most of the fructose 
utilised by HeLa cells was metabolised via the pentose phosphate 
pathway with very little accumulating as pyruvate or lactate. The 
substitution of glucose by fructose or galactose has therefore been used 
by a number of workers to reduce the lactate concentration in culture 
media and improve pH control (Imamura et al., 1982; Reitzer et al., 1979; 
Low and Harbour, 1985b). 
1.6.2 The effect of glucose and lactate on antibody production. 
Products of glucose catabolism have been found to repress 
biosynthetic pathways in lower organisms and there is some evidence 
that catabolite repression may also occur in mammalian cells. For 
example higher titres of interferon were achieved in glucose-limited 
chemostat culture of mouse LS cells than in batch cultures with high 
glucose concentrations (Tovey eta)., 1973). The production of interferon 
from Nalmalva cells was also found to be inhibited by increased glucose 
concentrations in chemostat culture (Kromer and Katinger. 1982). 
Studies on glucose-limited chemostat cultures of hybridomas have 
revealed that the specific antibody production rate is highest at low 
growth rates which coincides with the lowest metabolic quotient for 
glucose (Birch et al.. 1985b; Miller et al., 1988a). Such an effect would 
be consistent with catabolite repression but there is evidence to suggest 
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that this is not the case in hybridoma cells. 
1. Low and Harbour (1985b) found that high glucose concentrations do 
not inhibit antibody production in batch culture. These findings are 
supported by Tharakan and Chau (1986c) who found no apparent 
relationship between glucose uptake rate and antibody production rate. 
2. Substitution of more slowly metabolised carbohydrates such as 
fructose for glucose does not improve antibody titres (Low and Harbour, 
1985b). 
3. Miller et al. (1988a) found that at constant growth rate the highest 
metabolic quotient for antibody production coincided with the highest 
metabolic quotient for glucose uptake, an effect which is not consistent 
with catabolite repression. 
The inhibitory effect of lactic acid on cell growth is probably due 
to the lowering of the culture pH to suboptimal levels although it has 
been suggested that the lactate ion per se inhibits hybridoma growth 
and antibody production independently of pH (Glasken et al.. 1986). 
Others (Reuveny et a!., 1986a; Miller et al., 1988b) have found that 
lactate concentrations in excess of 25mM exhibit little effect on either 
cell growth or antibody production. The sensitivity of cells to lactate 
toxicity may therefore vary considerably between cell lines. 
1.6.3 Amino acid metabolism. 
Early studies on the amino acid requirements of animal cells were 
largely empirical being based either on the composition of biological 
fluids (Fischer. 1948; White, 1949; Morgan et al. 1950) or by the 
evaluation of the effect of individual amino acids on cell proliferation 
(Eagle, 1955; Eagle, 1959). Later studies on changes in amino acid 
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concentrations during cell growth have shown that patterns of uptake 
or accumulation of amino acids in culture media vary with the cell type, 
medium composition and proliferation state. However, in general it 
appears that glutamine is the most rapidly utilised followed by leucine, 
isoleucine, lysine and valine (McCarty, 1962; Kruse et al., 1967. 
Griffiths and Pirt, 1967; Stoner and Merchant, 1972; Roberts et al., 
1976). When non-essential amino acids are omitted from medium they 
are synthesized by cells during growth and may accumulate in the 
medium (McCarty. 1962; Griffiths and Pirt. 1967; Stoner and Merchant, 
1972) but are consumed during the stationary phase (Stoner and 
Merchant. 1972). When non-essential amino acids are included in the 
medium they are utilised by the cells (Pasieka et al., 1960; Kruse et al., 
1967) and the consumption of essential amino acids is reduced (Griffiths 
and Pirt, 1967). There are few reports concerning the amino acid 
requirements of hybridoma cells but it has been reported that there is 
rapid consumption of Blutamine, arginine and serine with isoleucine, 
leucine, methionine, valine. phenyalanine and tyrosine being used to a 
lesser extent (Merten et al.. 1986). The rapid consumption of serine may 
reflect a requirement for serine in common with certain other cell lines 
(Kruse eta).. 1967; Stoner and Merchant, 1972; Birch and Hopkins, 1977), 
serine being an important intermediate in the synthesis of purines and 
pyrimidines via tetrahydrofolate and glycine. 
The importance of glutamine for the growth of animal cells in 
culture has long been known (Eagle et al., 1956, Kitos et al.. 1961) and 
its role in cell metabolism has been reviewed recently by McKeehan 
(1985). The rapid utilisation of glutamine appears to be a characteristic 
of proliferating cells such as tumour cells (Kvamme and Svenneby, 
1961; Kovacevic and Morris, 1972; Regan et a)., 1973) or rapidly 
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dividing normal cells . Glutamine is also consumed rapidly by mouse 
myeloma cells (Roberts et al., 1976), lymphocytes (Ardawi and 
Newsholme, 1982) and hybridomas (Seaver et al., 1984). This 
requirement for glutamine is due In part to the central role that 
glutamine plays in many biosynthetic pathways. Glutamine is the 
amino donor in the synthesis of purines and pyrimidines, amino 
sugars, pyridine nucleotides and asparagine in mammalian cells. Indeed 
it has been shown that the availability of glutamine regulates the 
rate of synthesis of purines and pyrimidines and hence cell growth 
(Fontanelle and Henderson, 1969; Ley and Tobey, 1970; Zetterberg and 
Engstrom, 1981). 
Glutamine carbon has been shown to accumulate as glutamate and 
aspartate with lesser amounts of alanine, pyruvate and lactate in 
lymphocytes (Ardawi and Newsholme, 1982a). Reitzer et al. (1979), 
discovered that lactate was a significant product of glutamine 
metabolism accounting for up to 13% of glutamine carbon in HeLa cells. 
Hybridoma cells produce large amounts of alanine during cell growth 
(Seaver et aL, 1984; Merten. 1986) suggesting that alanine transaminase 
activity is high in these cells and may account for a significant 
proportion of glutamate nitrogen. Figure 1.2 shows the possible fate 
of glutamine in hybridomas. 
There is also considerable evidence to suggest that glutamine 
is an important energy source for animal cells and the appearance 
of large amounts of glutamine carbon as C02 indicates a high rate of 
glutamine oxidation. Lavietes et al. (1974) showed that glutamine 
oxidation accounted for 70 to 80% of oxygen uptake in lymphoma cells 
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and Donnelly and Scheffler (1976) found that the oxidation of 
glutamine could provide 40% of the energy requirements in Chinese 
hamster ovary cells. The work of Reitzer et al. (1979), on HeLa cells 
suggested that in the presence of glucose, glutamine oxidation via the 
TCA cycle provided greater than 50% of the cells energy requirements 
whilst 80% of glucose was converted to lactate and only 5% of glucose 
carbon entered the TCA cycle. Furthermore when glucose was replaced 
by fructose almost all the fructose carbon passed through the pentose 
phosphate cycle and they suggested that glutamine oxidation provided 
98% of the cells energy requirements. However Lazo (1981) has 
suggested that whilst glutamine may be the preferred respiratory 
substrate in many cells, aerobic glycolysis may still provide much of the 
cells energy requirements in rapidly growing cells. 
A number of authors have shown an apparent reciprocal 
regulation of glycolysis and glutamine oxidation. Kvamme and 
Svenneby (1961) noted that glutamine oxidation was inhibited by 
glucose in Erhlich ascites tumour cells and Zielke et al. (1978) found 
that glutamine utilisation in human diploid fibroblasts was regulated 
by glucose concentration and vice versa. A similar phenomenon has 
been noted in hybridomas by Hu et al. (1987) who found an increase in 
glutamine oxidation in low glucose media. Miller et al.. (1989a) have also 
observed that pulse addition of glucose to steady state hybridoma 
cultures leads to a decrease in the glutamine consumption rate and a 
reduced rate of oxygen uptake. They suggested that the increased ATP 
to ADP ratio due to a higher rate of glycolysis was responsible for 
inhibition of oxidation in Krebs cycle. Alternatively, Glacken (1988) has 
postulated that the increased ATP production from glycolysis lowers the 
intracellular phosphate pool which in turn lowers phosphate-regulated 
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glutaminase activity assuming that glutaminase is of the 
phosphate-dependent type as has been suggested for many cultured 
cells (McKeehan, 1986). The mechanisms of this reciprocal regulation 
have yet to be elucidated and the subject is further complicated by 
Ardawl and Newsholme (1982) who showed that glutamine uptake is 
stimulated by glucose in proliferating lymphocytes. However it is 
likely that the changes in these major metabolic pathways will have 
profound effects on energy metabolism and biosynthesis and are thus 
important areas for study when considering the optimisation of antibody 
production in hybridoma cells. 
1.6.4 The effect of Blutamine on antibody production. 
Crawford and Cohen (1985) found that not only was glutamine 
essential for lymphocyte differentiation in vitro but also that 
immunoglobulin synthesis and secretion was considerably enhanced in 
the presence of glutamine. 
The effect of glutamine concentration on antibody 
production by hybridomas has not been extensively studied. Birch et a). 
(1986b) have used a glutamine-limited chemostat culture to study the 
effect of cell growth rate on antibody production. They found that the 
antibody production rate increased slightly with increasing growth 
rate. This may be a result of the increased uptake and presumably 
higher intracellular concentrations of glutamine at high growth rates. 
This may stimulate antibody production which would be consistent with 
Crawford and Cohens observations perhaps by providing a larger amino 
acid pool for protein synthesis. However metabolic data was not 
discussed in Birch et als paper and it is not possible to determine the 
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effects of glutamine on cell metabolism from their data. Hence the 
relationship between glutamine metabolism and antibody production 
remains obscure. Other studies have been concerned with prolonging 
cell viability and reducing ammonia accumulation by feeding glutamine 
(Luan et al.. 1987a, 1987b; Glacken et al., 1986; Reuveny et al., 1986b) 
and although this has led to improved cell yields and hence higher 
antibody titres, the effect of glutamine on the specific production rate 
of antibody has not been investigated. 
It has not yet been determined if the changes in cell metabolic 
pathways associated with different energy sources or cell growth rate 
affect protein synthesis or secretion in hybridomas. Such information 
would facilitate the design of improved media for immunoglobulin 
production and the design of production processes. 
1.6.5 The effect of ammonia on cell growth and antibody production. 
Ammonia is a major product of glutamine metabolism due to 
glutaminase activity. Griffiths & Pirt (1967) found that the 
incorporation of nitrogen into biomass was very inefficient when 
glutamine was present but was almost 100% efficient when cells were 
adapted to grow on glutamate suggesting that glutamine is the main 
source of ammonia in culture media. The rate of glutamate oxidation As 
low (Lazo, 1981) and - it has been suggested that glutamate 
aminotransferases are more important than glutamate dehydrogenase in 
the conversion of glutamate to a-ketoglutarate (Glazer et a!.. 1974; 
Ardawi and Newsholme. 1982; Moreadith and Lehninger, 1984) resulting 
in a more efficient incorporation of nitrogen and lower ammonia levels. 
There is also some evidence that exogenous glutamate is metabolised 
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differently to glutamate derived from glutamine. It appears that 
exogenous glutamate is more likely to be converted to a-ketoglutarate 
by transamination reactions whereas glutamate derived from glutamine 
Is oxidatively deaminated by glutamate dehydrogenase (Borst, 1962; 
Kovacevic, 1971; Schoolwerth and LaNoue, 1980). This may be an effect 
of compartmentation because both glutaminase and glutamate 
dehydrogenase are located within the mitochondrion whereas the 
transaminases are located predominantly in the cytosol. 
The rate of ammonia production is also increased at high 
glutamine concentrations and the controlled feeding of glutamine to 
maintain low levels of ammonia was successfully employed by Glacken 
et al. (1986). 
Ammonia has been shown to inhibit cell growth at levels above 
2mM in several cell lines (Visek et al., 1972; Holley et al., 1978; Butler, 
1985) including hybridoma cells (Reuveny et al., 1986a; Dodge et al., 
1987). Ammonia has also been shown to inhibit the production of viruses 
(Eaton and Scala, 1961; Jensen and Liu, 1961) and interferon (Ito and 
McLimans, 1981) and its inhibitory effect on hybridoma growth is 
reflected in lower antibody titres achieved in media containing high 
levels of ammonia (Reuveny et al., 1986a). Whether the effect Is due to 
inhibition of immunoglobulin synthesis per se or a reflection of a general, 
depression of cell metabolism caused by ammonia has not been 
ascertained but the latter seems more likely. 
1.6.6 Oxygen requirements by cells in culture. 
Animal cells in culture have been reported to have oxygen 
uptake rates of between 0.05 and 0.5 pmoles/106 cells/hour (Fleischaker 
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and Sinskey. 1981). The oxygen uptake rate for hybridoma cells falls 
within this range with a maximum uptake rate of 0.2 pmoles/106 
cells/hour (Boraston et a1.. 1984; Miller eta!.. 1987). The oxygen uptake 
rate also appears to be related to cell growth rate (Katinger. 1987) and 
has been used as an indicator of the metabolic state of cells in 
immobilised cell systems (Lydersen, 1985; Pugh, 1988). However the 
observation that oxygen uptake is inhibited by high glucose 
concentrations (Crabtree, 1929; Frame and Hu, 1984; Glacken et al.. 
1986; Miller et al.. 1988) means that care must be taken when 
correlating oxygen uptake with cell growth rate. 
The optimum oxygen concentration for cell growth varies with cell 
type but is generally about 60% air saturation (Kilburn and Webb, 1968; 
Radlett et al., 1972). A similar optimal concentration of oxygen for 
hybridomas has been noted by some authors (Reuveny et al., 1986a; 
Phillips et al., 1987) whilst Boraston et al. (1984) found little effect on 
growth rate for oxygen concentrations between 8 and 100% air 
saturation. Oxygen concentrations greater than those of atmospheric air 
have been reported to be toxic to mammalian cells (Cooper et al., 1958; 
Brosemer and Rutter, 1961; Mizrahi et al., 1972) although the 
mechanisms for such toxicity have not been elucidated. 
Cell damage by air bubbles has also been reported by a number of 
authors (Telling and Esworth, 1965; Kilburn and Webb, 1968; Radlett et 
al.. 1972; Spier, 1982) which Handa and colleagues (1987) suggest is due 
to the energy dissipation in the region of bubble disengagement. For this 
reason various devices have been described which provide bubble free 
aeration by the use of silicone tubing (Kuhlmann, 1987). porous 
membranes (Lehmann et al.. 1987) or caged aerators (Whiteside and 
Spier. 1985). High concentrations of serum and surface active polymers 
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have been reported to protect cells from bubble damage (Kilburn and 
Webb, 1968; Handa et al., 1987), however Birch and colleagues have 
successfully cultured several cell types (including hybridomas, Rhodes 
and Birch, 1988) in airlift reactors using low protein media and have not 
reported any such cell damage due to bubbles. 
1.6.7 The effect of oxygen on antibody production. 
Mlzrahi and colleagues (1972) studied the effects of oxygen on 
antibody production by a human lymphocyte cell line and found that 
specific antibody, production rates were highest at oxygen 
concentrations which were below the optimum for cell growth. 
Some hybridomas also show a similar phenomenon in that optimal 
growth occurs at 60-60% air saturation whilst optimal antibody 
production occurs at 15-25% air saturation (Reuveny et a1., - 1986a; 
Phillips et al., 1987) and Birch et al. (1985) found that antibody 
production rate was higher at low growth rates in oxygen limited 
chemostat culture. These observations suggest that high oxygen 
concentrations inhibit antibody productiornllowever Miller et al. (1987) 
have studied the effect of oxygen concentration on -antibody 
production by hybridomas at constant growth rate and have 
Indicated that optimal antibody production occurs at 50% air 
saturation which coincides with the highest metabolic quotient for 
oxygen uptake. In addition Bodeker et al. (1987) found that IgM 
production by Immobilised hybridomas was favoured at high oxygen 
consumption rates. It thus appears that the effect of oxygen on antibody 
production Is not an effect of direct inhibition but rather a reflection of 
the balance of cell metabolism at different growth rates. 
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1.6.8 The effect of PH on cell growth and antibody production. 
The effect of pH in animal cell cultures has been measured largely 
in terms of cell growth. Eagle (1973) showed' that in general, normal 
fibroblasts of human or rodent origin favoured a more alkaline 
environment (pH 7.4-7.9) than transformed cells from the same species 
(pH 6.6-7.4) although rodent cells tolerated wider pH ranges. The 
optimum pH range for hybridoma cell growth falls within the lower pH 
range typically between 6.9 and 7.4 (Harbour et al., 1988). 
There have been few reports on the effects of pH on hybridoma cell 
metabolism although Miller et al. (1988a) have observed that the glucose 
consumption rate was lower at pH 6.8 than pH 7.2 whilst oxygen 
consumption remained unaltered at different pH values in chemostat 
culture. Pugh (1988) also found that the rate of oxygen consumption by 
hybridomas was unaffected by pH values between 6.6 and 7.2. Reduced 
glucose consumption at low pH has been noted by other authors working 
with different cell lines (Barton, 1971; Birch and Edwards, 1980). These 
authors also found that there is a reduced rate of conversion of glucose 
to lactate at low pH. a phenomenon which has also been described for 
hybridomas by Luan et al. (1987b). They found that production of 
lactate by hybridomas ceased when the pH had reached 6.8 but by 
adjusting the culture pH to 7.2 lactate production was restored. 
There are also few reports concerned with the effect of pH on antibody 
production by hybridoma cells. However Miller et al. (1988a) have found 
that specific antibody production rates were higher at pH 6.8 than at pH 
7.2. Antibody production rates were also slightly higher at pH 7.7. The 
underlying mechanisms for this phenomenon have not been explained but 
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Miller and colleagues postulated that antibody production may be 
enhanced in stressed cells. However it is also likely that the changes in 
cell growth rate and metabolic activity observed at low pH may favour 
antibody production. The effects of pH on cell growth and antibody 
production require further examination. pH is a readily controllable 
parameter in bioreactors and any effect on antibody production or cell 
growth has important consequences in process optimisation. 
1.6.9 The role of serum in cell growth. 
The use of animal sera to supplement culture media is common 
practice and serum is included typically at concentrations of 6-10%. 
Serum components fulfil a number of defined functions in culture (see for 
example Griffiths, 1986; Maurer, 1986) as shown in table 1.2 and it is 
likely that there are many components in serum which exert stimulatory 
or antagonistic effects in cell culture which are as yet undefined. 
However there is a limited number of serum components which are 
necessary in order to achieve cell proliferation and maintain cell 
viability in the absence of serum. The use of serum free media for the 
cultivation of mammalian cells is the subject of several reviews (Ham 
and McKeehan, 1979; Barnes and Sato, 1980; Waymouth. 1981) and 
recently a review devoted to serum free culture of hybridoma cells has 
been published (Glassy et al.. 1988). The serum components which are 
considered important for the growth of hybridoma cells in serum free 
medium are described below. 
The protein, transferrin is considered to be essential for the 
growth of hybridomas (Chang et al., 1980; Murakaml et al., 1982; Kovar 
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Table 1.2. Defined components and properties of serum. 
Hormaies e. g. insulin 
Growth factors e. g. epidermal growth factor 
fibroblast growth factor 
insulin-like growth factors 
Attachment factors e. g. fibronectin, fetuin 
Transport/carrier proteins e. g. transferrin, albumin 
Nutrients e. g. trace elements, lipids 
keto-acids, amino acids, 
polyamines 
Buffering of pH and redcx e. g. albumin, g1utathione 
Protease inhibitors e. g. 2-macroglobulin 
Mechanical protection e. g. albumin, other proteins 
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and Franek, 1985). The growth stimulatory effect of transferrin appears 
to be due mainly to the transport of iron to cells via specific receptors 
(Aisen and Listowsky, 1980; Trowbridge and Omary, 1981) in that some 
of the effects of transferrin can be reproduced with iron salts or iron 
chelators (Mather and Sato, 1979; Yabe et al., 1987). 
Insulin is also commonly included in serum free media and has a 
number of roles. Insulin stimulates uridine and glucose uptake and the 
synthesis of RNA, protein and lipid (Schubert, 1979) and increased 
incorporation of glucose into fatty acids and glycogen in the presence 
of insulin has been noted (Mather and Sato, 1979; Mather et al., 1981). 
Optimum insulin concentrations of 5-20ug/ml have been reported for 
hybridoma culture (Murakami et al., 1982; Darfler and Insel, 1982; 
Kovar, 1986). 
Ethanolamine was also shown to be important for the growth of 
hybridoma cells in serum free medium as reported by Murakami et al. 
(1982) and supported by the findings of Kovar (1986) and Tharakan and 
Chau (1986). Ethanolamine is thought to be involved in membrane lipid 
synthesis and the presence of ethanolamine has been shown to increase 
phosphatidyl ethanolamine levels in cell membranes (Murakami et al., 
1982). Ethanolamine has also been described as having insulin-like 
activity (Barseghian, 1984), increasing the rate of glucose oxidation and 
lipogenesis although this may be a non-specific membrane effect. 
Albumin is a common component of serum free medium and its 
main function appears to be as a carrier molecule for lipids, although it 
also serves as a carrier for hormones, growth factors and some trace 
minerals (Barnes and Sato, 1980). Albumin may also have a role in the 
detoxification of peroxide (Darfier and Insel, 1982) or excess trace 
elements (Guilbert and Iscove, 1976; Iscove and Melchers, 1978). Most 
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cells can carry out the de novo synthesis of both cholesterol and many 
fatty acids from acetyl CoA (King and Spector, 1981) but will utilise 
lipids from culture media in which case the de novo synthesis of fatty 
acids and cholesterol is suppressed (Jacobs and Majerus, 1973; McGee 
and Spector. 1974; Alberts et al., 1974). 
Selenium is a trace element which is frequently included in 
serum-free media at concentrations of 10-100nm due to its growth 
promoting ability (McKeehan et al., 1976; Guilbert and Iscove, 1976; 
Murakami et al., 1981; Kovar, 1988). It appears that selenium functions 
as a cofactor for glutathione peroxidase which protects cells from 
damage by peroxides (McKeehan et al.. 1976). 
Serum also provides a source of growth factors which have widely 
differing effects on the proliferation of different cell lines (see James 
and Bradshaw, 1984 for review). The presence in serum of trace minerals, 
hormones and a complex pool of metabolites may also enhance cell 
growth. 
1.6.10 The effect of serum on cell growth and antibody production 
The serum requirement by cells is measured typically in terms of 
the extent of cell proliferation or relative cell growth rate. However it 
has been noted that the serum requirement of non-proliferating high 
density cultures such as hollow fibres and perfusion systems is 
considerably reduced (Hopkinson, 1985; Reuveny et al., 1985) which may 
indicate that the serum requirements for cell maintenance are less than 
the requirements for cell proliferation. However it has also been 
suggested that high density cell cultures create a microenvironment in 
which the need for serum factors is reduced possibly due to synthesis of 
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such factors by the cells themselves (Merten, 1987). 
Low serum or serum free media have been used for the growth of 
many hybridoma cell lines (see review by Glassy et al., 1988). Sustained 
growth and antibody production by several hybridoma and myeloma cell 
lines has also been reported using a protein free medium (Cleveland et 
a!., 1983). Many authors have noted an increased specific production 
rate of antibody in serum deficient media in both murine hybridomas 
(Baker et al., 1985; Tharakan and Chau, 1986; Tharakan et al., 1986) 
and human hybridomas (Cole et a!., 1985; Glassy et al., 1987; Glassy, 
1987). A similar phenomenon has also been observed in other lymphoid 
cell cultures (Tanno et al., 1982; Sharath et al., 1984; Glassy et al., 
1987). This has been interpreted by some to suggest that serum contains 
factors which inhibit antibody production (Tharakan and Chau, 1986, 
Glassy et al., 1987) although no evidence of such an inhibition 
mechanism has yet been presented. However in a recent review Glass), 
et al. (1988) have shown that in general, hybridoma and lymphoid 
cultures have lower growth rates in serum free media than in serum 
supplemented media which suggests that immunoglobulin synthesis is 
enhanced in more slowly growing cells. Further work is required in order 
to clarify the relationship between serum and antibody production in 
hybridomas. 
1.7 Cell cycle-related changes in protein expression. 
In the previous section the effects of physiological parameters on 
the production monoclonal antibodies have been discussed and it has 
become apparent that many of the effects may due to the regulation of 
cell growth. This suggests that antibody production may be regulated 
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within the cell division cycle and there is evidence of this in other 
immunoglobulin producing cell lines as will be discussed below. 
The basic model for the cell division cycle is that of Howard and 
Pelc (1953) which divides the cell cycle into four phases characterised 
by the observable processes of DNA synthesis (S phase) and cell mitosis 
(M phase) and the gaps between those processes termed Gi (the gap 
between M and S) and Gz (the gap between S and M). It has been observed 
that under adverse environmental conditions such as nutrient 
starvation, cells tend to arrest in the Gi phase and will not resume cell 
division unless favourable conditions are restored (Ley and Tobey, 1970; 
Brooks, 1975; Melvin et al., 1979; Wynford-Thomas et al., 1985). This 
phenomenon has also been demonstrated in hybridoma cells by the use 
of flow cytometry which shows that the cells accumulate in the Gi phase 
of the cell cycle as they enter the stationary phase (Schliermann et al., 
1987). Pardee (1974) proposed that there is a single point within Gi 
(restriction point) at which cells are more sensitive to arrest but become 
comitted to divide once beyond that point (see also review by Pardee et 
al., 1986). It is now generally accepted that much of the variability in 
the length of cell division cycles is attributable to variations In the 
length of the Gi phase (Pardee et al., 1978) and that the duration of S, 
G2 and M phases are relatively constant. It would therefore follow that 
cell population distributions would vary at different growth rates and 
Indeed population distribution studies of yeast in chemostat culture 
have shown that the proportion of cells in the Gi phase decreases with 
increasing growth rate (Scheper et al., 1987). 
There are a number of proteins whose expression appears to be 
related particular phases of the cell cycle (Milcarek and Zahn, 1978; 
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Bravo and Celis, 1980; Westwood et al.. 1984) and the expression of many 
of these proteins can be related to specific events within the cell 
division process. For example many of the enzymes involved in DNA 
synthesis such as thymidine kinase, dihydrofolate reductase and 
thymidylate synthase are expressed during S phase (Littlefield, 1966; 
Johnson eta!., 1978; Marsani eta!., 1981; Conrad, 1971; Denhardt eta!., 
1986). There is also evidence that the regulation of histone synthesis 
is closely coupled with DNA synthesis (Delisle eta!., 1983; Artishevsky 
et a!., 1984; Schumperli, 1986). Expression of several of the oncogenes 
is also related to specific cell cycle phases and these proteins probably 
have roles in cell growth regulation (Denhardt et al., 1986). 
The expression of other cell cycle related proteins may not be so 
readily linked with cell division processes. For example plasminogen 
activator secretion appears to be associated with the Gz phase in a rat 
adenosarcoma cell line (Scott et al., 1987) and albumin production by rat 
hepatoma cells was greatest during the Gl' phase (Chen and Redman, 
1977). Studies on synchronised populations of various lymphoblastoid 
cell lines have indicated that immunoglobulin synthesis may be 
restricted to the late Gi /early S phase (Buell and Fahey, 1969, 
Takahashi et al., 1969; Lerner and Hodge, 1970; Byars and Kidson, 1970; 
Garatun-Tjeldsto et al., 1976; Turner et al., 1985). Other investigators 
have found either no evidence of cell cycle dependent immunoglobulin 
expression (Cowen and Milstein, 1972; Liberti and Baglioni, 1972; 
Damlani et al.. 1979) or variable levels of expression (Killander et al.. 
1977). It is still not yet clear whether these effects are a result of the 
non-physiological conditions used to synchronise the cells or genuine 
cell-cycle dependent variation in Immunoglobulin expression. However 
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this poses a number of questions in the study of immunoglobulin 
production by hybridoma cells. 
1) Is immunoglobulin production restricted to the Gi phase in 
hybridoma cells? 
2) Could the increased rate of immunoglobulin production seen under 
growth inhibitory conditions be due to accumulation of cells in the G1 
phase? 
3) Could variation in specific immunoglobulin production rate seen in 
chemostat cultures (Birch et al., 1985; Miller et al., 1988) be 
explained by variations in the duration of the Gi phase at different 
growth rates? 
1.8 Summary and objectives. 
The use of animal cells for the production of proteins is receiving 
increasing attention and monoclonal antibodies represent one such 
product with considerable potential in diagnosis, therapy and protein 
purification. The realisation of this potential requires that monoclonal 
antibodies can be produced economically and on a large scale and the 
identification of those parameters which influence antibody production 
by hybridomas is a prerequisite for the optimisation of the antibody 
production process. 
It has become clear that several factors have apparent effects on 
the rate of antibody production in hybridomas but that the underlying 
mechanisms for these effects have not been elucidated. It has been 
observed that some conditions which are suboptimal for cell 
proliferation enhance the specific antibody production rate and studies 
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in chemostat culture have shown that antibody production rates are 
often increased at low growth rates. These observations suggest that 
there is an underlying relationship between cell growth rate and 
antibody production. Whether this is a consequence of the changing 
demands for macromolecular synthesis in rapidly dividing cells, cell 
cycle regulated expression of immunoglobulin as observed in other 
antibody producing cell lines or due to some repression/inhibition type 
control is yet to be determined. The understanding of this relationship 
will have important consequences for process design. 
The aims of this study are therefore to examine the effects of 
environmental factors on hybridoma growth and antibody production. In 
particular the relationship between cell growth, metabolism and 
immunoglobulin production will be addressed In an attempt to determine 
those parameters which can be optimised for an antibody production 
process. 
The study of antibody production kinetics in cultured cells would be 
greatly facilitated by direct on-line monitoring of antibody 
concentrations. Therefore the preliminary obhective of this study was 
to design an automated assay system for the real time determination of 
antibody levels in hybridoma cultures. 
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Chanter 2 
Materials and Methods 
The materials and methods described in this chapter are those 
which are applicable to all of the subsequent chapters. More specific 
experimental procedures will be described in the relevant results 
chapter. 
2.1 Cell culture. 
2.1.1 Cell line. 
The hybridoma cell line used throughout this investigation was an 
NS1 derived mouse-mouse hybridoma, designated 321 which secreted 
IgG to paraquat (Wright et al., 1987). The cell line was a gift from Dr A. 
Wright, Central Toxicology Laboratory, ICI. 
2.1.2 Media 
The hybridoma was routinely cultured in RPMI 1640 (Flow Labs Ltd. ) 
containing 2mM glutamine, 0.2% sodium hydrogen carbonate and 10% 
newborn calf serum (Seralab). Filter sterilised glutamine stock solution 
(200mM) was stored in working aliquots at -200 C. Sodium hydrogen 
carbonate stock solution (8.8%) was autoclaved and stored at 4° C. 
Newborn calf serum was stored in working aliquots at -20° C. 
Antibiotics were not added to culture media. 
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2.1.3 Cell culture. 
Hybridoma, cultures were seeded with 1 or 2x10' cells/ml. Cultures 
seeded with 1x105 cells/ml were passaged after 3 days whilst cultures 
seeded with 2x10° cells/ml were passaged after 2 days. During the 
passaging procedure, cells were harvested by centrifuging at 100xg for 
b minutes and resuspended in fresh medium at 370 C. Cell number was 
determined by diluting aliquots of cells in 0.5% trypan blue in saline 
-and counting in a modified Fuchs-Rosenthal counting chamber. Cells 
which incorporated trypan blue were considered to be non-viable. 
2.1.4 Cryopreservation. 
Cells in early to mid exponential phase i. e. 24 hours after passage, 
were harvested by centrifugation then resuspended at a density of 
lx106 cells/ml in a freezing mixture of 80% RPMI 1640,10% newborn calf 
serum and 10% dimethylsulphoxide (DMSO). Nunc Cryotubes were filled 
with 1.8m1 aliquots of the cell suspension. The cells were then frozen 
at an approximate rate of 1-3° C per minute for 1 hour then 
transferred to the vapour phase of a liquid nitrogen container. The 
initial rate of freezing was controlled by placing ampoules in a 
polystyrene block with walls of approximately 2cm thickness in a 
freezer at -700. 
To check that the cells had been successfully preserved an aliquot 
of cells was removed to check that they could be revived. Cells were 
revived by thawing rapidly in a 370 C water bath. Once thawed the cells 
Were immediately added to 10ml of prewarmed medium and then 
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centrifuged at 100xg for 5 minutes. The cells were then washed in a 
further l Oml of medium to ensure complete removal of DMSO. The cells 
were finally suspended in 10ml of medium in a 25cm2 plastic tissue 
culture flask and incubated in a 370 C incubator with an atmosphere 
containing 5% COz. 
2.2 Assay techniques. 
2.2.1 Glucose determination. 
Glucose concentrations were determined by the o-toluidine test 
based on the procedures of Hyvarinen and Nikila (1962) and Feter 
(1965). and as described in Sigma test bulletin no. 635. 
Samples for glucose assay were centrifuged at 100xg for 5 minutes to 
remove cells and debris and stored at -200 C until required. For the 
assay, 0.1ml of medium was added to 5m1 o-toluidine reagent in a glass 
test tube which was then placed in a boiling water bath for 10 minutes. 
A blank containing 0.1ml water and a standard containing 0.1ml of a 
1mg/ml standard glucose solution were also included. The tubes were 
cooled rapidly to room temperature in cold water before measuring 
the absorbance of the resulting complex at 635nm against the blank. 
The standard glucose sample typically gave an absorbance reading 
of 0.260 ±0.010. 
The assay response was linear for glucose concentrations between 
0 and 2.5 mg/ml and therefore the glucose concentration in mg/ml could 
be determined by dividing the absorbance of the sample by the 
absorbance of the standard and multiplying by the glucose concentration 
of the standard. 
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2.2.2 Lactate determination. 
Lactate concentrations were determined enzymatically by 
monitoring reduction of NAD during the conversion of lactate to 
pyruvate by lactate dehydrogenase. 
a) Reagents. 
1) NAD Grade III from yeast (Sigma) 30mg/ml in distilled water. 
il) Glycine-hydrazine buffer pH 9.0.11.4g glycine + 25m1 hydrazine 
hydrate made up to 300m1 with water. 
iii) Lactate dehydrogenase (LDH) Type X from bovine muscle 1000U/ml 
(Sigma). 
iv) Perchloric acid 8% w/v. 
v) L-lactate standard 0.4mg/ml (Sigma). 
b) Method. 
Samples for lactate determination were centrifuged at 100xg for 
5 minutes to remove cells and debris then deproteinised by the addition 
of lml ice cold perchloric acid to 0.5m1 sample. The samples were kept 
on ice for 20 minutes then centrifuged at 11,600xg for 10 minutes to 
remove the precipitated protein. The deproteinised samples were 
stored at 40 C until required. 
For the assay 200p1 of sample was added to 2.5m1 glycine buffer. 
A blank containing 200p1 perchioric acid and a standard containing 
200p1 of a 0.4mg/ml (4.44 mmoles/1) lactate standard diluted 1/3 In 
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perchloric acid. were also included. NAD (200p1) was then added to 
each tube and the initial absorbance at 340nm of each sample, 
including the blank and standard, was measured against 
glycine-hydrazine buffer. To lml of each sample was then added 25p1 
LDH and all samples were incubated at 370C for 30 minutes. The 
final absorbance at 340nm for each sample was then measured. The 
lactate concentration was proportional to the increase in absorbance 
due to the reduction of NAD during the conversion of lactate to 
pyruvate and was calculated as follows: 
Lactate mmol/1 = (dS-dB) x 7.11 
where dS = difference between initial and final absorbance of the 
sample and dB = difference between initial and final absorbance of the 
blank. 7.11 is a conversion factor based on an absorbance change of 
6.22/mmole NADH and a dilution factor of 44.2. 
The assay results were considered valid if the value for the 
standard was within 5% of the expected value. 
2.2.3 Ammonia determination. 
The ammonia content of the culture medium was determined using 
an EIL ammonia probe model 8002-8 (Kent Instruments). For the assay 
O. lml 1M NaOH was added to 0.9m1 sample and the free ammonia thus 
liberated was detected with the ammonia probe. A calibration curve 
for the probe was constructed using aqueous ammonium chloride 
standards in the range of 10-1 to 10-5 M and samples were read against 
50 
this curve. 
2.2.4 Glutamine determination. 
The glutamine concentration was determined enzymatically by 
monitoring the liberation of ammonia during the deatnination of 
glutamine by glutaminase. 
a) Reagents. 
1) 0.1 M sodium acetate buffer pH 4.9 
11) Glutaminase grade V from Escherichia cola (Sigma) 5U/ml in sodium 
acetate buffer 
b) Method. 
For the assay 450p1 sodium acetate buffer and 50p1 
glutaminase were added to 500p1 sample. Controls were also set up for 
each sample containing 500p1 sample and 500pl sodium acetate 
buffer only. Samples and controls were incubated at 370C for 30 
minutes. The ammonia content of each was measured as described in 
section 2.2.3. The ammonia liberated due to the action of glutaminase 
on glutamine was evaluated by subtracting the ammonia present in 
the controls from the ammonia present in the glutaminase-treated 
samples. Assuming 1 mole of ammonia was liberated from the complete 
breakdown of 1 mole of glutamine the glutamine concentration of each 
sample could therefore be quantified. 
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2.2.5 Antibody determination. 
Antibody concentration in the medium was determined by 
sandwich enzyme-linked Immunosorbent assay (ELISA). Samples for 
ELISA were centrifuged at 100xg for 5 minutes to remove cells and 
debris then stored at -201 C until required. 
a) Reagents. 
1) Wash buffer. Phosphate buffered saline (PBS), pH 7.4 containing 0.1% 
Tween 20. 
ii) Diluent. PBS + 10% newborn calf serum 
ill) Coating buffer. 0.1M sodium carbonate buffer pH 9.6. 
iv) Coating antibody. Sheep anti-mouse IgG (Scottish Antibody 
Production Unit) diluted 1/1000 in coating buffer. 
v) Enzyme-conjugated antibody. Sheep anti-mouse IgG-alkaline 
phosphatase (Seralab) diluted 1/1000 in PBS containing 10% 
newborn calf serum. 
vi) Substrate for alkaline phosphatase. p-Nitrophenyl phosphate 
(Sigma) 1mg/ml in coating buffer. 
vii) Standard antibody. Affinity purified 321 monoclonal antibody 
(see section 2.3). 
b) Method. 
1. Nunc Immunoplates were coated with IOOpI of coating antibody in 
coating buffer and left overnight at 411 C. 
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2. The plates were washed 4 times with wash buffer. 
3. Appropriate dilutions of the samples in diluent were applied to 
the plate at 100jil per well and serial twofold dilutions were 
carried out. The 321 standard antibody was also applied in twofold 
dilutions starting at a dilution of 1/1000 (ipg/ml). 
4. The plates were incubated at room temperature for 2 hours then 
washed 4 times with wash buffer. 
6. A 1/1000 dilution of antibody enzyme conjugate in diluent was 
applied to each well at 100p! per well and incubated for a 
further 2 hours at room temperature. 
6. The plates were washed 4 times with wash buffer. 
7. Enzyme substrate at 1mg/ml In substrate buffer was applied to all 
wells at 100p1 per well. The plates were incubated for 1-1.5 hours 
before reading absorbance at 405nm in a Dynatech MR600 plate 
reader. 
B. Titration curves of the 321 standard and samples were constructed.. 
The antibody concentrations of the samples were calculated from 
the titration curves by dividing the titre of the sample at 50% 
maximum absorbance by the titre of the standard at 50% maximum 
absorbance. 
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2 .3 Purification and characterisation of the 
321 antibody standard. 
2.3.1 Preparation of Paraguat-AH Sepharose affinity column. 
Paraquat propionate (90mg) was dissolved in 2m1 distilled water 
and the pH was adjusted to 4.5.50mg 1-cyclohexyl-3 
-(2-morpholinoethyl)-carbodiimidemetho-p-toluenesulphonate(CMC) 
Was dissolved in lml distilled water and the pH was adjusted to 4.5. The 
paraquat ligand and CMC were added to 16m1 washed and reswollen 
AH-Sepharose (Pharmacia) and mixed by rolling for 18 hours. Another 
26mg CMC was then added and the suspension was mixed for a further 
64 hours before washing with PBS. The paraquat content of the 
washings was assayed by adding 0.5ml to 2.5m1 of fresh 1% sodium 
dithionite in 1M NaOH. The absorbance of the coloured product was 
measured at 600nm. A standard curve for paraquat propionate was 
constructed with standards ranging from 15 to 500pg/ml paraquat 
propionate (figure 2.1). The amount of paraquat ligand bound to the 
column was assessed by subtracting the total paraquat content of the 
washings from the paraquat content of the original solution. The 
coupling solution had been shown to contain 91.6mg paraquat 
propionate by the above assay before mixing with the Sepharose. 
Initial paraquat content of coupling solution 91.5mg 
Total paraquat content of washings 62.6mg 
Amount bound to 16m1 AH-Sepharose 29.0mg 
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Figure 2.1. Standard curve for the determination of paraquat 
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Data provided by Pharmacia indicated that there were between 6 , 
and 
10 pmol of available spacer groups per ml of AH-Sepharose which gave 
between 90 and 150 pmol spacer groups on 15 ml Sepharose to which 
were bound 72pmol of paraquat propionate (molecular weight 403). 
This means that there was between 48 and 80% saturation of the 
available spacer groups. 
2.3.2 Affinity purification of the 321 antibody. 
Spent medium (100ml) from a3 day culture of the 321 hybridoma 
was recirculated through 15m1 of paraquat-AH-Sepharose packed in a 
20m1 syringe. at 0.5m1/minute overnight at 40 C. The column was then 
washed with PBS containing 1M NaCl (pH 7.2) at a flow rate of 
lml/minute until no more protein could be detected in the effluent. The 
column was then washed quickly with PBS containing 0.15M NaCl (pH 
7.2) then eluted with 0.2M glycine-HCI (pH2.5) at a flow rate of 0.6 
ml/minute. The protein content of each 0.5m1 fraction was estimated 
by absorbance at 280nm and those fractions containing significant 
amounts of protein were pooled giving a total volume of 2.5m1 and the 
pH was adjusted to 7.0 by the addition of Tris buffer. The mouse IgG 
content of the pooled fractions was assessed by ELISA as described in 
section 2.2.5 and gave a titre of 1/32,000 at 50% of maximum 
absorbance. 
2.3.3 Determination of the protein content of the Pooled fractions. 
The protein content of the pooled fraction was assessed using the 
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Biorad Protein assay, a modification of Bradfords dye binding assay 
(Bradford 1976). A standard curve was constructed using bovine 
serum albumin (BSA) standards ranging from 0 to l00pg/ml BSA (figure 
2.2). The protein content of the pooled fraction was calculated to be 
1.02mg/ml from the standard curve. 
2.3.4 Assessment of antibody purity by SDS-volyacrylamide gel 
electrophoresis. 
The purity of the protein in the pooled fraction was assessed by 
SDS-polyacrylamide gel electrophoresis using the discontinuous buffer 
system of Laemmli (1970). 
a) Reagents. 
1) Acrylamide stock solution. 30% acrylamide, 0.8% bis-acrylamide 
In distilled water. The solution was filtered and stored in the 
dark at 4" C. 
Ii) Reservoir buffer. 0.025M tris (PH 8.5), 0.05M glycine, 
0.1% SDS. 
iii) Sample buffer. 0.1M tris (pH 8.0), 0.75 mM EDTA. 1% SDS, 20% 
glycerol. For reducing gels. 5% mercaptoethanol was added. 
iv) Stacking gel buffer x4.0.6M tris-HC1 (pH 6.8). 0.4% SDS. 
v) Separating gel buffer x4.1.5M tris-HC1 (pH 8.8). 0.4% SDS. 
vi) Stain. 0.2% Coomassie blue (Sigma) in 95% ethanol. The stain was 
mixed with an equal volume of 20% acetic acid immediately before 
use. 
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Figure 2.2. Standard curve for the determination of protein 
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b) Method. 
A discontinuous gel 1.5mm thick was cast between two glass 
plates. The separation gel (10% acrylamide) was overlaid with ai cm 
depth of stacking gel (5% acrylamide) cast around a comb to form sample 
application wells. 
The cast gel was run in a vertical gel tank with the upper and lower 
reservoirs filled with reservoir buffer. Protein was dissolved in sample 
buffer by boiling for 5 minutes, and loaded onto the gel in the sample 
application wells. A standard mixture comprising proteins of known 
molecular weights (Sigma; SDS-6H) was also loaded. Electrophoresis 
conditions were 40mA constant current for approximately 4 hours at 
room temperature or until the dye front had reached the bottom of the 
gel. 
The gel was released from the plate assembly and stained for 1 
hour. Protein bands were revealed by destaining in several changes of 
10% methanol, 10% acetic acid in water. Destained gels were dried under 
vacuum onto filter paper sheets. Under non-reducing conditions a single 
band at 15OkD was observed and under reducing conditions single bands 
at 50kD and 25kD molecular weight were observed representing heavy 
and light chains (Plate 2.1). 
69 
Plate 2.1. Analysis of the purity of the 321 antibody standard 
polyacrylamide gel electrophoresis 
The plate shows the result of polyacrylamide gel electrophoresis of the 
321 antibody standard under reducing (lane 3) and non-reducing 
conditions (lanes 4 and 5). Lane 2 shows spent medium from the 321 
hybridoma before affinity chromatography. Lane 1 shows molecular 
weight standard marker mixture (Sigma SDS-6H) comprising 
ß-galactosidase (mw 116kD), phosphorylase b (mw 97kD), bovine 
albumin (mw 66kD). egg albumin (mw 45kD) and carbonic anhydrase (mw 
29kD). 
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2.3.5 Assessment of antibody purity by high performance liquid 
chromatography. 
The purity of the antibody was also assessed by high 
performance liquid chromatography (HPLC). A TSK 4000 column was 
equilibrated in O. 1M sodium phosphate buffer pH 6.8. Samples were 
injected through a 20p1 loop at a flow rate of lml/minute and 
absorbance at 280nm was measured with a Beckman detector and 
recorded by a BBC microcomputer. Figure 2.2 shows absorbance traces 
of the purified protein sample and the protein standards (molecular 
weight markers for gel filtration; Sigma MW-GF-200) used to calibrate 
the column. Integration of the relative peak areas showed that the 
l5OkD peak represented 90% of the protein. 
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Figure 2.3. HPLC analysis of the purified 321 antibody 
20111 samples containing approximately 10pg of protein were loaded In 
each case. Absorbance profiles and retention times (Rt) are shown for 
the purified 321 antibody standard and for standard protein solutions 
of known molecular weight. The detector sensitivity was set to a full 
scale deflection of 0.1 absorbance units. 
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Chapter 3 
The Automated Assay System 
3.1 Requirements for an automated assay system. 
The optimisation of a cell culture system requires that regular and 
precise measurements of process variables can be made and that these 
measurements can be applied to control of the process. Whilst 
parameters such as pH and oxygen concentrations can be readily 
measured and controlled in bioreactors (Harris and Spier, 1985), the 
detection and quantification of proteins and other macromolecular 
products requires off-line assays which often precludes the direct 
control of their production. The initial aim of this project therefore, was 
to develop a system for the automated on-line quantification of 
monoclonal antibody concentration In bloreactors and to apply the 
system to the identification of parameters which Influence antibody 
production by hybridomas. 
In order to be effective as a monitoring system for antibody 
production in fermenters the system must fulfil three main 
requirements. 
i) Sensitivity. The assay must be sufficiently sensitive to detect small 
changes in antibody concentration over the concentration range seen in 
a typical culture. This may vary from 1-1000pg/ml depending on the 
hybridoma line and the process intensity. 
ii) Reproducibility. The assay should give accurate and reproducible 
results because it will not be possible to replicate samples in a 
dynamic process. 
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iii) Reliability. The monitoring of product formation in bloreactors 
requires that the automated assay will run reliably for several days or 
weeks. 
3.1.1 Methods for the monitoring of product formation in bloreactors. 
High performance liquid chromatography (HPLC) and fast protein 
liquid chromatography (FPLC) are both fast and reproducible methods 
-for the separation and quantification of protein and because they 
work on a flow through basis they can be readily automated. The main 
disadvantages of such systems are that they are expensive for use In 
a dedicated monitoring system and the identity of the protein is 
assumed by its retention time and may be confused with molecular 
species with similar retention times. 
A direct sensing device would represent the ideal situation whereby 
the device would generate a detectable signal only on contact with 
the desired molecule. In reality the device has to be sensitised with a 
highly specific mediator which will convert the analyte into a product 
whose activity can be determined by more conventional sensors . such 
as ion selective probes or conductimetric, thermometric or light 
sensitive devices. 
Enzymes have received considerable attention as mediators due to 
the specificity of their catalytic activity and the ability of the 
appropriate enzyme to generate detectable moieties from its interaction 
with the analyte. The most common example of this type of sensor is the 
enzyme electrode where enzyme is bound directly to the porous 
membrane of an electrode. The probe is selective for ions generated 
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by the specific interaction of the enzyme with its substrate and because 
the reaction takes place in the immediate vicinity of the probe it is a 
highly sensitive system. A typical example of this type of probe is an 
enzyme pH electrode to detect glucose by immobilised glucose 
oxidase (Nilsson et al., 1972). 
However the use of enzymes is limited because it is necessary to 
have a well . characterised enzyme-substrate 
interaction which will 
also elicit a detectable response. Such enzymes are readily available 
for simple molecules such as glucose or amino acids but more 
complex or novel molecules present considerable difficulties in the 
Identification and characterisation of an enzyme system. 
An alternative to the enzyme is the use of specific antibodies 
to capture the analyte. This in itself will not generate a detectable 
response for conventional probes, although research is progressing 
into the use of direct sensing devices such as sensitised- piezo 
electric crystals (Roedere and Bastiaans, 1983) or antibodies bound 
to fibre optics (Sutherland et al., 1984) which will directly detect 
antibody antigen interactions. It is therefore necessary to introduce 
a second component into the assay. This, could be either labelled 
antigen in a competitive assay or labelled second antibody in a 
sandwich assay. The labels could be isotopic, fluorescent or enzymic 
in nature making the assay analogous to the solid phase immunoassay 
which is widely used in research and clinical applications. The main 
limitation with conventional solid-phase assays is In the time 
required for the assay due to the small available surface area and 
long diffusion distances encountered in the tubes or microwell plates 
which are generally used. The use of a suspension of small 
particles as the solid phase in ELISA provides a much greater surface 
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area for a given volume of fluid and allows more rapid interactions 
between free and surface-bound molecules. Sepharose appears well 
suited as a solid phase with a small particle size of less than 100um and 
a well characterised surface chemistry allowing the covalent coupling 
of proteins. Sepharose beads formed the basis of the ELISA devised by 
Engvall and Perlman (1971). Washing stages however required 
the separation of beads from the suspension at each stage making the 
process difficult to automate although an automated ELISA using 
membrane separation of the beads during washing has been developed 
(Ismail et al., 1981). 
The use of a packed bed of Sepharose would eliminate the need 
for the separation of Sepharose from the reactants in that the bed 
could be perfused sequentially with the reactants and wash buffers 
and would facilitate automation. Such systems have been used for the 
assay of protein molecules, for example Mattfasson et al. (1977) used 
anti-human albumin antibody bound to Sepharose in a competitive 
ELISA for human albumin. Bound enzyme-antibody conjugate was 
quantified using a thermistor to detect the heat generated from the 
enzyme reaction with a substrate. They were able to repeatedly 
regenerate the bed (>30 times) in order to assay further samples. 
In addition Preston and Spier (unpublished results) demonstrated 
the feasibility of a sandwich ELISA with Sepharose-bound antibody 
for the detection of foot and mouth disease virus antigen on a 
continuous basis. 
The initial part of this investigation was to modify and develop this 
type of assay with the aim of producing a fully automated ELISA for 
the detection of monoclonal antibody in culture. For the purposes of 
the assay a colorimetric determination of enzyme activity was adopted 
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as a simple detection system which could be readily automated. In the 
system of Preston and Spier peroxidase-labelled second antibody was 
used to develop the chromogen whereas in this study the use of 
alkaline phosphatase was adopted due to the greater stability of the 
substrate (p-nitrophenyl phosphate). 
3.2 Immunosorbent preparation. 
3.2.1 Preparation of IgG fraction from sheep serum. 
Sheep anti-mouse immunoglobulin was obtained from the 
Scottish Antibody Production Unit. The IgG fraction was prepared by 
anion exchange chromatography as follows. 
Washed DE52 cellulose (Whatman) was poured into a 2.6 cm 
diameter glass column to a bed height of 30cm. The column was then 
equilibrated overnight against 0.0175M sodium phosphate buffer 
pH6.4. A lOml aliquot of sheep anti-mouse serum was dialysed 
against the same buffer overnight. The serum was then centrifuged at 
1800xg for 10 minutes to remove any precipitate and the clarified serum 
was pipetted directly onto the surface of the column bed. The bed was 
then eluted with sodium phosphate buffer at a flow rate of 
iml/minute and 2m1 fractions were collected. The, absorbance at 
280nm of the column effluent was monitored using a imm pathlength 
flow cell (LKB) in an LKB Ultrospec spectrophotometer. The data was 
recorded using a BBC microcomputer connected - via the RS232 
port of the spectrophotometer: The absorbance of a 1mg/ml solution 
of IgG was taken as 0.14 for a 1mm pathlength flowcell. Under these 
conditions the IgG fraction of the serum eluted at the void volume 
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of the column whilst other serum proteins were retained. Bound 
proteins were desorbed with 0.4M sodium phosphate buffer (pH 6.8) and 
the column was then re-equilibrated in 0.0175M phosphate buffer as 
above. 
The mouse immunoglobulin-specific titre of each fraction was 
assessed by competitive ELISA. Each fraction was titrated against 
mouse IgG with alkaline phosphatase-labelled anti-mouse IgG as the 
competing antibody. Figure 3.1 shows the recorded absorbance and the 
mouse immunoglobulin specific antibody titre of the collected 
fractions. 
Those fractions showing anti-mouse immunoglobulin activity were 
assessed for purity by SDS-polyacrylamide electrophoresis. Plate 3.1 
shows a non-reducing gel of the IgG fraction from the ion exchange 
column. Essentially all proteins have been removed except for a protein 
band at 150kD corresponding to immunoglobulin. The bands visible at 
5OkD and 25kD suggest that there was some degradation to the heavy 
and light chain components of IgG. 
3.2.2 Coupling antibody to Sepharose CL4B. 
Immunoglobulin was bound to Sepharose CL4B by a modification of 
the periodate oxidation method of Wilson and Nakane (1976). 
The required amount of Sepharose was washed with distilled 
deionised water to remove preservatives and fine particles. The 
Washed Sepharose was added to 100 mg/ml aqueous sodium periodate 
solution and mixed gently for three hours at room temperature. The 
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Figure 3.1. Purification of the IgG fraction of sheep anti-mouse serum 
using anion exchange chromatography. 
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The figure shows the elution profile obtained from a DEAE ion exchange 
column loaded with 10ml sheep serum and eluted using 1r . 5mM sodium 
phosphate buffer (pH6.4). 
Anti-mouse immunoglobulin titre as determined by 
competitive ELISA. 
Absorbance at 280nm. 0.1cm path length. 
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Plate 3.1 PAGE analysis of the protein fractions obtained from the DEAE 
cellulose column 
The plate shows the result of PAGE analysis of fractions obtained by 
anion exchange chromatography of sheep anti-mouse IgG serum. Lanes 
1-5 show fractions obtained from the DEAE cellulose column 
corresponding to the major protein peak as shown in figure 3.1. Lane 6 
shows dialysed sheep serum before fractionation and lane 7 shows 
molecular weight standard marker mixture (Sigma SDS-6H) comprising 
myosin (mw 205kD), ß-galactosidase (mw 116kD), phosphorylase b (mw 
97kD), bovine albumin (mw 66kD), egg albumin (mw 45kD) and carbonic 
anhydrase (mw 29kD). 
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gel was then washed quickly with saline, followed by 10% aqueous 
ethanediol and finally coupling buffer (0.1M carbonate buffer pH9.5). 
A 1mg/ml solution of immunoglobulin in coupling buffer was added to 
the activated Sepharose at a ratio of 5m1 per gram dry weight of 
Sepharose and the suspension was mixed gently overnight at 40 C. After 
coupling, any remaining aldehyde groups were reduced with 
sodium borohydride. This also served to stabilise the Schiff bases 
formed during coupling and made the matrix less prone to leakage of 
antibody. The amount of antibody coupled by this procedure was 
assessed' by subtracting the amount of protein remaining in solution 
from the initial concentration before coupling. 
The gel was finally washed with copious quantities of phosphate 
buffered saline (PBS, pH7.2) and stored in PBS+0.01 % thimerosal 
(Sigma) until required. 
3.2.3 Assessment of the Immunosorbent In the ELISA. 
Conditioned medium from a 48 hour culture of the 321 hybridoma was 
used as a source of mononclonal antibody. The medium was assayed by 
conventional ELISA (see section 2.2.5) using purified 321 antibody as a 
standard and was found to contain 100pg/ml of IgG. The medium was 
stored at- -2011 C in 5m1 aliquots and was used throughout the 
characterisation of the immunosorbent. 
Conditioned medium was diluted from neat to 1/10.000 in fresh 
growth medium. A 60p1 aliquot of packed immunosorbent beads was 
added to 1.5m1 centrifuge tubes containing iml aliquots of each 
medium dilution and a medium control of fresh medium only. The tubes 
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were mixed by rolling for 1 hour at room temperature. The 
beads were washed twice with Iml aliquots of PBS containing 0.1% 
Tween20. An appropriate dilution of alkaline phosphatase labelled 
sheep anti-mouse IgG In PBS was added to each tube and mixed for a 
further hour. The beads were washed again with PBS Tween then 0.5m1 
of a 1mg/ml solution of p-nitrophenyl phosphate in 0.1M carbonate 
buffer pH9.5 was added to each tube. The tubes were then mixed for 
30 minutes to allow the colour to develop. After centrifuging, 100p1 
samples from each tube were transferred to a microtitre plate and the 
absorbance at 405nm read with a Dynatech plate reader. 
To ensure that the effects were not due to nonspecific 
interaction on the Sepharose two control experiments were also set 
up. The first control was normal sheep serum bound to Sepharose by 
the same method and the second was similarly treated Sepharose but 
with no bound protein. Figure'3.2 shows absorbance readings obtained 
for each experiment. 
It was apparent that there was a significant increase In 
absorbance with increasing monoclonal antibody concentration for the 
sheep anti-mouse immunosorbent. The assay was sensitive to a 
concentration of 100ng/ml of antibody but the absorbance fell again 
at high concentration indicating that the column had become saturated 
with mouse monoclonal antibody. The controls showed no increase in 
absorbance with increasing monoclonal antibody concentration 
indicating that there was little non-specific interaction with the 
Sepharose. 
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Figure 3.2. ELISA using anti-mouse IgG bound to Sepharose as the solid 
phase 
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The figure shows the absorbance obtained at 410nm for diluted medium 
samples containing 0.001-100pg 321 antibody/ml. 
0 Sepharose with immobilised anti-mouse IgG. 
Sepharose with immobilised normal sheep serum. 
0 Sepharose without bound protein. 
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3.2.4 Continuous flow ELISA. 
The use of Sepharose with covalently bound sheep anti-mouse 
Immunoglobulin for ELISA has been demonstrated in tubes and it was 
necessary to demonstrate that the ELISA could be run on a continuous 
flow principle using a packed bed of immunosorbent beads. 
Initial experiments were carried out with a 3mm id x 100mm glass 
column (Omnifit Ltd) with a bed volume of 600p1. The column was filled 
with immunosorbent and equilibrated with phosphate buffered saline 
(pH7.2). The flow rate through the column was maintained at 
0.25m1/minute by a Gilson peristaltic pump. Samples were injected onto 
the column using a iml loop accessed via a 3-way valve (figure 3.3) and 
were washed through with 2m1 PBS. Alkaline phosphatase labelled 
anti-mouse IgG was then introduced through the sample loop 
followed by a further wash of PBS. ' Finally p-nitrophenyl 
phosphate was injected through the sample loop and allowed to react 
on the column for 10 minutes. The reacted substrate was then passed 
through a flow cell (1mm pathlength) in an LKB Ultrospec 
spectrophotometer and absorbance readings were recorded at 10 
second intervals. In the initial experiments the column was 
regenerated with a 2ml wash with 3M sodium thiocyanate between 
samples. 
Dilutions of conditioned medium samples were assayed using the 
continuous flow ELISA. Figure 3.4 shows a typical set of data from 
the ELISA and figure 3.5 shows peak area plotted against antibody 
concentration for the same data. The assay was sensitive to 
concentrations of 321 antibody between 1 and 100 jig/ml and although 
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Figure 3.3 The continuous flow ELISA system 
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Spectrophotometer Buffer 
Figure 3.4. Absorbance traces for the continuous flow ELISA 
The absorbance traces were obtained using the continuous flow ELISA 
for the assay of diluted medium samples containing a)1001ig, b)1011g, 
c)111g, d)O. lpg 321 antibody and e) a medium control without antibody. 
The assay was performed using a 3mm ID glass column containing 600u1 
Sepharose with 4.5mg Immobilised anti-mouse IgG/g Sepharose. 
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Figure 3.5. Assay of medium samples using the continuous flow ELISA 
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The ELISA curve was obtained using the continuous flow ELISA for 
diluted medium samples containing 0-100lig/ml 321 antibody. The assay 
was performed using a 3mm ID glass column containing 600µl Sepharose 
with 4.5mg Immobilised anti-mouse IgG/g Sepharose. Each point 
represents the area of the substrate peak measured for each sample. 
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the background absorbance was considerably higher than that found 
with the tube assay it served to demonstrate that the assay could be 
performed on the column. 
3.3 The automated assay. 
Having demonstrated the feasibility of a continuous flow ELISA 
it was possible to develop a fully automated system operated by 
computer. A BBC microcomputer was adopted for operation of the 
assay because the BBC lends itself well to the input/output operations 
required for the assay and because software for the control of the 
LKB spectrophotometer had already been developed and could be 
readily modified for the purposes of the automated assay (see section 
3.3.1). 
The system designed (figure 3.6) utilised 12v miniature solenoid 
valves (Lee Engineering) to actuate the various additions of 
reagents and a peristaltic pump (Gilson) to determine the flow rate. 
A sample loop ensured that a constant volume of sample was added in 
each assay cycle whilst all other reagents were added by a timed 
sequence at constant flow rate. 
The solenoid valves were operated by the computer via an 
interface which provides a 12 volt power supply in response to a +b 
volt signal from the computer. The interface was designed and built by 
Karel Newman, Department of Microbiology. University of Surrey (see 
Appendix I). 
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Figure 3.6. Schematic diagram of the automated continuous flow ELISA 
system 
Key to numbered parts. 
1) Reservoir containing phosphate buffered saline. 
2) Sample loop. 
3) Reservoir containing alkaline phosphatase-labelled anti-mouse IgG. 
4) Reservoir containing p-nitrophenyl phosphate solution (lmg; ml). 
5) Reservoir containing the column regenerating buffer (see text for 
details). 
6) Immunosorbent column containing Sepharose with immobilised 
anti-mouse IgG. 
7) Spectrophotometer. 
8) BBC microcomputer. 
9) RS232 interface. 
10) Sample injection point. 
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3.3.1 Computer operation of the assay. 
The BBC microcomputer was programmed in BBC basic. The 
program is listed in Appendix II. The timed control of the solenoid 
valves was made by reference to the computers internal clock. The 
clock was set to zero at the beginning of the assay and was referred 
to constantly to provide a record of elapsed time. The solenoid 
valves were operated via the 8 bit input/output port (user port). 
The user port is memory mapped by the 6622 VIA (versatile Interface 
adapter) and switching of any of the 8 lines was achieved by writing 
to the user port memory area designated SHEILA. This is achieved 
using an operating system byte (OSBYTE) call with the A register 
containing &FFF4 (write to memory) and the x and y registers 
containing the address and the byte to be written respectively. Each 
of the 8 output lines operated one valve so all of the 8 valves were 
operated independently. 
The computer also controlled the LKB spectrophotometer via the 
RS232 serial data interface and data was sent back to the computer by 
the same route. When coloured substrate was passed through the flow 
cell in the spectrophotometer the absorbance was recorded by the 
computer at 5 second intervals. This data was stored until all 
readings had been taken then the computer calculated the area of the 
substrate peak and stored the result on disc with the time of the 
reading. The VDU screen displayed a graph of substrate peak area 
against time which was updated each time an assay cycle was 
completed. Because all data was stored on disc it was possible to 
retrieve and display data from previous runs. 
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3.3.2 Sequence of events during the automated assay. 
1) Sample was drawn from the sample reservoir into a lml sample 
loop. Buffer already in the loop was run to waste until the 
loop contained the sample only. 
ii) The sample was run onto the Immunosorbent column followed by 
PBS which flushed the sample loop. The column was washed with 
3m1 of PBS to remove any unbound material. Mouse monoclonal 
antibody in the sample was bound by the immunosorbent column. 
iii) Alkaline phosphatase labelled anti-mouse IgG was then run 
onto the column. Anti-mouse IgG will bind to any mouse 
monoclonal antibody on the column. 
iv) The column was washed with a further 3m1 of PBS. 
v) Enzyme substrate (p-nitrophenyl phosphate) was then run onto 
the column. 
vi) The flow through the column was stopped and the substrate 
allowed to react for 10 minutes. 
vii) Reacted substrate was washed off the column through a flow 
cell in the LKB spectrophotometer. 
viii) The column was regenerated by eluting the antibody complex. 
ix) The column was washed with 3m1 PBS before the next sample was 
applied. 
The entire assay was carried out at a flow rate of 
0.3m1/minute. The valve sequence was designed so that the 
peristaltic pump was operating continuously eliminating the need for 
a second interface to control the pump. This also alleviated power 
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spikes caused by the switching of high Inductive loads such as pumps. 
The RS232 interface had been found to be sensitive to power spikes on 
previous occasions but in the configuration described there were no 
instances of program failure. 
3.4 Optimisation of the automated assay. 
3.4.1 Determination of the optimum labelled antibody dilution. 
The optimum antibody dilution for alkaline phosphatase labelled 
anti-mouse IgG was determined by comparing absorbance values for 
medium containing 100ug/ml 321 antibody with fresh medium 
containing no antibody for a range of dilutions of labelled antibody. 
The optimum dilution was considered to be that which produced the 
greatest ratio between background and sample readings. 
Figure 3.7 shows background absorbance levels for labelled 
antibody dilutions between 1/250 and 1/2000. Labelled antibody 
dilutions of 1/750 and 1/1000 gave the lowest background level and 
1/1000 was used as the optimum dilution in subsequent experiments. 
3.4.2 Buffer composition. 
The high background absorbance observed In the automated ELISA 
was initially thought to be due to insufficient washing of the 
immunosorbent. Increasing washing times with PBS between the various 
additions of reagents did not significantly reduce the background 
level. The inclusion of 0.1% Tween 20 in the wash buffer reduced 
the background absorbance only slightly. The use of high ionic 
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Figure 3.7. Determination of the optimal enzyme-labelled second 
antibody dilution 
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The assay was performed using a 6mm ID glass column containing 500{1 
Sepharose with 4.5mg immobilised anti-mouse IgG/g dry weight 
Sepharose. The bars represent the substrate-peak area measured at 
405nm for fresh medium without antibody expressed as a percentage of 
the peak area obtained for a sample containing 100ug 321 antibody. The 
background absorbance levels were compared for a range of dilutions of 
the enzyme-labelled second antibody. 
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strength buffers with 0.5M salt reduced overall absorbance readings 
but the ratio between background absorbance and sample readings was 
not greatly increased. 
It appeared that the nature of the background seen In the column 
ELISA was not due to non-specific binding of antibody nor was it due 
to insufficient washing of the Immunosorbent. It had been shown 
previously that there was little non-specific interaction with 
Sepharose in the tube experiments (Section 3.2.3). It was observed 
however that the background level in the first assay cycle was 
considerably lower than in subsequent cycles. This would suggest 
that one or more of the assay components was not being fully eluted 
from the column by the use of 3M sodium thiocyanate. In order to 
determine which of the assay components was not being fully eluted a 
fresh immunosorbent column was used. 
Absorbance values for the following reagent combinations were 
recorded on two successive assay cycles. 
1. Substrate only. 
2. Labelled antibody and substrate. 
3.100pg 321 antibody, labelled antibody and substrate. 
Figure 3.8 shows absorbance values for each step. 
The background due to substrate alone did not increase on the 
second cycle indicating that the labelled antibody was being fully 
eluted. However the background due to labelled antibody + substrate 
was considerably higher on the second cycle than on the first implying 
that the 321 monoclonal antibody was not being completely eluted 
from the column. The sample absorbance was similar on successive 
cycles. 
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Figure 3.8. Determination of the nature of the high background levels 
observed in the continuous-flow ELISA 
The assay was performed using a 6mm ID glass column containing 500it1 
Sepharose with 4.5mg immobilised anti-mouse IgG/g dry weight 
Sepharose. The bars represent the substrate peak area measured at 
405nm. The background levels for freshly prepared Sepharose (bars A. 
B and C) were compared with the background levels for Sepharose In the 
second assay cycle (D, E and F). 
A and D Substrate only 
B and E Enzyme labelled second antibody + substrate 
C and F 100pg 321 antibody + enzyme labelled second antibody + 
substrate. 
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The computer program was modified to determine whether increased 
elution time resulted, in more antibody being eluted from the 
immunosorbent column. The percentage background was assessed for 
medium containing 100µg/ml 321 antibody after elution cycles of 
varying duration. However it was found that increased elution time 
had no effect on the amount of antibody desorbed from the column 
(figure 3.9). 
Other agents were investigated for their effectiveness in eluting 
bound antibody from the column. Glycine-HC1 (0.2M, pH 2.5) is 
commonly used for the desorption of proteins in affinity 
purification but it was found to be only slightly more effective 
than 3M sodium thiocyanate (figure 3.10). The use of 0.5M acetic acid 
was recommended by Smith et al. (1977) as being more effective than 
chaotropic agents in the elution of bound antigens whilst Janatova 
and Gobel (1984) advocate the use of 1M acetic acid. The effectiveness 
of acetic acid for column regeneration and its effect on column stability 
were investigated. The use of 1M acetic acid was found to be most 
effective in desorbing antibody (figure 3.10) reducing background 
readings to 20-25% of the 100ug/ml sample reading. Furthermore, 1M 
acetic acid did not have any immediate deleterious effects on the 
stability of the immunosorbent because the substrate peak area for 
100pg 321 antibody remained the same over a period of 24 hours (figure 
3.11). 
Molar acetic acid was therefore used as an eluting agent for the 
automated ELISA. All other conditions were as described previously 
with the exception that 0.1% Tween 20 was included in the wash 
buffer to prevent any accumulation of protein on the valve surfaces. 
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Figure 3.9. The effect of increasing the volume of 3M sodium thiocyanate 
used to elute bound antibody. 
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The assay was performed using a 6mm ID glass column containing 500µ1 
Sepharose with 3.9mg immobilised anti-mouse IgG/g dry weight 
Sepharose. The volume of 3M NaSCN used to elute the bound antibody 
complex was Increased during successive assay cycles. The points 
represent the substrate peak area measured at 405nm for fresh medium 
without antibody expressed as a percentage of the peak area obtained 
for a sample containing 10011g 321 antibody. 
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Figure 3.10. Assessment of the effectiveness of different elution buffers 
The assay was performed using a 6mm ID glass column containing 500$11 
Sepharose with 3.9mg immobilised anti-mouse IgG/g dry weight 
Sepharose. The bars represent substrate peak areas recorded for medium 
samples containing 100ug 321 antibody and medium samples containing 
no antibody (hatched bars). Each bar is the average of two readings 
obtained in successive assay cycles using the following elution buffers: 
A 3M sodium thiocyanate 
B 0.2M glycine/HC1 pH 2.5 
C 0.5: ß1 acetic acid 
D iM acetic acid 
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Figure 3.11. The effect of different elution buffers on the assay stability 
The assay was performed using a 6mm ID glass column containing 5O0µ1 
Sepharose with 4.5mg immobilised anti-mouse IgGig dry weight 
Sepharose. Each set of data points represents the peak area at 405nm 
recorded over a 24 hour period for a medium sample containing 100pg/ml 
321 antibody. 
Elution buffer 
O 3M NaSCN 
p 0.5bi acetic acid 
Q 1M acetic acid 
96 
Figure 311 
3 
9 
CD 
4J 
c0 
cu 
Q_ 
1 
oý 
0 
97 
5 10 15 20 25 
Time -- (hours) 
3.5 Assay performance. 
To assess the usefulness of the assay for the detection of 
monoclonal antibody in culture supernatant a standard curve was 
constructed by assaying increasing concentrations of the 321 
monoclonal antibody over a period of 36 hours. 
A 100ml gradient mixer (Biorad) was used for the experiment with 
the starting buffer consisting of fresh medium and the limiting 
buffer consisting of conditioned medium diluted to contain 100pg/ml 
of 321 antibody. As samples of constant volume were drawn from the 
reservoir, the Increase in antibody concentration could be calculated. 
The experiment was left to run automatically for 36 hours and 
absorbance readings were plotted against concentration on 
completion of the run. Figure 3.12 shows a typical antibody 
concentration curve obtained with the automated ELISA. The plot of 
antibody concentration against absorbance was linear over the range 
of 5-100pg/ml of monoclonal antibody and analysis of the curve by 
linear regression gave a correlation coefficient of 0.99. 
The reproducibility of the automated assay was assessed by 
repeated determinations of antibody In two samples containing 25 and 
100pg/ml respectively. The samples were assayed alternately with 6 
replicates for each sample. 
Table 3.1 shows absorbance readings for samples of medium 
containing 25 and 1001jg/ml. These readings corresponded to 28 and 
92pg/ml as calculated from the standard curve above. 
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Figure 3.12. Standard curve for the continuous flow ELISA 
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The assay was performed using a 6mm ID glass column containing 500µ1 
Sepharose with 4.5mg immobilised anti-mouse IgG/g dry weight 
Sepharose. The curve represents the substrate peak area recorded for 
each sample plotted against the calculated antibody concentration for 
that sample. 
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Table 3.1 Reproducibility of the automated ELISA 
Determination Peak area 
321 Antibody Baseline 
25}ßg/ml 100}ßg/ml 
1 1.21 2.06 0.75 
2 1.23 2.05 0.81 
3 1.20 2.03 0.78 
4 1.25 1.99 0.72 
5 1.23 1.99 074 
6 1.30 2.08 0.74 
Mean 1.24 2.03 0.76 
Standard 0.036 0.037 0.035 
deviation 
100 
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3.6 The use of the automated ELISA for monitoring bioreactors. 
The principle of using an immunosorbent column for automated 
ELISA has been demonstrated under experimental conditions. The 
reproducibility of the assay was comparable to a conventional plate 
ELISA with a coefficient of variation of less than 6% for a limited 
number of samples. The sensitivity of the assay was limited by time 
and sample size but would detect paräquat antibody to bug/ml In 
the configuration described. Greater sensitivity could be obtained by 
increasing the sample size but this caused column saturation at the 
higher antibody concentrations seen in late batch cultures of the 321 
hybridoma. 
When the assay was applied to monitoring of bloreactors however, 
a number of problems were encountered. 
3.6.1 Column comoresslon. 
After prolonged use the column packing became compressed. This 
typically, occured between 36 and 48 hours resulting in a reduction 
of flow rate and a consequent loss of accuracy and reproducibility. It 
was also found that the packing was Irreversible In that the 
Immunosorbent could not be readily redispersed within the column. 
Reversing the direction of buffer flow through the column merely caused 
the compacted plug of Sepharose to move down the column without 
dispersing. Several attempts were made to alleviate the compression 
of the immunosorbent. 
i) Immunosorbent column dimensions. The dimensions of the column were 
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a compromise between the speed and sensitivity of the assay. The 
immunosorbent volume was kept to a minimum to allow a rapid assay 
and economical use of reagents. The sensitivity of the assay dictated 
the minimum volume of immunosorbent that could be used. 
By increasing the cross-sectional area of the column whilst 
maintaining the same bed volume, the pressure drop through the bed 
could be reduced which In turn reduces the compression of the 
immunosorbent. In early experiments a 3mm ID xlOOmm column which 
held 6001i1 of immunosorbent was used. The maximum flow rate that 
could be achieved was 0.3m1/minute but such flow rates caused rapid 
compression of the column packing and increased back pressure. In 
an attempt to improve the flow characteristics of the column a 6mm ID 
glass column was adopted. With 500p1 of immunosorbent the flow rate 
could be maintained for longer periods of time but compression of the 
Immunosorbent still occured after approximately 3 days. It was not 
possible to increase the column diameter further without increasing 
the volume of Immunosorbent and increasing the assay time. 
11) Flow rate. Reducing the flow rate through the column would also 
serve to reduce compaction of the Immunosorbent. However a 
reduction in the flow rate increases the time required for the assay 
of a single sample. A cycle of the assay takes 76 minutes at a flow 
rate of 0.3ml/minute and the need to check baseline and standard 
samples at regular intervals increases the time between samples to 
approximately 2 hours. 
iii) Direction of buffer flow. All reagents and buffers were routinely run 
upwards through the Sepharose bed in an attempt to alleviate 
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compression due to gravity. This had very little effect at the flow 
rates required for the assay as these were considerably more than the 
settling velocity of the Sepharose. Reversing the direction of buffer 
flow by inverting the column at regular intervals did not alleviate 
the problem of column packing. 
iv) Solid phase. The problems encountered were largely due to the 
compressible nature of the Sepharose which was being used as the solid 
phase. It would therefore appear that a more rigid and less cohesive 
solid phase would overcome these problems. The use of a rigid particle 
would also allow the assay to carried out more rapidly. 
Preliminary experiments with silanised porous glass as a solid 
phase were carried out. The activated porous glass was kindly provided 
by Dr P. Kwasowski of the Department of Biochemistry. University of 
Surrey. The IgG fraction of sheep anti-mouse antibody was coupled to 
the porous glass by cross linking with glutaraldehyde and any 
remaining groups were blocked by the addition of 1M ethanolamine. 
These preliminary experiments however showed very high background 
levels which masked any specific interaction between sheep anti-mouse 
and 321 monoclonal antibody. The high background levels were 
probably due to non-specific interactions with the modified 
surface chemistry of the glass. It is possible that such non-specific 
interactions could be reduced or eliminated by modification of the 
surface chemistry of the glass or by the use of other blocking agents 
but this would need much further investigation. 
The coupling of proteins to other rigid particles such as modified 
polystyrene (Neurath and Strick. 1981). nylon (Morris et al.. 1975; 
Hendry and Herrmann, 1980) or various inorganic matrices 
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(Weetall, 1976) has been described and may prove useful as the solid 
phase in ELISA but would need extensive investigation and 
characterisation. 
An alternative to solid phase immunoassays is the use of 
homogeneous enzyme immunoassays. Such assays do not require 
separation of reagents because the enzyme activity is directly 
modulated by antibody antigen reactions. The most common form is 
widely known under the trade name EMIT (Syva Corporation) and was 
first developed by Rubenstein etal. (1972). This system is effective only 
with smaller antigens such as drugs due to the configuration of the 
assay. 
A more promising technique for larger antigens such as antibody 
molecules is the proximal linkage system where two monoclonal 
antibodies against different epitopes on the same antigen are 
labelled with different enzymes (Ngo and Lenhoff, 1981). In this 
system, the product of one enzyme is the substrate of the other and 
significant substrate conversion only occurs when both antibodies 
react with the antigen bringing the labels close together. 
Homogeneous enzyme immunoassays are rapid and readily 
automated and could provide a powerful technique for the 
monitoring of fermentation products. The main limitations with such 
techniques is that the assay requires specifically designed reagents for 
each antigen and the sensitivity is often low. 
3.6.2 On-line sampling of the bloreactor. 
Sampling of the bloreactor is a major limitation in any on-line 
system where small and reproducible samples are required. There are 
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two main requirements in sampling the fermenter which are firstly 
avoiding contamination of the culture fluid and secondly the 
generation of a sample free of cells and debris for the assay. The use 
of a 0.2µm pore diameter filter would appear to fulfil both these 
requirements, however membrane filters are very susceptible to 
blocking which limits their long term use in fermenters. In an attempt 
to overcome this problem a cross-flow filter was developed 
(Appendix III). The device was designed to recirculate fluid from the 
fermenter across the membrane to flush any debris from the 
membrane surface. Samples would then be periodically drawn 
through the membrane to be assayed In the automated ELISA. The 
cross-flow filter could be operated maintenance-free for several days 
using conditioned medium containing cells and cell debris but 
blocking of the membrane could not be completely eliminated. 
Furthermore, when applied to hybridoma cultures It was discovered 
that circulation of cells and medium at flow rates sufficient to 
prevent blockage of the membrane was detrimental to cell growth. 
Figure 3.13 shows the growth of cells in a1 litre fermenter 
(Gallenkamp) with and without medium recirculation. 
The recirculation of cell-free medium from a fermenter would 
eliminate cell damage but would generate the same problems 
encountered with the filter device in that large numbers of relatively 
small particles would have to be retained in the reactor by some 
porous barrier. Spinning filters have been used to retain hybridomas in 
perfusion reactors (Tolbert et al., 1985; Reuveny et al.. 1986) and could 
provide a cell-free stream of medium which could then be sampled for 
the automated assay. A further possible solution to this problem would 
be the use, of an immobilised cell reactor. Immobilised cell reactors 
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Figure 3.13. The effect of medium recirculation on hybridoma growth 
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Each curve represents the number of viable cells in a 500m1 stirred 
culture recorded over 100 hours either with (0) or without(Ö) medium 
recirculation. 
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can be perfused by cell free medium which can be sampled by 
tangential or cross-flow filters with high flow rates. However the main 
limitation with these systems for the investigation of production 
kinetics is that the measurements of cell numbers or biomass necessary 
to determine specific production kinetics is impracticable in such 
systems. 
3.7 Conclusions. I 
1) The use of a packed bed of Sepharose with covalently bound 
anti-mouse antibody could be employed as a solid phase for a sandwich 
ELISA. The increased surface area and reduced diffusion distances in a 
packed bed greatly reduced the time for the ELISA to approximately 75 
minutes/sample. The assay could be operated on a continuous flow basis 
and was readily automated using a microcomputer. 
ii) The reproducibility of the assay was comparable to a microplate 
ELISA with a coefficient of variation between samples of <5%. . 
iii) The high background binding levels experienced initially with the 
continuous ELISA were not due to non-specific binding of the labelled 
antibody but due to incomplete desorption of the antibody antigen 
complex between successive assay cycles. The use of iM acetic acid was 
found to be more effective than glycine-HCI or sodium thiocyanate for 
elution of the bound complex and resulted in reduced background levels. 
iv) The column could be repeatedly regenerated (>30 assay cycles) 
without loss of sensitivity. 
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v) Column compaction occured due to the compressible nature of 
Sepharose at high flow rates. Attempts to alleviate this problem by 
changes in the bed geometry or periodically reversing the buffer flow 
were unsuccessful. This limitation makes the assay impracticable for the 
long term monitoring of bloreactors in its present configuration. 
The development of a system based on a more rigid solid phase would 
overcome this problem and allow higher flow rates and hence faster 
assay times. However such a development would require extensive 
investigation and it was considered that this would diverge from the 
main aim of this investigation which was to investigate factors 
affecting antibody production by hybridomas in culture. 
vi) Difficulties were experienced in producing a cell-free sample from 
the fermenter. Recirculation of medium through a cross flow filter 
provided a cell free sample stream but caused a loss of cell viability at 
the flow rate necessary to prevent filter blockage. 
It was therefore decided adopt a more conventional ELISA system 
using microwell plates to assay manually taken samples. Although the 
conventional ELISA is a time consuming technique it does allow the 
simultaneous testing of large numbers of samples and standards and 
can be replicated to reduce the influence of assay errors. 
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Chapter 4 
Hybridoma growth and antibody production kinetics in batch culture. 
4.1 Introduction. 
Many studies have been centred around the improvement of 
hybridoma growth characteristics in culture (Low and Harbour. 1985a; 
Low and Harbour, 1985b; Reuveny et a!., 1986a; Reuveny et al., 1986b; 
Glacken et a!., 1986; Hu et a!., 1987). These strategies have led to 
greater cell yields and improved cell survival with a consequent 
increase in antibody yields. It has also become apparent that antibody 
production characteristics vary depending on the hybridoma line. Merten 
has separated hybridomas into two groups, low producers where the 
antibody production rate falls rapidly during growth resulting In low 
antibody titres (( 1 jig/ml) and high producers where the rate of antibody 
production is sustained throughout the cell growth phase and also 
during the stationary or decline phase. The latter type of production 
kinetics suggests that monoclonal antibody production is not 
growth-associated, a view supported by the results of continuous 
culture studies by Birch et al. (1985b) and Miller et al. (1988a). 
The effect of environmental factors on antibody production rate has 
received less attention in the literature although some trends may be 
discerned from various studies. Enhanced antibody production has been 
noted in low serum or serum free medium (Glassy et al., 1988), reduced 
oxygen concentrations (Reuveny et al., 1986a; Phillips et al.. 1987) low 
pH (Miller et a!., 1988) or at low growth rates (Birch et a!., 1985b; Miller 
et al., 1988a) although the underlying mechanisms have yet to be 
elucidated. 
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The purpose of this investigation was therefore to determine the 
effect of environmental factors on the production of antibodies by the 
321 hybridoma and to investigate possible mechanisms for, some of the 
effects described above. 
4.2 Materials and methods. 
Determinations of cell number and viability, all metabolite 
determinations and media for cell growth were as stated in Chapter 2. 
Any modifications made are described where relevant in the text. 
4.3 Results. 
4.3.1 Hybrldoma growth and antibody Production in static flasks. 
The study of cell growth In static batch culture was carried out in 
150cm2 tissue culture flasks. Cells were Inoculated at a density of 
2x105 per ml in 100 ml RPMI 1640 supplemented with 10% newborn calf 
serum. Cells were cultured at 37° C with 5% C0z /95% air. Cell number 
and viability were evaluated daily and samples for monoclonal 
antibody, glucose, lactate, glutamine and ammonia determinations 
were taken simultaneously and stored at -20° C for later analysis. 
Figure 4.1 shows a typical cell growth curve for the 321 hybridoma 
in a static flask. Maximum cell density was achieved after 
approximately 60 hours with a subsequent rapid loss in cell viability 
leading to total cell death after 120-140 hours. There was no 
apparent stationary phase with the 321 hybridoma cells. Maximum cell 
densities achieved under the conditions described were typically 
7-9x105/ml with a mean specific growth rate of 0.025h-1. 
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Figure 4.1. Growth of the 321 hybridoma in static flasks 
The figures represent typical growth, metabolism and antibody 
production profiles for the 321 hybridoma in"static culture. Cells were 
cultured in 100ml RPMI 1640 supplemented with 10% newborn calf serum 
in 150cm2 tissue culture flasks. 
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With an initial concentration of 11mM the glucose was never 
exhausted by the 321 hybridoma with 25-50% remaining in the medium 
after cell growth had ceased. By contrast glutamine was exhausted by 
about 60 hours after which there was no further increase in cell number. 
Lactate accumulated in the medium reaching a plateau 
concentration of 8-10mM shortly after the peak in cell density. In 
static flasks approximately 1.5 moles of lactate were produced for each 
mole of glucose consumed. Ammonia also accumulated In the medium 
and reached a maximum concentration (1.5 mM) when Blutamine was 
exhausted. The increase in ammonia concentration corresponded to 
the decrease In glutamine concentration with approximately 1 mole of 
ammonia liberated for each mole of glutamine metabolised. 
Antibody was produced throughout the growth phase and it was 
notable that antibody continued to accumulate in the medium after the 
peak cell concentration. Furthermore the mean antibody production rate 
(jig antibody/106 cells/hour) during the decline phase was higher than 
during the growth phase (table 4.1) and approximately 60% of antibody 
was accumulated in the latter half of the culture. Antibody titres of 
160-180pg/ml were achieved in these cultures. 
4.3.2 Hybridoma growth and antibody production in stirred batch 
culture. 
The study of cell growth in stirred batch culture was carried out in 
a llitre Gallenkamp fermenter which was modififled by replacing butyl 
rubber seals with silicone rubber and agitated using a large magnetic 
follower mounted through the stirrer shaft. Aeration was provided by a 
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95% air 5% COz mixture passed through the headspace at a flow rate of 
50ml/minute. With an agitation rate of 100rpm and a working volume of 
500m1 a KLa value of 1.19h-1 was achieved (see Appendix IV). pH was 
monitored with a sterilisable pH probe (Russell). 
Cells were inoculated at a density of 2x105 per ml in 500 ml RPMI 
1640 supplemented with 10% newborn calf serum. Cell number and 
viability were evaluated daily and samples for antibody, glucose, 
lactate, glutamine and ammonia determinations were taken 
simultaneously and stored at -201 C for later analysis. 
Figure 4.2 shows a typical growth curve for a stirred batch culture 
of the 321 hybridoma. Cell growth rates were higher in stirred culture 
than in static culture and cell densities of 0.9-1.1 x106 /ml were 
achieved after 40-48 hours with a mean specific growth rate of 
0.035h-1. The decline of the culture was also rapid and total cell death 
was seen after approximately 100 hours. 
Glucose consumption and lactate production were similar to that 
seen in static batch cultures. Glutamine was again completely depleted 
by the end of the growth phase although cell densities achieved in 
stirred culture were higher than in static culture. The pH of the culture 
declined during the growth phase reaching a final pH of 6.7 which 
probably reflects the large amount of lactic acid produced by these cells. 
Antibody titres achieved in stirred batch culture were generally 
lower than those seen in static cultures with titres of approximately 120 
jig/ml. Mean antibody production rates during the growth phase were 
also lower in the fermenter than in static flask cultures (table 4.1). As 
before, the mean specific antibody production rate durl1flg the decline 
phase was higher than during the growth phase. 
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Figure 4.2. Growth of the 321 hybridoma in stirred culture 
The figures represent growth, metabolism and antibody production 
profiles for the 321 hybridoma in stirred batch culture. Cells were 
cultured in 500m1 RPMI 1640 + 10% newborn calf serum in a1 litre 
Gallenkamp fermenter. 
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4.3.3 The effect of Blutamine on cell growth and antibody production, 
In the previous studies the onset of the decline phase in batch 
cultures of the 321 hybridoma coincided with the exhaustion of 
glutamine. Antibody production rates were also higher during this 
phase. 
Stirred batch cultures at initial glutamine concentrations of 2,1.3, 
0.6 and 0.3mM (0.3,0.2.0.1 and 0.05mg/ml) were set up in parallel. 
Duran bottles (250m1) were used for 100mi cultures and were agitated 
with a magnetic follower at 100rpm. 
Figure 4.3 shows cell growth curves for each glutamine 
concentration. Glutamine was exhausted in each case and cell growth 
ceased at the same time. The initial growth rate was similar for each 
glutamine concentration and the maximum cell density declined with 
decreasing glutamine concentration, demonstrating the requirement for 
glutamine in proliferating cells. 
The mean specific uptake rate of glutamine was greatly reduced at 
lower glutamine concentrations (table 4.2) which suggests that 
glutamine uptake rate is influenced by the glutamine concentration in 
the medium. Ammonia concentrations reached maximum levels when all 
the glutamine had been utilised except for the lowest initial glutamine 
concentration of 0.3mM where only small amounts of ammonia were 
detectable. 
The total amount of glucose utilised by cells was similar at 2,1.3 
and 0.6 mM glutamine whereas the mean specific consumption rate 
increased at the lower Blutamine concentrations (table 4.2). At 
0.3mMglutamine, glucose consumption rate was reduced. 
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Figure 4.3. The effect of reduced glutamine concentration on hybridoma 
growth and antibody production 
Cells were cultured in 100m1 stirred suspension cultures In RPMI 1640 
+ 10% newborn calf serum with glutamine concentrations of 2.0, (0); 
1.3 (0); 0.6 (0) and 0.3 (0) mM. 
The figures represent a) viable cells, b) 321 antibody concentration, c) 
glutamine, d) ammonia, e) glucose and f) lactate. 
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Antibody production rates for the growth phase of the culture 
and overall production rates were calculated and are shown in table 
4.2. The antibody production rate was , similar 
for initial glutamine 
concentrations of 2,1.3 and . 
0.6 mM but with a significant decrease 
in the mean antibody production rate at the lowest glutamine 
concentration. 
It was also notable that the mean antibody production rate for the 
growth phase of the culture was lower than the overall antibody 
production rate, which was in keeping with earlier observations that 
the antibody production rate increases during the decline phase of the 
culture. 
4.3.4 The effect of nH on cell growth and antibody production 
The effect of pH on cell growth and antibody production was 
investigated. The initial experiments were carried out by varying 
the sodium bicarbonate concentration to give the required pH values 
in equilibrium with 5% C02. The pH drifted rapidly due to the poor 
buffering capacity of low concentrations of sodium bicarbonate. In 
addition it has been suggested that bicarbonate is an Important 
nutrient for cell growth and may affect cell growth independently of 
pH (Geyer and Chang, 1958; McLimans, 1972). In order to overcome 
these problems 20 mM HEPES buffer was included in the medium and 
the sodium bicarbonate concentration was reduced to 5mM. To minimise 
the effect of pH drift cell growth rates were evaluated overnight from 
a culture of cells in exponential growth: Cells in early to mid 
exponential phase were harvested by centrifugation and 
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resuspended in HEPES buffered RPMI1640 at pH values of 6.6,6.8.7.0, 
7.2,7.4 and 7.8. Cell growth and antibody production rates were 
determined after 18 hours incubation. 
Figure 4.4 shows cell numbers and antibody concentrations 
after 18 hours incubation. Whereas the optimum pH for cell growth was 
at pH 7.2 (figure 4.5a) with a growth rate of 0.051 h-1 (cell doubling time 
= 13.6 hours) the maximum antibody production rate was achieved at pH 
6.8 (figure 4.5b). Antibody production and cell growth were depressed at 
lower pH (pH 6.6) and high pH (pH 7.8). 
4.3.5 The effect of serum on cell growth and antibody production. 
The effect of varying newborn calf serum concentration on cell 
growth was investigated. Cells were seeded at a density of 2x10' 
cells/ml in 100ml RPMI1640 in a 150cm2 tissue culture flask. 
Experiments were set up at 1,2.5 and 10% newborn calf serum. Cell 
number and viability were recorded daily and samples were taken for 
antibody determination. 
Figure 4.6a shows "cell growth 'curves for each serum 
concentration. As serum concentration was reduced cell growth 
declined until at 1% serum there was little or no growth. There was 
little loss of viability at low serum concentrations and cell 
viability was maintained longer than with high serum 
concentrations. It is notable that cell yields were comparable for each 
concentration of serum. 
Figure 4.6b shows antibody accumulation for each serum 
concentration. The final antibody titres for each serum 
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Figure 4.4. The effect of pH on hybridoma growth and antibody 
production. 
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Cells were cultured in RPMI 1640 with 10% newborn calf serum, 5mM 
NaHCO3 and 20mM HEPES buffer. The pH wasadjusted to the values 
shown by the addition of either NaOH or HCI. The bars represent the cell 
number and antibody concentration. Error bars are the standard 
deviation (n=4). 
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Figure 4.5. The effect of pH on cell growth rate and antibody production 
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The figure represents a) the mean specific cell growth rate and b) the 
mean specific antibody production rate (APR) as calculated from the 
data shown in figure 4.4. 
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Figure 4.6. The effect of serum concentration on cell growth and 
antibody production. 
Cells were cultured in RPMI 1640 supplemented with 10% (0), 5% (13), 216 
(") or 1% (0) newborn calf serum. The figures represent a) viable cell 
numbers, b) antibody concentration and c) the specific antibody 
production rate (APR) as calculated from the data shown In figures 4.6a 
and 4.6b. 
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concentration were similar but the specific antibody production rate 
(figure 4.6c) showed a general trend of increasing antibody 
production rate with decreasing serum concentration. 
4.3.6 The effect of excess thymidine on cell growth and antibody 
production. 
The emerging trend from the previous experiments is that 
conditions which are suboptimum for cell growth may enhance antibody 
production. There is some evidence that antibody production rate is 
enhanced at low cell growth rates (Birch et al., 1985; Miller et al.. 1988). 
The following experiments therefore investigate the effect of 
preventing cell proliferation by blocking DNA synthesis. 
, 
Excess thymidine acts as an inhibitor to DNA synthesis due to 
inhibition of nucleoside diphosphate reductase (Xeros, 1962). The effect 
of excess thymidine on the 321 hybridoma was investigated. 2mM 
thymidine has been found to be optimum for Inhibition of DNA 
synthesis In HeLa cells (Puck, 1964) and was found to be suitable for 
this investigation. 
Cells In early to mid exponential phase were harvested by 
centrifugation and resuspended in RPMI 1640 containing 2mM thymidine 
(Sigma). A control flask without thymidine was also set up. 
Figure 4.7 shows the effect of 2mM thymidine on cell growth. The 
control flask shows continued cell growth in the absence of thymidine 
(figure 4.7a) whilst cells treated with thymidine stop dividing after 
approximately 12 hours (figure 4.7b). A constant cell number was 
maintained for approximately 40 hours before cells began to die. The 
antibody titres were comparable despite the difference in cell number 
132 
Figure 4.7. The effect of 2mM thymidine on cell growth and antibody 
production. 
Cells were cultured in 100ml RPMI + 10% newborn calf serum either a) 
without thymidine or b) with 2mM thymidine. The figures show cell 
numbers (0, ") and antibody concentrations (p, M) for each experiment. 
Solid and open symbols represent the results of two experiments. 
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but the mean specific antibody production rate was higher in thymidine 
blocked cells (5.1±0.42pg/106 cells/h) than in the control culture 
(3.5±0.34pg/106 cells/h). These data indicate that not only does 
antibody production continue in non proliferating cells, but that the 
non-proliferative state appears to be more favourable for antibody 
production. 
4.3.7 The effect of glutamine concentration on thymidine-blocked cells. 
Maximum antibody production rates were observed in the decline 
phase of hybridoma cultures (Table 4.1). The onset of the decline phase 
was characterised by the depletion of glutamine and it is therefore 
possible that glutamine level affects the rate of antibody production in 
hybridoma cells perhaps by repression of antibody synthesis. However 
the effects of cell growth may obscure any specific effects of glutamine 
limitation on antibody production. The effect of glutamine on antibody 
production in non-proliferating cells was therefore investigated. 
Cells in early exponential phase were blocked with 2mM thymidine 
for 24 hours then harvested by centrifugation at 100xg for 5 minutes. 
The cells were resuspended in RPMI containing 5,2,1.0.5,0.25 and 
0.125 mM glutamine. Thymidine at 2mM was also Included in all media. 
After 24 hours. cell number and antibody titre were determined. 
Figure 4.8 shows cell number and antibody titre for each glutamine 
concentration after 24 hours incubation. Cell viability remained high at 
glutamine concentrations of 0.5 mM and above but there was a loss of 
cell viability at 0.25 and 0.125 mM indicating the requirement of 
non-proliferating cells for glutamine. Antibody titres were similar 
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Figure 4.8. The effect of glutamine concentration on antibody production 
in thymidine blocked cells. 
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Cells were cultured in RPMI 1640 with 10116 newborn calf serum and 2m11 
thymidine at glutamine concentrations of 0.125 - 5.0 mM. The figure 
shows viable cell numbers and antibody concentrations measured after 
18 hours incubation. 
136 
between 1 and 5 mM glutamine but declined at lower glutamine 
concentrations. This was reflected in the mean specific antibody 
production rates (figure 4.9). These data suggest that there is no 
repression of antibody synthesis by high levels of glutamine and that 
glutamine is required for antibody synthesis as low levels of glutamine 
were accompanied by a reduction in the rate of antibody synthesis. 
4.3.8 The effect of nH on thymidine-blocked cells. 
Variations in pH have a profound effect on cell growth rate (figure 
4.5a) which In turn may influence antibody production. It is not possible 
to determine whether the effect of pH on antibody production is due to 
a direct effect on antibody synthesis or secretion. In order to eliminate 
the effects of cell growth rate the effect of pH on thymidine-blocked 
cells was investigated. 
Cells were prepared as described in section 4.2.7. The cells were then 
resuspended in HEPES buffered RPMI at pH values of 6.6,6.8,7.2,7.4 
and 7.8. All media also contained 2mM thymidine. After 24 hours 
incubation cell number and antibody concentration were determined for 
each pH value. 
Figure 4.10 shows cell number and antibody titre at each pH value. 
Cell viability was not affected by pH over the range tested. Antibody 
titres were highest within the pH range 7.0-7.4 with decreasing titres 
below pH 7.0 and at pH 7.8. Mean antibody production rates calculated 
from this data were also similar at pH 7.0-7.4 but were depressed 
outside this range (figure 4.11). This is in contrast to the situation seen 
in dividing cells where the optimum pH for antibody production was 
found to be 6.8. 
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Figure 4.9. The effect of glutamine concentration on antibody production 
rate in thymidine blocked cells. 
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The figure shows the effect of glutamine concentration on the mean 
specific antibody production rate as calculated from the data shown in 
figure 4.8. 
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Figure 4.10. The effect of pH on antibody production In thymidine 
blocked cells. 
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Cells were cultured in RPMI 1640 with 10% newborn calf serum, 2mM 
thymidine, 5mM NaHCO3 and 20mM HEPES buffer. The pH was adjusted to 
the values shown by the addition of NaOH or HCi. The figure shows the 
viable cell numbers and antibody concentrations measured after 18 
hours Incubation. Error bars are the standard deviation (n=4). 
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Figure 4.11. The effect of pH on the antibody production rate in 
thymidine blocked cells. 
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The figure shows the effect of different pH values on the mean specific 
antibody production rate as calculated from the data shown in figure 
4.10. 
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4.3.9 The effect of serum concentration on thymidine blocked cells 
As with pH, the serum concentration has a considerable effect on cell 
growth rate (figure 4.6a) which may obscure any direct effect of serum 
on antibody synthesis or secretion. The effects of serum in 
non-proliferating cells were therefore investigated. 
Cells were prepared as described in section 4.2.7 then incubated in 
RPMI with 2 mM thymidine and newborn calf serum concentrations of 0, 
1,2,5,10 and 20%. Cell numbers and antibody titres were determined 
after 24 hours incubation. 
Figure 4.12 shows cell number and antibody titre at each serum 
concentration. Cell viability was not affected by serum concentration 
except in the complete absence of serum where a loss of cell viability 
was observed. Antibody titres showed an increasing trend with 
increasing serum concentration in contrast to the results obtained in 
growing cultures. This implies that serum does not inhibit antibody 
production and the enhanced antibody production rate seen at high 
serum concentration (figure 4.13) suggests a possible role for serum in 
the synthesis or secretion of antibody. 
4.4 Discussion. 
The data presented in this chapter showed that antibody was 
produced continuously during cell growth but that there was an 
apparent increase In the mean specific production rate during the 
decline phase of the culture. This observation is consistent with the 
observations of several other authors who have found similar 
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Figure 4.12. The effect of serum concentration on antibody production 
in thvmidine blocked cells. 
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Cells were cultured In RPMI 1640 with 10% newborn calf serum and 2mM1 
thymidine at serum concentrations of 0-20%. The figure shows cell 
numbers and antibody concentrations measured after 24 hours 
incubation. Error bars are the standard deviation (n=4). 
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Figure 4.13 The effect of serum concentration on the antibody 
production rate in thymidine blocked cells. 
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The figure shows the effect of different serum concentrations on the , 
mean specific antibody production rate calculated from the data shown 
in figure 4.12. 
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production kinetics In hybridomas producing high monoclonal 
antibody titres (Birch et al., 1987; Emery et al., 1987; Reuveny et al., 
1987). The explanations for this behaviour can be incorporated Into 
two hypotheses. Emery et al. (1987) suggested that the increase in the 
apparent production rate was due the release of accumulated 
intracellular antibody from dying cells. They provided data 
which showed Increased Intracellular antibody concentrations during 
the latter phase of the cell culture. A similar investigation by Birch 
and colleagues (1987) did not show such accumulation and they 
concluded that the specific antibody production rate increases during 
the decline phase. Subsequent work (Renard et al., 1988) has linked 
antibody production kinetics to the integral of the viable cell growth 
curve which strongly suggests that antibody production during the 
decline phase is secreted by the viable cell population and not 
released from dying cells. 
It therefore seems that antibody production is not growth-associated 
and this is further supported by the finding in this investigation that 
cells prevented from dividing by blocking with thymidine, continue to 
produce antibody. The antibody production rate was also higher in the 
non-dividing cells suggesting that a non-proliferative state Is more 
favourable for antibody production. 
It was also found that cell growth rates and cell yields were generally 
higher in stirred culture than In static culture but that antibody yields 
were often lower In stirred batch culture. The lower antibody yields were 
due In part to the lower antibody production rates observed during the 
growth phase In stirred cultures but may also have been contributed to 
by the more rapid decline of the stirred batch cultures which would 
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reduce the antibody yield. Various other comparisons 
between stirred 
and stationary cultures have been made. The results of Seaver et al., 
(1984) were similar to those seen in this investigation. whereas Dodge 
and Hu (1986), found that growth rates and cell yields were similar in 
stirred and stationary cultures but did observe lower antibody titres in 
stirred batch culture. By contrast Fazekas de St Groth (1983) found 
lower growth rates but increased cell yields in stirred batch as 
opposed to stationary culture. This range of observations may reflect 
the behaviour of different hybridomas in stirred culture but may also be 
affected by the type of vessel used for the stirred culture experiments. 
The hydrodynamic environment may differ between the various types of 
vessel and comparisons between the performance of hybridomas in 
different vessels must therefore be treated with caution. 
Studies on the metabolism of the 321 hybridoma showed that 
glutamine was consumed at a high rate and was exhausted at the point 
at which cell growth ceased. This suggested that glutamine was an 
essential nutrient for hybridoma proliferation and it was found that 
the cell density achieved in stirred suspension culture 
decreased with decreasing glutamine concentration. Other studies on 
the amino acid utilisation by hybridomas have shown that growth is 
accompanied by the rapid utilisation of glutamine (Seaver et a1.. 1984; 
Miller et al., 1988a). 
The reduced Blutamine uptake rate at lower glutamine concentrations 
may be evidence of a change in the metabolism of glutamine which is 
supported by the reduced ammonia yield observed with low glutamine 
concentrations. At low glutamine concentrations glutamine nitrogen 
may be more efficiently utilised in the manufacture of cellular 
components accounting for the lower uptake rate and lower ammonia 
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yields. However"in their study on human diploid cells, 
Glacken et 
al. (1986) found that whilst the glutamine uptake rate 
by MDCK cells 
was decreased at low glutamine concentration, the ammonia yield 
remained relatively constant. 
Glucose was never exhausted by the 321 hybridoma under the 
conditions described and glucose uptake ceased at the end of the 
growth phase. Lactate accumulation followed glucose uptake very 
closely with 1.5-2 moles of lactate formed for each mole of glucose 
consumed. The rapid conversion of glucose to lactate appears to be a 
characteristic of proliferating cells including hybridomas (Low and 
Harbour, 1985; Adamson et al., 1983) and causes a substantial pH drop 
which inhibits cell growth. 
The decreasing glutamine utilisation rate observed at low glutamine 
concentrations was accompanied by an increasing glucose uptake rate 
although glucose uptake was reduced at the lowest glutamine 
concentration. 
These observations may reflect the reciprocal regulation of 
glutamine and glucose metabolism which has been reported for other 
cell types (Kvamme and Svenneby, 1961; Zielke et al., 1978). A similar 
phenomenon has been observed in hybridoma cells by Hu et al. (1986) 
where glutamine utilisation was found to be increased at low glucose 
concentrations. This implies that hybridomas can switch between 
glucose and glutamine utilisation depending on the availability of 
each substrate. It is also possible that glycolysis is unable to 
proceed in the complete absence of glutamine because In this 
investigation, glucose utilisation ceased when glutamine was 
exhausted. This may also explain the apparently contradictory findings 
of Ardawi and Newsholme (1982) who found that glucose uptake was 
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stimulated by glutamine In proliferating lymphocytes because they 
measured the uptake of each nutrient in the total absence of the other. 
Antibody production rates were not affected by high 
concentrations of glutamine in neither growing nor thymidine-blocked 
cells but low glutamine concentrations restricted antibody production. 
This is a surprising finding because antibody production continues for 
some considerable time after the exhaustion of glutamine In batch 
cultures. It may be the case that large pools of glutamate. aspartate 
and alanine that accumulate in cells grown on glutamine (Ardawi and 
Newsholme, 1983; Seaver et al., 1984; Merten et al., 1986) provide 
sufficient Intermediates for protein synthesis but without stimulation 
of cell division. This may be due to the effect of glutamine limitation on 
the rate of purine and pyrimidine synthesis which In turn limits DNA 
synthesis effectively arresting cells In the G1 phase (Fontanelle and 
Henderson, 1969; Ley and Tobey, 1970; Zetterberg and Engstrom, 1981). 
The 321 hybridoma showed an optimum pH for growth of 7.2 whilst 
antibody production in growing cells was optimum at 6.8. This 
phenomenon has been noted by Miller et al. (1988a) who found specific 
antibody production rates were higher at pH 6.8 and 7.7 than at pH 
7.1-7.4. A similar increase in the specific rate of antibody 
production at low pH was also found in this investigation. This is 
perhaps surprising as both protein synthesis and cell growth have been 
found to be suppressed at low and high pH (Ceccarini and Eagle 1971) 
due perhaps to effects on nutrient uptake (Barton. 1971; Birch and 
Edwards, 1979; Miller et a1., 1988a). One explanation for this 
behaviour arises from the observation that the relative rate of 
immunoglobulin synthesis increases in myeloma cells in stationary phase 
although the overall rate of protein synthesis is suppressed (Kimmel. 
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1971). This may be due to a preferential translation of immunoglobulin 
mRNA in stationary or nutrient starved myeloma cells (Sonenshein and 
Brawerman, 1976): This suggests that conditions which suppress cell 
growth do not necessarily suppress, and indeed may favour 
immunoglobulin synthesis. 
A further finding in this investigation was that that the optimum pH 
for antibody production in thymidine-blocked cells was different from 
that seen in proliferating cells with the optimum production rate at p11 
7.1-7.4. This suggests that the effect of low pH on antibody production 
rate-in proliferating cells may be a reflection of the changes in the 
demands on the cells energy and metabolite reservoir at low cell growth 
rate. A pH range of 7.1-7.4 provides a more favourable environment for 
protein synthesis as illustrated by a more rapid growth rate but in the 
absence of cell division this extra capacity for protein synthesis may be 
diverted to antibody production. 
The concentration of newborn calf serum in the medium had a 
significant effect on cell proliferation. Cell growth was supressed 
at lower serum concentrations suggesting that serum contains a 
component which is essential for cell proliferation. However as high cell 
viability was maintained for longer periods of time in low serum 
concentrations it would appear that high concentrations of the 
component are not necessary for cell survival. 
It was also found that specific antibody production rates in growing 
hybridoma cultures were enhanced in media containing less serum. This 
phenomenon has been noted by others who have found that the 
specific production rate for antibody is generally higher in 
serum-free or low serum media than in serum-supplemented media 
(Tharakan and Chau. 1986c; Glassy et al., 1988) which has led to the 
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suggestion that factors in serum inhibit antibody production (Glassy 
et al., 1987). However it has been shown in this investigation that this 
is probably not the case because antibody production was found to be 
enhanced at high serum concentrations with thymidine-blocked cells. 
This would tend to suggest that the effects of serum on antibody 
production seen in proliferating cells may be due to the effect of the 
reduced cell growth rate at low serum concentrations. This hypothesis 
is supported in the review by Glassy et al (1988) where it was shown 
that hybridoma growth rates in serum-free media are generally lower 
than in serum-supplemented media. The increased antibody yields at 
high serum concentration in blocked cells may be due to the stimulation 
of nutrient uptake by serum factors such as growth factors (James and 
Bradshaw, 1984) or insulin (Schubert, 1979) providing a larger 
metabolite pool for protein synthesis. 
The various findings discussed above suggest that the production 
of antibody by hybridomas is affected by the both the rate of cell 
proliferation and the metabolic state of the cell. It appears that more 
slowly growing or non-dividing cells have a higher rate of antibody 
production. This may be due to a change in the demands on the cell's 
metabolite pool as the rate of cell growth is reduced. At high growth 
rates the rapid synthesis of structural components for cell growth and 
division places a greater demand on the cell's energy or metabolite pool 
at the expense of antibody synthesis. 
It has been shown in this investigation that while certain conditions 
which were suboptimal for growth increased the apparent rate of 
antibody production in growing cells, the optimum conditions for 
antibody production In thymidine-blocked cells were similar to the 
optimum conditions for growth in dividing cells. This may be due to 
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enhanced cell metabolism or nutrient uptake in ideal conditions which 
would normally lead to rapid cell division. In the absence of cell division 
the metabolic state of the cell will greatly influence antibody 
production. 
The influence of cell growth rate on antibody production makes it 
difficult to determine the effects on antibody production of 
environmental factors which also affect the growth rate. In order to 
investigate more fully the effect of cell physiology on antibody 
production rate it would therefore be necessary to maintain cells at a 
constant growth rate. In the next chapter therefore, the effect of cell 
growth rate on antibody production and cell physiology was examined 
under steady state conditions which were achieved using chemostat 
culture. 
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Chapter 5 
Continuous culture 
5.1 Introduction. 
The data generated from batch cultures in the previous chapter 
suggests that factors that affect the growth rate of hybridomas may 
be important in the production of monoclonal antibody. The nature of 
batch cultures however means that metabolite concentrations and 
physiological conditions are continuously changing making it difficult 
to accurately identify those factors which influence cell productivity. 
In order to investigate the effects of growth rate or environment on 
cell metabolism it is desirable to maintain cells in a constant 
environment. This can be achieved by the use of a chemostat. 
The theory of cell growth in continuous culture is based on the 
principle of Monod (1942). that at submaximal growth rates, the growth 
rate of a cell is determined by the concentration of a single 
growth-limiting nutrient. Monod showed that the growth of an organism 
on a limiting nutrient can be described by the equation: 
p= ileax S (1) 
S+ Ka 
where p is the growth rate, s is the substrate concentration, pm. x is 
the maximum growth rate and Ks is the substrate affinity constant. This 
equation is analogous to the Michaelis-Menten model of enzyme 
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kinetics with Ks equivalent to K.. 
The chemostat, which was first demonstrated by Monod (1960) 
and Independently by Novick and Szliland (1950), is a reactor which 
maintains a constant volume with a constant rate of medium addition 
such that cells'and medium are removed at the same rate. The medium 
feed has a single growth limiting nutrient so that' at feed rates less 
than the maximum growth rate of the cell the cell growth rate is 
determined by the feed rate or dilution rate (D). At a 'constant dilution 
rate a steady state will be established during which the cell number 
and the physiological environment are constant, and the growth rate 
(p) is equal to the dilution rate. The theoretical principles of 
chemostat culture have been discussed more fully by Pirt (1975) and 
Herbert et al. (1956). 
Attempts to grow mammalian cells in a chemostat were made as 
early as 1958 by Cooper et al. but the limited success by early workers 
in maintaining a stable steady state may explain why comparatively 
few studies of animal cell physiology have employed the chemostat. 
Most of the chemostat studies that have been made have used glucose 
as a limiting substrate (Moser and Vecchio, 1967; Tovey and 
Brouty-Boye, 1976, Tovey 1980) although in many cases the limiting 
nutrient was not known (Griffiths and Pirt, 1967; Van Hemert et al., 
1969; Fazekas de St Groth, 1983). Tovey and Brouty-Boye (1976) 
showed that it was possible to maintain long term steady states and 
that the'growth of animal cells in chemostats correlates well with the 
Monod equation (equation 1). 
There is still little published work on the growth of hybridoma 
cells in chemostats but Birch's group in the UK (Boraston et al., 1982, 
Birch et al., 1986b) and Millers group (Miller et al., 1988a, b, 1989a, b) 
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in the USA have published data derived from chemostat culture. These 
studies have suggested that antibody production is not directly linked 
to cell growth rate and there is evidence that antibody production 
declines at high growth rates. 
In this study chemostat culture has been used to investigate 
the effect of growth rate on monoclonal antibody production by 321 
hybridoma cells. The data indicate that antibody production rate 
decreases at higher growth rates. The utilisation of Blutamine and 
glucose and the production of ammonia and lactate have also been 
monitored and the effect of growth rate on the metabolic quotients for 
these metabolites is discussed. The monitoring of these major 
metabolites should provide information on the changes in cell metabolic 
activity at different growth rates. 
Glutamine was selected as the limiting nutrient for these 
studies as the results of the previous chapter suggest that glutamine is 
the first nutrient to be exhausted In batch cultures and the 
stationary/decline phase begins at that time. It was therefore decided 
that a glutamine-limited chemostat might provide useful information 
on the production of antibody under steady state conditions with low 
glutamine concentrations. 
5.2 Materials and methods. 
5.2.1 Apparatus for continuous culture of hybridoma cells. 
The vessel used for chemostat culture was a1 litre glass 
reactor with a stainless steel headplate (Gallenkamp). The temperature 
in the vessel was maintained by a water jacket connected to a 
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circulating water bath at 37° C. Agitation was provided by a large 
Teflon-coated stirrer bar fixed through the stirrer shaft and driven by 
magnetic coupling. The agitator speed was maintained at 100rpm. 
Aeration and pH control of the culture was achieved by passing 
95% air 5% C02 through the headspace at 311tres/h. 
The pH was monitored by a Russell autoclavable pH probe 
connected via an amplifier to a BBC microcomputer. The computer was 
programmed to record pH data at 30 minute intervals. The data was 
displayed on screen with the elapsed time and also stored on disc so 
that it could be retrieved at a later date. 
Medium was fed to the reactor from a 2litre reservoir which could 
be refilled via a sterile coupling. The medium reservoir was kept at 
between 0 and 40C. Waste medium was collected in a 1011tre vessel 
which was connected via a sterile coupling so that the vessel could be 
replaced when full. The medium flow rate was controlled by a 
peristaltic pump (Gilson). Figure 6.1 shows the apparatus used for the 
continuous culture of the 321 hybridoma. 
5.2.2 Continuous culture. 
For the continuous culture a 500m1 working volume was used. 
The medium comprised RPMI 1640 supplemented with 2g/I sodium 
hydrogen carbonate and 10% newborn calf serum with glutamine as 
the limiting nutrient. The actual glutamine concentrations used are 
mentioned at the relevant points In the results section. Cell numbers 
and viability were determined daily and samples were also taken for 
antibody, glucose, lactate, glutamine and ammonia determinations. 
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Figure 5.1. Apparatus used for the chemostat culture 
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Sample volumes were typically 5m1 representing 1% of the culture 
volume. Steady state was said to be achieved when five consecutive 
samples gave comparable cell counts and metabolite concentrations. 
5.2.3 Metabolic quotients. 
The metabolic quotient (q) for a metabolite is the specific rate 
of uptake or production of that metabolite under steady state 
conditions. 
If perfect mixing within the reactor is assumed such that the 
concentration of a metabolite (C) in the outlet is the same as the 
concentration of C within the reactor, the production rate (P) for a 
metabolite could be described as follows: 
P=FCout -FCin +VdCout 
dt 
where F is the flow rate, Ci a is the concentration of a metabolite 
in the inlet, Cout is the concentration of a metabolite in the 
outlet, V is the volume of the chemostat and dCo ut /dt is the rate of 
change of concentration of metabolite in the reactor. 
At steady state however Co ut is constant and dCo ut /dt =0 
Furthermore the concentration of a product in the inlet is also zero 
therefore: 
P=FCout 
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The specific production rate qp is 
qp = FCont 
Vx 
where x is the number of cells/ml 
Because the dilution rate is given by D= F/V 
then 
qp = DCout. (2) 
x 
The rate of uptake (U) at steady state can similarly be described by: 
U=FCIn -FCout, 
and the specific uptake rate (qu) by: 
qu = D(Cin - Cout). (3) 
R 
It should be noted that these equations hold true only if cells and 
metabolites are perfectly mixed and adherence of cells to the walls of 
the vessel can cause deviations from these equations. However, 
adhesion of the 321 hybridoma to the vessel walls did not occur and 
perfect mixing was assumed. 
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5.3 Results. 
5.3.1 Establishment of steady state growth. 
The vessel was seeded at a cell density of 2x105 cells/ml. The 
cells were grown initially without the medium feed for 24 hours to 
allow cells to attain the exponential phase. Medium containing 0.7 mM 
glutamine was then introduced at a flow rate of 20.8 ml/hour 
corresponding to a dilution rate of 0.042h-1. The cell number at this 
point was 3x105 cells/ml with 98% viable. Figure 6.2 shows the progress 
of the hybridoma during the initial stages of the continuous culture, 
The cells quickly reached equilibrium at 3.6xl05 cells/ml and 
measurements of the glutamine concentration showed residual levels 
of 0.2 mM. Increasing the glutamine feed concentration to 1mM did not 
result in an increase in cell number which Indicated that the cells were 
not glutamine limited. However when the dilution rate was reduced to 
0.024h-1 there was an immediate increase in cell number to 6.0x105/ml 
and the residual glutamine concentration fell below detectable levels. 
A glutamine pulse confirmed that cells were substrate limited because 
the addition of 75mg of glutamine to the fermenter led to a transient 
Increase in cell number which then returned to the previous steady 
state level on depletion of the excess glutamine (figure 5.3). It was 
also observed that when the dilution rate was subsequently increased 
back to 0.042h-1 the cell number was maintained at the higher 
level (6.0x105/ml). 
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Figure 5.2. Initiation of the chemostat culture of the 321 hybridoma 
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The figure shows the viable cell numbers and the residual Blutamine 
concentrations observed during the Initial stages of the chemostat 
culture. The nutrient feed comprised initially RPMI 1640,10°o newborn 
calf serum and 0.7mM glutamine introduced at a dilution rate of 0.042 
h-1 after 24 hours (first arrow). The glutamine feed concentration was 
adjusted to 1. OmM/l after 96 hours (second arrow). The dilution rate 
was reduced to 0.024h-1 after 180 hours (third arrow). 
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Figure 5.3. The effect of a glutamine pulse on the cell concentration 
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The figure shows cell numbers (0) and residual glutamine 
concentrations (0) after a pulse addition of 0.26mmoles of glutamine to 
the fermenter. 
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5.3.2 The effect of the specific growth rate on the metabolism of the 321 
hybridoma. 
Steady states were established at three specific growth rates of 
0.024,0.033, and 0.042h-1 while cell washout occured at a dilution 
rate of 0.05h-1. Figure 5.4 shows cell growth and metabolite 
concentrations during successive steady states. Steady state values for 
cell number and glucose. lactate, Blutamine, ammonia and antibody 
concentrations were determined for each growth rate as shown in 
table 5.1. Steady state growth was established for each of the three 
dilution rates on at least two occasions and was found to be 
reproducible. The data in table 6.1 represents the mean ± standard 
deviation for at least 10 data points determined during two or more 
steady states for each dilution rate. 
Table 5.2 shows metabolic quotients for antibody, glucose, 
lactate, glutamine and ammonia for each specific growth rate. 
5.3.2.1 Cell numbers and viability. 
Cell numbers were comparable at each dilution rate and the cell 
viability did not drop below 99%. A dilution rate of 0.05h-1 caused 
loss of cells due to washout (figure 6.5). The rate of cell loss at 
washout is related to the maximum growth rate (po. x) by the following 
equation: 
p ax = lnxt -Inxo +D (4) 
t- to 
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Figure 5.4. Steady state cell and metabolite concentrations at different 
growth rates 
The figure shows steady state cell numbers (0) and steady state 
concentrations of antibody (O), lactate (Q) and glucose (") at dilution 
rates of 0.024,0.033 and 0.042 h-1. The arrows represent the times at 
which the dilution rate was changed. 
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Figure 5.4 
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Figure 5.5. Cell washout kinetics at high dilution rate 
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The figure shows the effect on cell numbers of increasing the dilution 
rate from 0.042 to 0.05h-1. The cell numbers recovered after adjusting 
the dilution rate to 0.024h-1. The arrows represent the times at which 
the dilution rate was changed. 
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where xo is the population at time=0 and xt the population at time=t. 
This gave a theoretical p ax of 0.040h-1 which is slightly lower 
than the highest growth rate achieved in the chemostat. This value 
is somewhat lower than the maximum growth rate achieved in batch 
cultures but this may reflect the fact that the chemostat was 
operating at a pH of between 7 and 7.1 which is slightly below the 
optimal pH of 7.2 (Chapter 4, figure 4.5a). 
5.3.2.2 Glutamine and ammonia. 
Residual glutamine concentrations in the fermenter were below the 
limit of detection (<0.02mM) at dilution rates of 0.024 and 0.033h-1 but 
residual glutamine was detectable at a dilution rate of 0.042 with a 
steady state concentration of 0.05mM. The specific rate of glutamine 
utilisation (qg iutae1n e) increased with increasing dilution rate. 
Steady state concentrations of ammonia decreased with increasing 
dilution rate but qa  mo nia was similar at each dilution rate despite 
an increasing rate of glutamine consumption. As ammonia is a major 
product of glutamine metabolism the decreasing ammonia production 
from glutamine may be evidence that the metabolic fate of 
glutamine changes with increasing dilution rate. 
The substrate affinity constant K. (equation 1) is equivalent to 
the steady state substrate concentration at pmax/2. At an estimated 
paax/2 of 0.025h-1 the substrate concentration was below the limit 
of detection which implies that Ks has a value below 2x10-5M. This is 
somewhat lower that that determined for human diploid fibroblasts by 
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Sumbilla et al. (1981), which was of the order of 2-3x10-4 M. 
5.3.2.3 Glucose and lactate. 
Steady state concentrations of glucose remained relatively 
constant for all three dilution rates while lactate concentration 
increased approximately twofold from the lowest to the highest dilution 
rate. While the metabolic quotients for glucose and lactate increased 
with increasing dilution rate the ratio of qi sctat, to qo iucoss was not 
constant in that the amount of lactate liberated for each molecule of 
glucose consumed increased at higher growth rates. 
5.3.2.4 Antibody. 
The steady state concentration of antibody in the culture 
decreased with increasing dilution rate and q. nt Icody in was 5.4,4.6 
and 3.8pg/106cells/h at dilution rates of 0.024,0.033 and 0.042h-1 
respectively. 
Cell yields for glutamine were similar for each dilution rate 
but product yields (mg antibody/mg glutamine) declined at higher 
dilution rates (table 5.3). 
5.3.3 Hybridoma stability. 
The chemostat culture of the 321 hybridoma was maintained 
for 112 days representing approximately 100 generations. At 
comparable dilution rates and cell density the specific antibody 
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production rate was similar throughout the chemostat culture. This 
implies that the production of antibody by the 321 hybridoma was 
stable under continuous culture conditions which are highly selective 
due to the limitation of an essential nutrient. 
5.4 Discussion. 
A glutamine limited chemostat culture of 321 hybridoma cells was 
maintained at three different dilution rates over a period of 4 months. 
Cell numbers were comparable at each dilution rate and cell viability 
remained above 99% during each steady state. The high cell viability 
can in part be attributed to the washout of non-viable cells and the 
dilution of toxic metabolites. 
Batch culture experiments had indicated a maximum growth 
rate of 0.051h-1 but this could not be achieved in continuous 
culture in that washout of cells occurred at a dilution rate of 0.05h- 
1. Calculation of Amax by washout kinetics suggested a maximum 
theoretical growth rate of 0.04h-1. This is slightly lower than growth 
rates already achieved in the chemostat. This behaviour may be a 
result of the increasing lactate concentrations observed at higher 
growth rates. This in Itself might suppress growth rates by inhibition 
(Glacken et al., 1986) and it has indeed been demonstrated that lactate 
inhibits the growth of the 321 hybridoma cell independently of pH (J. 
S. Thorpe. personal communication). However it is also likely that the 
sub optimal pH in the chemostat is suppressing cell growth. It has 
been demonstrated in the previous chapter that small deviations 
from the optimum pH of 7.2 lead to a substantial decrease in the 
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growth rate of the 321 hybridoma. The data generated in the previous 
chapter (figure 4.5a) suggest that at pH 7.0 the maximum specific growth 
rate would be 0.04h-1 which agrees with the growth rate calculated by 
washout kinetics. 
The cell yield from glutamine observed in chemostat cultures 
was similar for each dilution rate and was . 
higher than achieved in 
batch cultures. The observation that glutamine limitation results in 
increased cell yields agrees with the findings in batch cultures where 
the lowest initial glutamine concentrations gave the highest cell yields 
(figure 4.3). 
In batch cultures with high Initial glutamine concentrations, 
as demonstrated in the previous chapter, there was typically 1 mole 
of ammonia liberated for each mole of glutamine consumed whereas In 
the chemostat the ratio was 0.5 at p=0.024h-1 and decreased with 
increasing dilution rate to 0.3 at p=0.042h-'. These observations 
suggest that the route for the metabolism of glutamine may be 
influenced by glutamine concentration. At low glutamine 
concentrations it is likely that there is more efficient incorporation of 
glutamine nitrogen into biomass. At high glutamine 
concentrations, increased ammonia concentrations and lower cell 
yields suggest that there is greater oxidative degradation of 
glutamine. This Is in agreement with the findings of Glacken et al. 
(1986) who found that maintaining low glutamine concentrations by 
periodic feeding greatly reduced the ammonia yield. 
Greater utilisation of exogenous glutamate under glutamine 
limitation would reduce the amount of ammonia liberated due less 
degradation of glutamine. It has been suggested that the 
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glutamate: 2-oxocarboxylate aminotransferases are more important 
than glutamate dehydrogenase in the conversion of glutamate to 
a-ketogiutarate in proliferating lymphocytes (Ardawl and Newsholme, 
1982) implying that ammonia is primarily a result of glutaminase 
activity. It has also been suggested that exogenous glutamate is 
primarily transaminated to a-ketoglutarate whereas glutamate 
derived from glutamine is oxidatively deaminated by glutamate 
dehydrogenase (Borst, 1962; Kovacevic, 1971; Schoolwerth and 
LaNoue, 1980). This may be an effect of compartmentation because both 
glutaminase and glutamate dehydrogenase are located within the 
mitochondrion 'while the transaminases are located predominantly in 
the cytosol. 
There is also evidence to suggest that the flux through the 
metabolic pathways used to catabolise glucose and glutamine change 
with increasing dilution rate. As the dilution rate is increased the ratio 
of glactate: qglucoaa increases 'while the ratio of 
qa   o n1a : qo 1utamine decreases. A number of explanations for this 
behaviour could be put forward. 
i) More glucose is converted to lactate at higher growth rates. It has 
been noted that in batch cultures of hybridomas the number of moles 
of lactate formed from each mole of glucose Increases with growth rate 
(Luan et al.. 1987; Hu et a1.. 1987). It also appears that as the rate of 
glucose uptake is increased carbohydrate molecules are Increasingly 
shunted through glycolysis to lactate (Zielke et a!.. 1978). At slower 
rates of glucose uptake or with more slowly metabolised sugars such 
as galactose or fructose it has been suggested that more carbohydrate 
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is shunted through the pentose phosphate cycle with the formation of 
less lactate (Reitzer et al., 1979). The data generated in this 
investigation would support such a hypothesis. 
In his studies on mouse LS cells in chemostat culture, Sinclair 0 980) 
found that while the amount of glucose converted to lactate was 
variable, the amount of glucose oxidised was constant over a wide range 
of growth rates. Based on his calculation that the metabolic quotient for 
glucose oxidised = qo 1acos e- 0.5(gi act. to), a similar constant value 
is obtained at the 3 growth rates studied in this investigation (qg iacoae 
0.5(gi actat e) = 0.14-0.16 )imol/106 cells/h). This suggests that at a 
glucose uptake rate of 0.14-0.16 pmol/106 cells/h there should be no net 
yield of lactate but such a prediction was not tested. 
Ii) More glutamine is incompletely oxidised to lactate at higher growth 
rates. Zielke and colleagues (1980) discovered that 13% of glutamine 
carbon was converted to lactate in HeLa cells but the contribution to 
qi act ate from glutamine might be expected to be small and it is likely 
that much of the increase in gi. ct. t. is attributable to increased 
glycolytic activity. 
iii) Since mammalian cells utilise glutamlne in the synthesis of 
asparagine, purines, pyrimidines and amino sugars (Levintow et al., 
1957; Salzman et a!., 1957; Meister, 1962) it is likely that the. 
requirements for glutamine increase in more rapidly growing 
cells. The metabolic quotient for glutamine does indeed increase with 
dilution rate in the chemostat whereas q... o. i. was similar at all three 
growth rates. The decreasing ammonia yield from glutamine in the 
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chemostat suggests that a greater proportion of glutamine nitrogen is 
being incorporated into cell biomass. However this investigation has 
also demonstrated that the cell yield from glutamine is constant over 
the range of dilution rates which may be evidence that glutamine carbon 
is accumulating in amino acid pools such as glutamate or alanine (Seaver 
et al.. 1984; Merten, 1986; Miller et al.. 1988a). 
iv) There is evidence that an increasing flux through the glycolytic 
pathway inhibits glutamine oxidation (Zielke et al., 1978; Hu et al., 
1987). The reduced yield of ammonia from glutamine seen in this 
investigation would be consistent with a reduction in the oxidative 
deamination of glutamine. The mechanisms of such regulation have not 
been elucidated but it is known that increased rates of glycolysis inhibit 
oxidation via the Krebs cycle (Frame and Hu, 1984; Glacken et al., 1986) 
possibly due to an increased cytosolic ATP/ADP ratio (Miller et al., 
1988a). Recently Glacken (1988) has postulated that the increased rate 
of ATP production from glycolysis depletes the intracellular phosphate 
pool which leads to a reduction in phosphate-regulated glutaminase 
activity. 
Antibody production showed a decreasing specific production 
rate and product yield from glutamine, with increasing dilution rate. 
This is consistent with other observations on the production of 
monoclonal antibodies 'by hybridomas. Higher specific production 
rates have been noted in perfusion culture systems with low cell 
growth rates (Van Wezel et al., 1985; Reuveny et al., 1986b) and Miller 
and colleagues (1988a) showed a similar relationship between growth 
rate and the specific production rate of antibody in a glucose limited 
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chemostat culture. Birch and colleagues (1985b) also made similar 
observations in chemostat cultures of hybridomas under oxygen or 
glucose limitation but contrary to the findings in this investigation 
they found that antibody production was depressed at low growth 
rates under glutamine limitation. The reasons for this difference are 
unclear and a lack of data concerning the culture conditions under 
which Birch and colleagues made these observations make it difficult 
to identify possible contributing factors. 
In general it appears that low growth rates favour higher 
antibody production rates in hybridomas. A number of hypotheses 
could be put forward to explain this behaviour. 
1) The capacity for macromolecular synthesis by hybridomas Is finite 
and monoclonal antibodies take up a substantial proportion of the 
cells capacity for protein synthesis. Hybridomas may produce in excess 
of 1000 molecules immunoglobulin/cell/second (Merten, 1987). It would 
therefore be reasonable to assume that at higher growth rates more 
of the cells synthetic capacity would be diverted towards 
macromolecular synthesis for the processes of cell division at the 
expense of antibody synthesis. The changing fate of glucose and 
glutamine at higher growth rates may be evidence of this change in the 
metabolic balance. The Increased efficiency of nitrogen incorporation at 
high growth rates may reflect the increasing demands on the cell 
metabolite pool while the increasing conversion of glucose to lactate 
could be supplying the increased energy needs of the cell. 
ii) Antibody synthesis is repressed or inhibited by a metabolite. If 
antibody synthesis is being adversely affected by a metabolite such as 
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glucose, glutamine, lactate or ammonia, then increased rates of uptake 
or production at high growth rates could account for the decline in the 
rate of antibody synthesis. 
If such a phenomenon exists in hybridomas it is a complex process 
as many factors have been shown to influence antibody production. 
Glucose, oxygen (Birch et al., 1985b; Miller et al., 1988a) and glutamine 
(this investigation) limited chemostat cultures show decreasing 
antibody production rates with increasing growth rate. There is some 
evidence to suggest that these effects are not due to 
inhibition/repression in that Miller et al. (1987) have noted that the 
optimum oxygen concentration for cell growth was different from that 
for antibody production but g91ta. init , goiuco.. and goxYoen were 
maximal at the highest qa ntibodV which would not be consistent 
with inhibition or repression by any of nutrients. In addition glucose 
does not affect antibody production in batch culture (Low and Harbour, 
1985; Tharakan and Chau, 1986), Bodeker et al. (1988) found antibody 
production by immobilised hybridomas was favoured at high oxygen 
consumption rates and in this investigation high glutamine 
concentrations had little effect on antibody production in batch cultures 
(Chapter 4, sections 4.2.3 and 4.2.7). 
Ammonia has been found to inhibit the production of viruses (Eaton 
and Scala, 1961; Jensen and Liu, 1961), interferon (Ito and McLimans, 
1981) and antibody production (Reuveny et a1., 1986a) but in this case 
q... o nia remains unaltered at each dilution rate and steady state 
ammonia concentrations decline at high growth rates. It therefore seems 
unlikely that inhibition by ammonia Is responsible for the decline In 
antibody production rate observed in the chemostat. 
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Increasing concentrations of lactate at higher growth rates may 
Inhibit antibody production as suggested by Glacken et al. (1986). 
however Reuveny et al. (1986a) and Miller et al. (1988b) have found 
that lactate levels above 20mM did not affect antibody production. It 
Is also notable that the highest rates of antibody production often 
occur In the latter stages of batch cultures when lactate 
concentrations are highest (see Chapter 4). 
iii) Cell cycle distribution. It has been reported that some 
lymphoblastold cell lines produce antibody in a cell-cycle 
dependent fashion with the highest production during the Gi phase 
(Buell and Fahey, 1969; Takahashi et al., 1969, Byars and Kidson, 
1970, Garatun-Tjeldsto et al., 1976; Turner et al., 1986). It has also 
been found that the distribution of cells throughout the cell cycle 
changes with growth rate where the S, Gz and M phases remain 
relatively constant and variations in the length of the cell cycle can 
be attributed to variations in the length of Gi. This has also been 
demonstrated in chemostat culture with yeast (Bailey et al., 1982; 
Scheper et al., 1988). They showed that proportionately more cells 
were in the Gi phase at low growth rates. If the synthesis of 
antibody by hybridomas is restricted to the Gi phase then it would 
follow that the rate of antibody synthesis would be higher at low 
growth rates. This could also account for the higher production rates 
observed in stationary phase or in Gi arrested cells (Chapter 4). It is not 
known whether immunoglobulin synthesis by hybridomas is under cell 
cycle regulation but this possibility was entertained by Low and Harbour 
(1985a) who detected a sub-population of hybridomas which were not 
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secreting antibody. Furthermore they found that the proportion of 
non-secreting cells did not change after subsequent cloning suggesting 
that non-secreting cells may have been passing through a 
non-productive stage of the cell cycle. 
Preliminary investigations have been carried out to determine 
whether such a phenomenon exists in hybridomas and the findings are 
described in the next chapter. 
Conclusions. 
1. Higher cell and antibody yields from glutamine were achieved in 
chemostat culture suggesting that glutamine utilisation is more efficient 
at low concentrations. The lower ammonia yields observed in the 
chemostat were also evidence of a more efficient incorporation of 
glutamine nitrogen. 
2. Glucose uptake rate increased at higher growth rates. The proportion 
of glucose converted to lactate was also increased at higher growth 
rates suggesting that energy production from aerobic glycolysis 
increases in rapidly growing cells. 
3. Glutamine uptake rate increased at high growth rates. The amount of 
ammonia liberated from each molecule of glutamine declined at high 
growth rates suggesting that glutamine nitrogen was being more 
efficiently incorporated into biomass at high growth rates. 
4. The specific production rate for antibody declined at high growth 
rates. This may be evidence that the increased demands on energy and 
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metabolite pools by rapidly growing cells is detrimental to antibody 
synthesis. Alternatively it may be evidence that antibody is only 
produced during the GL phase of the cell cycle, which is shorter at high 
growth rates, and hence represents a smaller proportion of the cell 
cycle. 
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Chapter 6 
Synchronised culture. 
6.1 Introduction. 
There is a considerable weight of evidence to suggest that many 
metabolic functions, including protein synthesis, are cell cycle- 
dependent (Mitchison, 1971; Lloyd et al., 1982; Denhardt et al., 1986). 
Many proteins which show cell cycle-dependent expression can be 
related to specific functions within the cell cycle, for example 
thymidine kinase (Liu et al., 1986) and histone synthesis (Delisle et al., 
1983; Artishevsky et al., 1984) are usually tightly coupled to DNA 
synthesis. However the expression of other proteins may not be so 
readily linked with the process of cell replication and immunoglobulin 
synthesis falls within this category. 
Based on the evidence from cell synchronisation experiments 
using different synchronisation procedures on different 
immunoglobulin secreting cell lines several investigators have 
suggested that the bulk of immunoglobulin production Is produced In 
the late Gi early S phases of the cell cycle (Byars and Kidson. 1970; 
Buell and Fahey. 1969; Takahashi. 1969; Garatun-Tjeldsto et al.. 1976; 
Turner et al.. 1985). Other investigators have disputed this finding in 
that they found no evidence for such variation with cell cry Je. (Cowan 
and Milstein. 1972; Liberti and Baglioni. 1973) although the latter 
authors observed that immunoglobulin synthesis was depressed during 
mitosis. It was also suggested that the variation was due to the 
synchronisation procedure and not a true reflection of protein 
expression in normally growing cells. This view was supported by 
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Damiani and collegues (1979) who investigated the production of 
immunoglobulin in an adherent myeloma cell line. Using a physical 
rather than chemical selection procedure to synchronise the cells they 
could find no variation in immunoglobulin expression during the cell 
cycle. However Killander et al. (1977) used cytophotometry to 
examine the production of IgE in asynchronous cultures of human 
myeloma cells and in At least some of their experiments there was an 
apparent increase in the accumulation of IgE in Gi with a subsequent 
decrease during S phase. 
There are therefore several different observations concerning the 
relationship between cell cycle and immunoglobulin production but 
the observations that the G, phase contributes much of the variability 
to the duration of the cell cycle and that cells, including hybridomas 
(Schliermann et al., 1987). tend to accumulate in Gi in sub-optimal 
growth conditions suggest that higher antibody production rates in G1 
could contribute to the variability seen in immunoglobulin production 
by hybridomas. 
In order to investigate the possibility that immunoglobulin 
synthesis or secretion is restricted to particular phases of the 
hybridoma cell cycle it is necessary to produce a population of cells 
which are predominantly in the same part of the cell cycle at one time. 
Cell synchronisation allows this approach in that a population of cells 
can be induced to perform the mechanisms of cell division in synchrony. 
The methods available for synchronisation of animal cells depends 
on the type of cell and a number of methods have been applied. 
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61 .1 Physical selection methods. 
1) Mitotic selection. The selection of cells in mitosis is a method which 
produces a population of cells with a high degree of synchrony 
(Terasima and Tolmach. 1963). The tendency for anchorage dependent 
cells to become - rounded and hence more loosely attached to the 
substrate during mitosis means that they are more readily shaken 
free of the surface and can be separated from the more strongly 
attached cells. This technique only produces a small number of cells 
and cannot be applied to suspension cells such as hybridomas. 
ii) Size selection. In progressing from one mitosis to the next a cell 
doubles in size. In fact there Is a gradual Increase in cell volume from 
Gi to M (Grazitt et al., 1978) and this has been used to separate cells 
by density gradient centrifugation (Mitchell and Tupper, 1977). 
iii) Cell sorting by cytofluorimetry. Fluorescence measurements of the 
DNA content of cells can be made at rates of 104 cells per second in a 
flow cytofluorimeter (Kamentsley et al., 1965) which allows the 
frequency distribution analysis of the cell cycle in randomly dividing 
cells. Cell subpopulations can thus be selected and the physical sorting 
of cells in particular phases can be achieved as the cells leave the flow 
chamber. Cells are isolated in tiny droplets and selected cells are 
electrostatically charged and deflected into a separate collection vessel 
for further analysis (Horan and Wheeless, 1977; Schaap et al., 1979). 
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6.1.2 Growth arrest. 
Other synchronisation procedures depend on the accumulation of cells 
at a particular point in the cell cycle by the use of inhibitors or 
nutrient starvation. 
1) Nutrient starvation. Under adverse environmental conditions 
mammalian cells have a tendency to accumulate in the Gi phase and this 
phenomenon has been used to synchronise cells. For example cells 
starved of isoleucine or glutamine (Ley and Tobey, 1970) or serum 
(Burk, 1970) arrest in Gi and subsequent addition of the missing 
nutrient can induce the cells to divide in synchrony. 
11) Inhibition. The use of metabolic inhibitors to specifically block an 
event necessary for the progress of the cell through the division cycle 
can be used to gather cells at a particular point in the cell cycle. 
Release from a reversible inhibitor can result in the synchronous growth 
of the cells. The use of colcemid to gather cells at metaphase by the 
Inhibition of spindle formation (Stubblefield, 1964). is useful In 
gathering greater numbers of anchorage dependent cells for mitotic 
selection but is not useful for suspension cells because exposure to 
colcemid for longer than 2-3 hours causes irreversible damage to the 
cells (Stubblefield, 1968). Inhibitors of DNA synthesis are more useful 
for suspension cells. Methotrexate (Rueckert and Mueller, 1960) or 
6-fluorodeoxyuridine (Littlefield, 1962) inhibit DNA synthesis by 
interfering with the methylation of thymidine. High 
concentrations of thymidine (Xeros, 1962). deoxyadenosine or 
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deoxyguanosine (Mueller and Kajiwara, 1966) inhibit DNA synthesis by 
feedback effects on other nucleotide precursors. Such methods will 
arrest cells at any point in the S-phase and consequently a single block 
will only produce a high degree of synchrony in cells where the 
S-phase represents only a small fraction of the complete division 
cycle. More rapidly growing cells such as hybridomas where the 
S-phase occupies a relatively large proportion of the cell cycle 
require a double block. The first block arrests cells in S-phase while 
cells in other phases complete the cycle and gather at the end of the 
Gi phase. The cells are then released from the block until all cells 
have traversed the S-phase then blocked a second time such that the 
majority of cells collect at the boundary between the Gi and S phases. 
On release the cells should resume growth in synchrony. 
Thymidine blocking of 321 hybridoma cells has already been 
successfully used in this investigation (see Chapter 4). The double 
thymidine block method was therefore adapted for the 
synchronisation of 321 hybridoma cells. 
6.2 Materials and methods. 
6.2.1 Synchronisation of the 321 hybridoma. 
The synchronisation of the 321 hybridoma was carried out 
according to the method of Puck (1964). The method was modified for 
the hybridomas. 
Cells growing in early to mid exponential phase were arrested 
by the addition of thymidine to 2mM. After 30 hours under the 
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thymidine block the cells were washed and resuspended in thymidine 
free medium at a density of 2.6x105 cells/ml. After 6 hours incubation 
2mM thymidine was added to the culture and the cells were incubated 
for a further 18 hours. The cells were resuspended at a density of 
2.5x105 /ml in thymidine free medium and the cell growth and 
productivity were measured for 2 cell divisions. 
6.2.2 Radiolabelling of proteins. 
" Glasgows modification of Eagles medium was used for the protein 
radiolabelling experiments. This was formulated to contain only 
3mg/l of methionine and was obtained from the Institute of Virology, 
University of Glasgow. 
For labelling experiments an aliquot containing 106 cells was 
washed twice with PBS at 37° C and resuspended in 200pl GMEM 
containing 35 S-methionine (Amersham) at a concentration of 
20liCi/ml. The cells were incubated with the radiolabel for one hour 
then lysed by the addition of 200p1 of sample buffer (100mM tris HCl 
pH6.8,10% 2-mercaptoethanol, 4% sodium dodecyl sulphate and 20% 
glycerol) and each sample was boiled for 6 minutes before storage at 
-2011 C. 
6.2.3 Radiolabelling of DNA. 
Periods of DNA synthesis were assessed by harvesting aliquots 
of 5x105 cells and resuspending them in iml RPMI containing 
3 H-thymidine (Amersham) at 6pCi/ml. The cells were incubated for 30 
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minutes then collected by centrifugation. The supernatant was 
discarded and 0.5 ml distilled water was added to resuspend the cells 
which were then lysed by the addition of 0.5m1 SDS-EDTA (0.01M NaCl; 
0.01M Tris chloride, pH 7.0; 1% SDS and 0.05M EDTA). 
Aliquots of the lysed cell suspension were placed onto filter 
paper strips and precipitated with ice cold 10% trichloracetic acid 
(TCA). The strips were washed in three changes of 10% TCA. Each 
strip was placed in a vial containing 4m1 Aqualuma scintillation fluid 
(LKB) and counted in a scintillation counter (LKB Rackbeta). 
6.2.4 SDS-Polyacrylamide gel electrophoresis. 
SDS-polyacrylamide gel electrophoresis was carried out as 
described in section 2.3.4. except that following electrophoresis the gel 
was fixed in a solution of 40% acetic acid, 30% methanol in water (v/v) 
for one hour then impregnated with En3 Hance (New England Nuclear) for 
one hour and finally washed in distilled water for one hour. The gel was 
then dried onto filter paper under vacuum. 
6.3 Results. 
6.3.1 Determination of the S-phase. 
The double block method of synchronising animal cells requires 
some prior knowledge of the length of S-phase so an experiment was 
devised which would give an estimate of the duration of the S-phase. 
Cells in the exponential phase of growth were blocked by adding 
thymidine to a final concentration of 2mM. After 24 hours the cells 
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were resuspended in thymidine-free medium. At this time and at 
subsequent 1 hour intervals, an aliquot of cells was removed and 
thymidine was added again to a final concentration of 2mM. After a 
further 24 hours incubation in thymidine the cells in each aliquot were 
counted. Assuming that there was no delay at the boundary between the 
Gi and S phases, the time at which the cell number reaches a plateau 
will correspond to the time taken for all cells to escape the S-phase 
and hence the duration of the S-phase. 
Figure 6.1 shows viable cell counts obtained during the thymidine 
block and release experiment. Cells were initially at a concentration 
of 3x105 cells/ml before release. After 5 hours a plateau for the cell 
concentration was reached indicating that it required approximately 
5 hours for all the cells to escape from the S-phase and hence an 
approximate duration of 5 hours for the S-phase. Based on this 
experiment it was possible to design a protocol for cell synchronisation. 
6.3.2 Cell synchronisation. 
Figures 6.2 and 6.3 show the results of synchronisation 
experiments with the 321 hybridoma. The data shown in figure 6.2 was 
the result of a single synchronisation experiment whilst figure 6.3 
represents the mean of three experiments. Figure 6.2 is shown 
separately as it was the highest degree of synchrony achieved with 
the 321 cells. 
In each experiment the cells were released from the thymidine 
- 
block at a density of 2.5x105/ml. The cell number remained constant 
for 9 hours after which time there was a rapid increase in cell number 
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Figure 6.1. Determination of the duration of S-phase 
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Cells were blocked with 2mM thymidine for an initial period of 24 hours. 
The graph shows the effect of of releasing cells from the thymidine block 
for increasing periods of time before blocking again with 2mM thymidine. 
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Figure 6.2. Cell growth and antibody production after release from the 
double thymidine block. 
The figure shows a) viable cell numbers, b) antibody concentration and 
c) the specific antibody production rate (APR) calculated from the data 
shown in figures 6.2a and 6.2b. 
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Figure 6.3. Cell growth and antibody production after release from the 
double thymidine block. 
The figure shows a) viable cell numbers, b) antibody concentration and 
c) the specific antibody production rate (APR) calculated from the data 
shown in figures 6.3a and 6.3b. Each point represents the mean of three 
separate experiments. Error bars are the standard deviation (n=3). 
191 
Figure 6.3 
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due to a high proportion of the cells dividing simultaneously. The 
cells reached a new constant level by which time 70-75% of the cells 
had undergone mitosis. The proportion of cells dividing at any one 
mitosis never exceeded 75% in these experiments and there was 
no significant accumulation of dead cells suggesting that the shortfall 
was not due to cell death. The second division occured some 13 hours 
later with approximately 70% of the cells undergoing mitosis. There 
was considerable loss of synchrony at the second cell division and 
this was especially noticeable in figure 6.3a. 
It was possible with the Information generated with these 
experiments to make estimates for the duration of some of the phases 
in the 321 cell cycle. The difference in the time to the first division 
and the time between the first and second divisions represents the 
duration of the Gi phase assuming that the duration of (S+G2 +M) was 
constant in subsequent division cycles. The point at which 50% of the 
cells had undergone mitosis was taken as the end of the division 
cycle. The approximate duration for Gi from these data was therefore 
3 hours and because the duration of the S-phase had been previously 
determined as 5 hours the G2 +M phases were regarded as occupying the 
remainder of the cell cycle which was 5 hours. 
Antibody accumulation in the medium was assayed by the 
sandwich ELISA as previously described (Chapter 2, Section 2.2.5). 
Figures 6.2b and 6.3b show the accumulation of antibody in the medium 
of a synchronised culture of the 321 hybridoma. The rate of 
production of antibody was not constant because there were detectable 
gradient changes on the antibody curve. Figure 6.2c and 6.3c 
Illustrate the variation in antibody production rate during the 321 
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cell cycle. The antibody production rate (APR) was expressed In jig/106 
cells/h and was calculated from the cell number and antibody 
accumulation curves. Both curves show decreased production rates 
coinciding with the M phase and in figure f. 2c there appears to be 
a second decrease in production rate which corresponds with the 
estimated position of the S-phase. In figure 6.3c the second decrease 
In accumulation rate is less apparent which may be the result of the 
poorer synchrony achieved in these experiments. 
These data however are based only on the accumulation of 
antibody in the culture medium and give no indication of the rate of 
synthesis of antibody within the cell. To investigate the rate of 
synthesis of antibody throughout the cell cycle, the 
incorporation of radiolabelled methionine into antibody was 
monitored at intervals throughout the cell cycle. 
6.3.3 The incorporation ofS-methionine into antibody. 
A synchronised culture was initiated at 2.5x105 cells/ml and aliquots 
of cells were removed at 90 minute intervals to measure the rate of 
incorporation of 35 S-methionine into 321 antibody. 
Figure 6.4a shows cell number in a synchronised culture of 321 cells 
over a period of 18 hours. Figures 6.4b and 6.4c show respectively, the 
incorporation of 3 H-thymidine Into DNA and the incorporation of 
30 S-methionine into protein over the same period. The rate of 
incorporation of thymidine was initially high but decreased after 
approximately 5 hours which is in agreement with previous estimates of 
the duration of the S phase. There was a subsequent increase in the 
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Figure 6.4. Incorporation of 3 H-thymidine and 35 S-methionlne býsynchronised 
hybridomas. 
The figure shows a) viable cell numbers, b) 3 H-thymidine incorporation 
into acid precipitable material and c) 35 S-methionine incorporation into 
acid precipitable material. 
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rate of thymidine incorporation with a 60% maximum point 13 hours 
from the release from the thymidine block. 
Plate 6.1 shows an autoradlograph developed from an 
SDS-polacrylamide gel of radlolabelled proteins from a synchronised 
culture of 321 cells. The heavy chain of the antibody was obscured by 
other bands around the same position on the gel and its relative 
density could not be readily determined. The light chain however was 
a easily distinguishable band with a molecular weight of 25kD. The 
relative density of the light chains was determined using a Quantimet 
970 image analyser (Cambridge Instruments) programmed to measure 
grey levels along an individual track. The variation in intensity 
between tracks was compensated for by dividing the intensity of the 
light chain peak by the average intensity of the entire track. The 
resulting graph (figure 6.5) shows that the incorporation of 
35 S-methionine into antibody light chains shows a similar periodicity " 
to the accumulation of antibody in the medium. Furthermore because 
both intracellular and secreted antibody was measured by this method 
it suggests that the observed fluctuations are due to the rate of 
antibody synthesis. The relative rates of antibody synthesis and 
secretion were not determined in this investigation but could be 
measured by pulse-chase radlolabelling experiments. 
6.3.4 The effect of PH on the cell cycle. 
In order to explain the variation in antibody production rate due 
to growth rate as a result of the periodic production of antibody within 
the cell cycle it would be necessary to demonstrate that variations in 
cell growth rate can be attributed to variations in the duration of 
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Plate 6.1 Autoradlograph of the separated 321 hybrldoma proteins. 
The plate shows an autoradlograph of the 321 hybridoma proteins 
which have incorporated 35S-methionine during a 60 minute pulse 
labelling of cells in a synchronous division cycle. Each lane represents 
a separate time interval after release from the thymidine block as shown 
by the times above the individual lanes. Molecular weight markers are 
14 C-labelled proteins (myosin, 200kD; phosphorylase-b, 92.6kD; bovine 
serum albumin, 69kD; ovalbumin, 46kD; carbonic anhydrase, 3OkD; 
lysozyme, 14.3kD; Amersham CFA 626). 
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Figure 6.5 Changes in the incorporation of 35 S-methionine into 
antibody light chains. 
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The figure shows the relative density of the light chain bands observed 
on an autoradlograph of a PAGE gel loaded with protein samples from the 
synchronised culture described in figure 6.4. The relative density of the 
bands was determined by image analysis using the Quantimet image 
analyser (Cambridge Instruments). 
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particular phases of the cell cycle. 
It has previously been shown that pH had a significant effect on 
the growth rate of the 321 hybridoma (Chapter 4, Section 4.2.4). For this 
reason the effect of pH on the cell cycle was investigated using a 
synchronised culture of 321 cells. Synchronised cells were prepared 
as previously described and were resuspended in HEPES buffered RPMI 
at initial pH values of 6.6,7.2. and 7.8. 
Figure 6.6 shows cell counts taken over 34 hours. It was observed 
that the cells underwent the first mitosis after release simultaneously 
and reached the same cell density. This implies that the S, G2, and M 
phases seem unaffected by a this pH range. However at the second 
mitosis cells at pH 7 underwent division some hours earlier than those 
cells at pH 7.8 whilst cells at pH 6.6 underwent division some hours 
later than cells at pH 7.8. If it is assumed that the S, G2 and M phases 
are still constant then the Gi phase appears to be contributing to the 
Increase In length of the cell cycle under unfavourable conditions of pH. 
6.4 Discussion. 
Synchronisation of the 321 hybridoma was achieved using the 
double thymidine block method. The cell cycle was approximately 13 
hours in length under these conditions and this agreed favourably with 
the maximum specific growth rate in batch culture of 0.051 h-1 which is 
equivalent to a cell doubling time of 13.6 hours. Analysis of the data 
from several experiments showed that the S phase was 5 hours long, the 
combined G2 +M phase 5 hours long suggesting that the minimum duration 
of the Gi phase was 3 hours. 
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Figure 6.6. The effect of pH on the duration of the cell cycle 
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The figure shows viable cell numbers determined for synchronised 
hybridoma cultures at pH 6.6 (0). pH 7.2 (0) and pH 7.8 (Q). The cells 
were cultured in RPMI 1640 with 10% newborn calf serum, 5mM NaHCO3 
and 20mM HEPES. The pH was, adjusted to the above values by the 
addition of NaOH or HCI. 
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The data generated from cell synchronisation experiments on 
the 321 hybridoma suggested that the rate of production of 
immunoglobulin was not constant throughout all phases of the cell 
cycle. In particular there was a marked and reproducible drop in the 
antibody accumulation rate during mitosis with evidence of a second 
decrease in the S phase. 
Depression of protein synthesis during mitosis has been described 
in many mammalian cells (eg. Prescott and Bender, 1962; Scharff and 
Robbins, 1966; Lloyd et al., 1976). This may be due in part to the well 
documented stop of RNA synthesis at mitosis (Feindengen et al., 1960; 
Terasima and Tolmach, 1963; Schiff, 1965) but some cell lines have 
been shown to continue protein synthesis during mitosis (Konrad, 
1963). Evidence has been produced to suggest that where a decrease 
in protein synthesis occurs it is due to inhibition of the translation 
of mRNAs which persist in the cytoplasm during mitosis (Fan and 
Penman, 1970). 
In this Investigation total protein synthesis was assessed by 
the Incorporation of 35 S-methionine Into TCA precipitable protein. 
On release from the thymidine blockade there was an Initial increase 
in the incorporation of the radiolabel until mitosis at which point 
there was a 35% decrease. The rate of 35 S-methlonlne Incorporation did 
not recover after mitosis but continued at the lower level. It was 
therefore difficult to determine whether there was a decrease in the 
rate of protein synthesis during mitosis. 
The incorporation of 3a S-methionine into Immunoglobulin 
light chains however, showed a decrease during mitosis with a 
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subsequent increase in the following Gi phase. This is in agreement 
with the observations of several authors who noted that the 
production of antibody was lowest during mitosis (Takahashi et al. 
1969; Buell and Fahey, 1969; Lerner and Hodge, 1970; Libertl and 
Baglioni, 1973; Turner et al., 1985). Several of these workers also 
showed that peak rates of antibody production in late Gi and during S 
phase were followed by a gradual decrease during G2 and mitosis: in 
both human lymphoblastoid cells (Buell and Fahey, 1969; Takahashi et 
al., 1969; Turner et al., 1985) and, mouse myeloma cells (Byars and 
Kidson, 1970; Garatun-Tjeldsto et al., 1976). 
However, in contrast to the patterns described above, the 
antibody accumulation rate In the synchronised hybridoma remained 
high during the latter half of the cell cycle. In one experiment two 
peaks in the rate of antibody accumulation could be resolved. These 
peaks corresponded to the estimated positions of the Gi and G2 phases 
with an apparent decrease in the antibody production rate during S 
phase. This is consistent with - the patterns of immunoglobulin 
production which have been observed in human myelomas by Killander 
et al. (1977) and in human lymphoblastold cells by Watanabe et al 
(1973). These authors found high production rates in Gi, decreased 
production rates during S phase and a later recovery in G2. 
Many experiments in this investigation did not show this decrease 
in antibody production rate during S-phase although there was an 
abrubt increase -corresponding to the G2 phase. However in the 
radiolabelling experiment, there was an apparent reduction in the 
incorporation of 3° S-methionine into antibody light chains coinciding 
with the peak rate of 3H-thymidine incorporation into DNA. This 
204 
suggests that there was a reduction in antibody production during the 
S phase which may have been obscured in some experiments by a 
lower degree of cell synchrony. However the reduction in the rate of 
antibody synthesis during S phase must be either partial or confined to 
a small portion of the S phase. If antibody production stopped completely 
for the duration of the S phase (40% of the cell cycle) the change In the 
rate of antibody accumulation might be expected to be greater than 
observed in this Investigation. 
The Increased rate of immunoglobulin synthesis seen In G2 In many 
experiments may be a reflection of increases in cell size and protein 
content due to cell growth. The dry weight of 'a cell increases 
continuously during the cell cycle and pulse labelling 
with amino acids shows an increasing rate of incorporation 
(Zetterberg and Killander, 1965). The rate of RNA synthesis also 
doubles between mitoses (Scharff and Robbins, 1966; Enger and Tobey. 
1969; Lloyd et al., 1982). This suggests that the specific rate of 
protein synthesis per cell increases and may account for the higher rate 
of antibody accumulation during the G2 phase. The incorporation of 
35S-methionine did show an initial increase in the rate of uptake on 
progression from S to M in the first cycle but this was not repeated in 
the second cycle. This may have been due to nutrient depletion causing 
a slowing of protein synthesis. 
The abrupt increase in antibody accumulation rate which was 
frequently observed immediately after the S phase might also be 
explained by a gene dosage effect. Several authors have noted that the 
rate of RNA synthesis doubles during S phase and this has been ascribed 
to a doubling of the gene complement after DNA replication which leads 
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to Increased rates of transcription (Zetterberg and Killander, 1966; 
Stambrook and Sisken, 1972). Further investigation would be required 
to confirm this hypothesis, such as the measurement of heavy or light 
chain immunoglobulin messenger RNAs by suitable cDNA probes to 
show whether there is increased transcription of immunoglobulin genes 
following DNA duplication. The same approach might equally be 
applied to all phases of the cell cycle to investigate whether the 
levels of immunoglobulin mRNA reflect the pattern of 
immunoglobulin synthesis during the cell cycle. 
The validity of data generated from synchronisation 
experiments has been questioned by a number of authors 
(Mitchison, 1971; Cowan and Milstein, 1973, John et al., 1981; Lloyd, 
1986) due to the techniques used to obtain synchronised cells. In 
particular methods of Induction synchrony require the maintenance of 
cells in restrictive conditions often for long periods of time. It Is 
known that many of the inhibitors of DNA synthesis, including 
thymidine (Xeros, 1962), allow continued RNA and protein synthesis 
and it has been suggested that blocking with inhibitors of DNA 
synthesis only synchronises those events which depend on or are 
coupled to DNA synthesis (Mueller, 1969) whilst protein and RNA 
synthesis remain asynchronous. This suggests that cell growth and DNA 
synthesis can be uncoupled from one another as first proposed by 
Mitchison (1971) however there is a considerable amount of evidence 
which suggests that the intiation of DNA synthesis is dependent 
ultimately on an event linked to cell size (Shields et al., 1978, Nurse and 
Fantes. 1981). 
With due regard to reservations concerning cell 
synchronisation methods the data presented In this investigation 
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indicate that antibody production rate is not constant throughout the 
cell cycle. However further work is required in order to confirm that the 
variations observed are not a result disturbances in cell metabolism due 
to the synchronisation method. Methods of synchronising cells which do 
not rely on perturbation of cell metabolism (e. g. density gradient 
separation) will provide a more accurate impression of antibody 
production patterns during the cell cycle. In an attempt to overcome 
perturbations introduced by cell synchronisation techniques, Altshuler 
et al.. 1986 examined the immunoglobulin content of an asynchronous 
population of hybridomas by flow cytometry. They observed two peaks 
in the intracellular concentration distribution of immunoglobulin which 
might suggest a cell cycle dependence for antibody synthesis. However 
they also showed with dual staining techniques for DNA and antibody 
content that both antibody peaks appeared to be present throughout 
the cell cycle and concluded that there was no simple on/off 
dependence of immunoglobulin production on cell cycle. However flow 
cytometry only measures the amount of antibody associated with a cell 
at a particular point in time and does not provide Information on the 
rate of antibody production. Thus their investigation may only have 
demonstrated the existence of two populations of hybridoma cells. 
It has not been ascertained' in this Investigation whether 
variations in the rate of antibody production were due a temporal 
regulation of antibody synthesis during the cell cycle or were a 
reflection of the changing demands for macromolecular synthesis during 
certain phases of the cell cycle. For example many enzymes involved in 
DNA synthesis increase in activity during S phase (Kit, 1976; Nakamura 
et al., 1984; Eriksson et al., 1984; Denhardt et al., 1986) and histone 
synthesis may account for 10% of total protein synthesis during this 
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period (Denhardt et al., 1986). This could account for a decrease in the 
rate of immunoglobulin synthesis during S phase. 
Variations in the rate of uptake of nutients during the cell cycle 
could also account for variations in the rate of antibody synthesis. 
Increased rates of amino acid uptake have been described during Gt' in 
human lymphocytes (Glassy and Furlong, 1981) and during mitosis in 
HeLa cells (Macmillan and Wheatley, 1981). Further studies on the rates 
of nutrient uptake, energy balance and metabolite pools during the 
hybridoma cell cycle may clarify the relationship between cell growth 
and monoclonal antibody production. Studies on the relative rates of 
immunoglobulin gene transcription and translation would be necessary 
to reveal whether antibody synthesis was regulated at the gene level or 
at a later stage. 
The other aim of this Investigation was to determine whether 
changes in cell growth rate were attributable to changes in the length 
of the Gi phase. It was found that conditions of adverse pH which have 
been shown to reduce the growth rate of the 321 hybridoma had little 
affect on the time taken to traverse the cell cycle when started from a 
point after the Gi phase but significantly lengthen the time taken 
to complete the cell cycle when the Gi phase Is present. This Implies 
that the Gi phase is more sensitive to the physiological environment 
which is in accord with the proposed restriction point of Pardee (1974) 
who showed that several different blocking conditions (low serum, 
amino acid starvation, elevated intracellular AMP and density 
dependent Inhibition) arrested cells at the same point In G1. 
These findings are consistent with the idea that changes in cell 
growth rate are due to variations in the length of the Gi phase and that 
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the proportions of cells in different phases of the cell cycle must 
therefore change with growth rate. This has been demonstrated In yeast 
cells growing in chemostat culture where the proportion of cells in the 
Gi phase was found to increase at low growth rates (Sheper et al.. 1987). 
This implies that the rate of synthesis of proteins which are linked to 
particular phases of the cell cycle, will also change with growth rate. It 
was not possible to make accurate estimates of the magnitude or 
duration of the changes in antibody production rate observed during the 
cell cycle of the 321 hybridoma due to imperfect synchrony and therefore 
any models of antibody production kinetics based on such data would be 
tentative. However it does illustrate that environmental parameters 
which affect cell growth rate may have profound effects on the 
distribution of cells in the cell cycle which in turn may affect the 
relative rate of production of any cell cycle associated proteins. The 
relatively high rate of antibody production in Gi would be consistent 
with the observation that Gi arrested cells or more slowly growing cells 
exhibit higher rates of antibody production. 
6.5 Conclusions. 
The purpose of this investigation was to determine, 
1) whether immunoglobulin synthesis was associated with the G1 phase 
of the cell cycle as shown in other Immunoglobulin synthesising cell 
lines and, 
11) if cell cycle regulated immunoglobulin synthesis could account for 
the increased rate of immunoglobulin synthesis observed at low growth 
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rates due to changes in the distribution of cells in the various phases 
of the cell cycle. 
In an attempt to answer these questions the 321 hybridoma was 
synchronised by the double thymidine block technique. Using this 
technique It has been found that whilst there is evidence of variation 
in the rate of immunoglobulin synthesis at different phases of the cell 
cycle. immunoglobulin synthesis did not appear to be restricted to the 
Gi phase. Antibody production was observed during the Gz phase but 
may be produced at a lower rate during the S phase than during the Gi 
or Gz phases. There was a reproducible drop in the rate of antibody 
production during the M phase which may be due to a general reduction 
in the rate of protein synthesis during this phase although this has not 
been conclusively demonstrated in this investigation. 
The consequences of such variation on monoclonal antibody 
production kinetics have not been ascertained unequivocally but it has 
been found that conditions which are detrimental to cell growth such as 
low or high pH Increase the length of the cell cycle in a manner which 
suggests that this was due to an increase in the length of the Gi phase. 
This in turn suggests that the cell cycle distribution changes with 
growth rate and that the relative rate of production of cell cycle 
associated proteins may change accordingly. This is therefore a possible 
mechanism which could explain the effects of certain environmental 
parameters such as pH. oxygen or serum concentration on antibody 
production by hybridomas. 
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Chapter 7 
Summary and Recommendations 
7.1 Summary. 
A survey of the literature has shown that the kinetics of antibody 
production by hybridomas varies greatly between different cell lines. 
Many hybridomas show continued antibody production during both the 
growth and decline phases of a batch culture and are characteristically 
high producers (see for example Birch et al., 1987, Reuveny et al.. 
1986a) while others show declining rates of antibody production during 
the growth phase and are characteristically low producers (Merten et al., 
1987). While many of these differences may be due to the characteristics 
of the myeloma and B-cell parent cells and any genetic recombination 
following cell fusion (Westerwoudt, 1986), some generalisations can be 
made. For example it has been found that restriction of the rate of cell 
proliferation by nutrient limitation or by other suboptimal physiological 
conditions, often enhances the specific rate of antibody production by 
hybridoma cells. This suggests that there is an underlying relationship 
between cell growth and antibody production in hybridomas but the 
mechanisms of such a relationship have yet to be elucidated. The 
purpose of this investigation was therefore to examine the effects of the 
culture environment on cell proliferation, cell metabolism and antibody 
production in an attempt to determine the relationship between 
hybridoma growth and antibody production. 
It was considered that the relationship between antibody 
production and cell growth could best be evaluated by the use of an on- 
line assay to monitor continuously product formation under a variety of 
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experimental conditions. In chapter 3, the development and evaluation 
of an automated on-line ELISA system for the determination of antibody 
concentrations in bioreactors was described. The assay employed a 
packed bed of Sepharose covalently linked to anti-mouse IgG and all 
the reaction and washing steps of the ELISA were effected by passing 
the reagents through the packed bed. It was demonstrated that such a 
system could produce accurate and reproducible data. However the 
application of the system to the monitoring of product formation in 
bloreactors was limited by the compression of the Sepharose bed after 
several assay cycles which reduced the accuracy of the assay. Further 
difficulties were experienced in producing a cell-free sample stream for 
the assay while maintaining the sterility of the reactor. The 
recirculation of cells and medium through a cross-flow filter device was 
found to be detrimental to cell growth. 
In chapter 4 the growth and antibody production kinetics for the 
321 hybridoma were examined. The 321 hybridoma was found to produce 
large amounts of antibody with titres of 120-200pg/ml achieved in batch 
culture and in common with other highly productive hybridomas, the 
production of antibody continued during the decline phase. Furthermore 
the specific rate of antibody production was higher during the decline 
phase and approximately 60% of the total antibody yield was produced 
during this phase. Glutamine was exhausted by the end of the growth 
phase suggesting that glutamine may not be necessary for the continued 
production of antibody. One possible explanation for the increased 
antibody production rate after glutamine depletion was that glutamine 
or products of glutamine metabolism may have been Inhibiting or 
repressing antibody synthesis. However while lower giutamine 
concentrations led to decreased cell numbers illustrating the importance 
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of glutamine for hybridoma growth (figure 4.3), an inhibitory effect of 
glutamine on antibody production was not apparent. Indeed, there was 
some evidence to suggest that antibody production was depressed at low 
glutamine concentrations. The continued production of antibody after 
the exhaustion of glutamine in batch cultures might be explained by the 
accumulation of amino acid pools during growth (Seaver et al., 1984, 
Merten et al.. 1986). These pools may be subsequently utilised for 
protein synthesis after depletion of exogenous amino acids such as 
glutamine (see for example Stoner and Merchant, 1972). 
There are several reports in the literature concerning the effect of 
serum on the production of antibody by lymphoblastold cell lines (as 
recently reviewed by Glassy et al.. 1988) and it has been observed 
frequently that antibody production rates are enhanced in serum-free 
or serum-depleted media. This has been interpreted by some to suggest 
that serum contains factors which are inhibitory to antibody production. 
In this Investigation it was found that the reduction of serum 
concentration retarded cell growth (figure 4.6a) and that the specific 
antibody production rate was enhanced at low serum concentrations 
which was in agreement with previous reports. However when cell 
proliferation was arrested by the inhibition of DNA synthesis with 
excess thymidine, the trend was reversed and the highest antibody 
production rates were observed at the highest serum concentration 
(figure 4.13). This suggested that the effect of serum on antibody 
production was not due to direct inhibition of antibody synthesis but 
was an indirect effect due to the effect of serum on cell growth. Glassy 
and colleagues have noted that cell growth rates in serum free media are 
generally lower than in serum containing media suggesting that low 
growth rates are more favourable for antibody production. The data from 
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this investigation is consistent with such a hypothesis. 
The optimal pH for growth of the 321 hybridoma was found to be 7.2 
which is within the expected range of 6.9-7.4 reported for hybridomas 
(Harbour et al.. 1988). However optimal antibody production rates were 
found to be at pH 6.8. a phenomenon also reported by Miller et al. 
(1988a) suggesting that conditions optimal for cell growth are not 
necessarily optimal for antibody production. This effect has also been 
noted for oxygen concentration where the optimal oxygen concentration 
for antibody production was suboptimal for cell growth (Mizrahi et a)., 
1972; Reuveny et al.. 1986a; Phillips et al., 1987). In this investigation 
further evidence was provided which suggests that the effects of these 
physiological parameters are indirectly linked to antibody production 
through their effects on the cell growth rate. For example, when cell 
proliferation was arrested with excess thymidine, the optimal pH for 
antibody production was pH 7.2 rather than 6.8 indicating that in the 
absence of cell growth the most favourable pH for cell proliferation was 
also optimal for antibody production. Furthermore It was shown that 
preventing cell proliferation by the inhibition of DNA synthesis led to 
an increase in the specific antibody production rate (section 4.3.6). 
Recently this has been further Illustrated by the observation that cyclic 
nucleotides which Inhibit hybridoma proliferation increase the specific 
rate of antibody production (Dalill and Ollis, 1988). 
Taken together, these observations Imply that low cell growth 
rates are favourable for antibody production and that those parameters 
which affect cell growth rate also affect the rate of antibody production. 
Several reports in the literature are consistent with this hypothesis. For 
example in high cell density perfusion culture systems where cell growth 
is restricted by nutrient supply, higher specific antibody production 
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rates have been observed (Van Wezel et al., 1985; Reuveny et al., 1986b) 
and higher antibody production rates have been associated with low 
growth rates in both glucose-limited and oxygen-limited chemostat 
cultures (Birch et al., 1985; Miller et al., 1988). 
In chapter 5a glutamine-limited chemostat culture of the 321 
hybridoma was studied in an attempt to determine the effects of cell 
growth rate on antibody production and cell metabolism. In common with 
the reports cited above it was found that antibody production rates were 
higher at low growth rates (table 5.3) and antibody yields from ) 
glutamine were also considerably higher at low growth rates. Three ý 
possible explanations for this behaviour were put forward. 
1) The metabolic costs of cell growth are high and there is greater 
competition for the energy and metabolite pools available for 
biosynthesis at high growth rates. These increased demands might be 
expected to be reflected by changes in cell metabolism and indeed 
studies on the steady state metabolism of the 321 hybridoma in 
chemostat culture showed that the fate of glutamine and glucose 
changed markedly with growth rate. High growth rates were accompanied 
by an increased rate of glucose uptake with an increased conversion of 
glucose to lactate. This is in agreement with the observations of Hu 
et al., 1987 and Luan et al. (1987b) who noted that there was an 
apparent relationship between growth rate and the yield of lactate from 
glucose in batch cultures of hybridomas. This increased flux through 
glycolysis may be a reflection of an increased demand for glycolytic 
intermediates in rapidly growing cells as suggested by Hume et al. 
(1977). Alternatively Lazo (1981) has suggested that many cells may 
derive much of their energy requirements from aerobic glycolysis and the 
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increased lactate yield at high growth rates may be, evidence of 
increased energy requirements especially as the alternative energy 
source (glutamine) was limiting in these cultures. 
The incorporation of glutamine nitrogen into cell biomass was also 
more efficient at high growth rates as illustrated by lower ammonia 
yields and was further evidence for an increasing demand for metabolic 
Intermediates. 
2) Products of cell metabolism are inhibiting or repressing antibody 
synthesis possibly due to feedback regulation of biosynthetic pathways. 
Whether this is the case for the 321 hybridoma has not been ascertained 
as only s limited number of metabolites were monitored at steady state. 
However there was no evidence that glutamine was inhibitory to 
antibody production from the batch culture experiments (chapter 4). The 
metabolic quotient for ammonia did not change at the higher growth 
rates (Table 5.3) and was therefore unlikely to be responsible for the S'a 
reduced antibody production rate. The increased metabolic quotients for 
glucose and lactate at high growth rates suggest that repression of 
antibody synthesis by glucose or products of glucose catabolism might 
occur as suggested by Glacken et al. (1986). However several workers 
have examined the effect of glucose and lactate on antibody production 
by hybridomas and have found no evidence of any such repression (Low 
and Harbour, 1985; Tharakan and Chau, 1986; Reuveny 'et al.. 1986a; 
Miller et al., 1989a). 
3) Antibody production is cell cycle related and changes in the cell 
population distribution at different growth rates may account for the 
changes in antibody production rate. The possibility that antibody 
216 
production might be restricted to certain phases of the cell cycle was 
investigated in chapter 6. In this chapter it was shown that the rate 
of production of antibody by a synchronised culture of the 321 
hybridoma varied during the cell cycle. Antibody production did not 
appear to be restricted to the G1 phase of the cell cycle as reported for 
other lymphoblastold cell lines (Buell and Fahey. 1969; Takahashi et al.. 
1969; Byars and Kidson. 1970; Garatun-Tjeldsto et a!., 1976; Turner et 
a!.. 1985) but continued during the G2 phase. There was a reproducible 
decline in the rate of antibody synthesis observed at mitosis (figures 6.2 
and 6.3) with some evidence of a further decline during the S phase 
although this was variable. It was also shown that pH conditions which 
were sub-optimal for cell growth, increased the length of the cell cycle 
(figure 6.6) in a manner which was consistent with the Idea that the GI 
phase contributes much of the variability to cell cycle times (Pardee, 
1978; Scheper et a!., 1988). The observation that the rate of antibody 
production may be depressed during the S and M phases when coupled 
with the observation that the proportion of cells in these phases is 
increased in rapidly growing cells (Schliermann et al., 1987) suggests 
that cell cycle related antibody expression cannot be discounted as a 
possible mechanism for the growth related effects observed in this and 
other studies on immunoglobulin production by hybridomas. 
In conclusion it has been found that physiological conditions which 
restrict the growth of hybridomas generally enhance the rate of 
antibody synthesis. The precise relationship between growth rate and 
antibody production rate has not been elucidated but may be a reflection 
of the changes in cell metabolism at low growth rates which favour 
antibody synthesis. The optimisation of antibody production in large 
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scale bloreactors might therefore be achieved by designing the process 
to maintain the cells at the most favourable metabolic state for antibody 
production. This might be achieved by the controlled feeding of a 
limiting nutient either in a batch or, continuous flow system. The 
controlled feeding of nutrients also increases the efficiency of the 
process as demonstrated by increased yields of both cells and antibody 
in chemostat culture and reduces the accumulation of waste metabolites 
such as ammonia and lactate which may be inhibitory. 
7.2 Recommendations. 
Much of the evidence presented in this invetigation strongly rý 
suggests that factors which influence the growth rate of the 321 
hybridoma also affect the rate of antibody, production although the 
explicit mechanisms behind this relationship have not been elucidated. 
Future studies would therefore be centred around the definition of this 
relationship and a number of approaches might be considered. 
1) Studies on the steady state metabolism of hybridomas in chemostat 
culture 
It has been hypothesised above that the increased rate of antibody 
production at low growth rates is due to a more favourable metabolic 
state for antibody production. At steady state the effects of specific 
metabolites on cell metabolism and antibody production could be 
monitored independently of growth rate. ' Changes in the steady 
state concentrations of nutrients such as glucose, glutamine or other 
amino acids should affect the relative flux through different metabolic 
pathways as suggested by several studies on cell metabolism (Reitzer et 
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al.. 1979). Changes in the metabolic balance could be identified by 
monitoring the products of metabolism such as lactate. ammonia, 
alanine, pyruvate and ATP and by changes in oxygen uptake. For 
example Glacken et al. (1986) have suggested that the relative yields 
of ATP from glycolysis or oxidative metabolism can be calculated by the 
yield of lactate from glucose and by oxygen uptake rates. Miller and 
colleagues have recently reported on the results of step and pulse 
changes of glucose, Blutamine, lactate and ammonia in steady state 
cultures of hybridomas and have shown that such an approach provides 
an insight into the regulation of cell metabolic pathways (Miller et al., 
1988aß 1988b, 1989). The effects of these changes on antibody 
production was not assessed by these authors but such an approach 
should prove invaluable in determining the effect of the metabolic state 
of the cell on antibody production. The effects of possible inhibitory 
metabolites such as lactate and ammonia could also be assessed 
independently of any effects on cell growth using the chemostat. 
2) Studies to identify the level at which antibody production is 
regulated. 
The possibility of cell cycle regulated expression of immunoglobulin 
genes in hybridoma cells has not been ruled out (see Chapter 6). 
Furthermore it has been shown that immunoglobulin mRNA may be more 
efficiently translated under nutrient starvation (Sonenshein and 
Brawerman, 1976) suggesting that post-transcriptional control of 
antibody synthesis may occur. Monitoring of the relative rates of gene 
transcription and translation should reveal whether immunoglobulin 
synthesis is regulated at the gene level or at a later stage by nutrient 
or energy limitation. Gene transcription could be monitored by measuring 
219 
immunoglobulin messenger RNA levels by suitable cDNA probes and 
translation by the rate of incorporation of radiolabelled amino acids into 
antibody. The possibility of nutrient or catabolite repression of 
immunoglobulin genes could also be investigated by monitoring the 
relative rates of gene transcription in the presence of high and low 
concentrations of metabolites such as glucose or lactate.. 
3) Studies on the hybridoma cell cycle. 
It has not been ascertained whether the variation in antibody 
production rate observed in synchronised cultures of the 321 hybridoma 
was due to a genuine cell cycle regulation of antibody synthesis or due 
to perturbations caused by the synchronisation method. Studies on the 
cell cycle of hybridomas by flow cytometry using double labelling 
techniques for DNA and antibody content as described by Altshuler et 
al., 1987 may provide evidence of cell cycle related immunoglobulin 
expression. However such a technique will not provide information on 
the relative rates of synthesis or secretion. It would thus be necessary 
to study cell populations at particular, phases of the cell cycle with the 
minimum perturbation of cell metabolism. This could perhaps best be 
achieved by the use of density gradient centrifugation (Mitchell and 
Tupper, 1977) or by fluorescence activated cell sorting. Cell populations 
thus selected could be analysed using the molecular techniques 
described above. 
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Appendix II. Automated ELISA control program. 
10 REM P. M. Hayter 1/11/85 
20 REM Online assay control program 
30 
40 
50 REM Set variables. Dimension arrays-Set up screen 
60 no% i 
70 DIM data(200)tDIM number%(100)tDIM time%(100)sDIM reading(100) 
80 MODE4, COLOUR 131tCOLOUR 0 
90 
100 REM Load graphics dump routine 
110 *LOAD"DUMP" 
120 
1ti0 REM Set all lines on user port for output 
140 PROCuser 
150 
160 REM Set up spectrophotometer 
170 PROCspec 
180 
190 REM Start routine 
200 PROCdetails 
210 PROCfi1e 
220 PROCgo 
230 
240 REM Control routine to switch solenoid valves and assay sample 
250 ON ERROR GOTO 326J 
260 PROCsampletF'ROCabsorb 
270 
280 REM Calculate peak area and store data 
290 PROCvalue 
300 PROCsavetPROCdelay(2) 
310 
320 REM Update graph showing progress of the culture 
330 FROCplot: PROCelute 
340 
350 REM Return to start of sequence 
360 no%-no%+i: GOT0260 
370 
380 
390 DEFFROCspec 
400 PROCcalibrate 
410 PROCsetup 
420 ENDFROC 
4Z0 
440 
450 DEFPROCsutup 
460 VDU121PRINT 7Aß(6.10)"Setting up spectrophotomettr"IFRINT TAE'1ýý12)"Flýeat 
e wait" 
470 PROCinitialisesFRCCdelav(2) 
480 commandt="W. 405" 
490 FROCsend(commandt)sF'RDCdelay(20) 
500 command$-"REF. "tPRCCsend(commandt)%PROCdolay(1) 
510 ENDFROC 
520 
530 
540 DEFPROCinitialise 
550 "FX7,2 
560 *FX8,2 
570 *FX2,0 
S8') *FX166,1,252 
590 ENDF*RCC 
252 
-60o 
610 
620 DEFF'ROCsend(command. t) 
670 "FX:. 7 
640 PRINT command$; CHR$(10)i 
66O "FX3, O 
660 ENDPROC 
670 
680 
690 DEFPROCdelay(interva1%) 
700 time7. TIME+(100"intervwl%) 
710 REPEAT 
720 UNTIL TIME>time% 
730 ENDFROC 
740 
750 
760 DEFPROCwrvia(address%. valuv%) 
770 address%-address% AND &FF 
780 IF (address%<t460)OR(address%>&6F) THEN ENDFROC 
790 A%n&973X%-address%tY%wvalue'I. tCALL &FFF4 
800 ENDPROC 
810 
820 
8Z0 DEFF'ROCuser 
840 F'ROCwrvia(L<62, &FF) 
850 PROCdelay(1) 
860 PROCwrvia(1<60, &20) 
870 VDU12iF'RINT TAS(15.10)"Start pump" 
887 INPUT TAH(8912)"Frass RETURN to continue "Al 
890 IF At", >'-THEN VDU71GOTO 880 
900 ENDFROC 
910 
920 
9zO DEFF'ROCcalibrate 
940 VCU12iF'RINT TAB(6,10) "Switch on spectrophotometer" 
95') INPUT TA6(14,12)"Press FETURN "AI 
960 IF AS<>""THEN VDU7sSOTO 950 
970 VCU12tPRINT TAH(2,10)"Spectrophotometer being calibrated" 
980 PRINT TAE(14,12)"Please wait" 
990 PROCdelay(14O) 
1000 ENDFROC 
1010 
1020 
10: '7 DEFFROCdetails 
1040 VDU12 
1050 PRINT TAB (16,15) "Date"i INPUT TAB(25q5)datv* 
1060 PRINT TA6(1697)"Time"i INPUT TA8(25,7)timet 
1070 PRINT TAE(1,9)"Run detailst Medium"sINPUT TAPi25,9)medl 
1080 PRINT TAB(7,11)"Dilution rate"tINFUT TAP(25,11)dil1 
1090 PRINT TAB(8,13)"Cell density"tINF'JT TAS(25,13)cellt 
1100 ENDF'ROC 
1110 
1120> 
11: 0 DEFF'ROCf ile 
1140 PRINT TAB(1.20)"Enter filename fo" data storage "tINPUT TAB(16,22)f1let 
1160 IF LEN(filei)>6 THEN VDU7sPRINT TAB(16,22)" "tGOTO 1140 
1100 IF filet-""THEN ENDPROC 
1170 ON ERROR GOTO 1240 
1180 channel-OPENIN filet 
1190 INFUT£channel, ES, E$, ES, ES 
1200 CLOSE channel 
1210 PRINT TAS(1,20)"** FILE IN USE-ENTER NEW NAME "*"1PRINT TA8(16.22)" 
1220 PROCdeley() 
1250 GOTO 1140 
1240 IF EFR<>222 THEN REFORTsON E'nF0 OF=iGOTO 210 
263 
1250 ON EKRUR OFF 
1260 channel-OF"ENOUTfilet 
1270 PRINTEchannel, datet. timet. meds. dil$. cell* 
1280 GOTO 220 
1290 
1300 
1310 DEFPRDCgo 
1320 VDU12sINFUT TAS(5910)"Press RETURN to start sampling "AS 
1330 IFA$<>1"I THEN VDU7sGOT0 1320 
13 0 VDU12iT%=TIME 
1360 ENDPROC 
1370 
1380 
1390 DEFPROCsample s 
1400 
1410 REM Sample from vessel 
1420 PRINTsFRINT TAB(15)"Sampling vessel" 
1430 PROCwrvia(&60. &C3) 
1440 PROCdelay(SO) 
1450 
1460 REM Sample onto column 
1470 VDU12iPRINTsPRINT TA6(12)"Sample onto column" 
1480 PROCwrvia(&60. &20) 
1490 PROCdelay(30) 
1200 
1510 REM Conjugated antiserum onto column 
1520 VDUI2IPRINTIPRINT TAS(10)"Antiserum onto column" 
15; 0 PROCwrvia(&60. $. 27) 
1540 PROCdelay(20) 
1550 
1560 REM Buffer wash 
1570 VDU12sF'RINTtPRINT TAB(1S)"Suffer wash" 
1630 PROCwrvia(&60. &20) 
1690 PROCdelay(Z. 0) 
1600 
1610 REM Substrate onto column 
1620 VDUI2zPRINTsPRINT TAE(12)"Substrate onto column" 
1630 PROCwrvia(&60. &28) 
1640 PROCdelay(45) 
1650 
1660 REM React for 10 minutes 
1670 VDUI2iPRINTsPRINT TAb(16)"Substrate reaction" 
1680 PROCwrvia(&60. &A0) 
1690 PROCdelay(Z) 
1700 
1710 REM Buffer on 
1720 VDUI2sPRINTsPRINT TA9(15)"Reading absorbance" 
1730 PROCwrvia(&60, L<20) 
1740 ENDE ROC 
1750 
1760 
1770 DEFF'ROCabsorb 
1780 commandt="REF. "sPFOCsend(commands; sPROCdelav(1) 
1790 commandt-"STATUS" 
1800 FOR I-1T050 
1810 PROCsend(command$) 
1820 PROCreceive 
18--0 PROCdelay(10) 
1640 NEXT 
1850 ENDPROC 
1860 
1870 
'1880 DEFF'ROCreceive 
1890 *FX2.1 
1900 *FX3,6 
1910 INPUTLINE As 
254 
1920 8s=M1Dz'AS, 14, s)sdata(l)"VAL(B$) 
19-'0 *FX3,0 
1940 *FX2,0 
1950 ENDPRCC 
1960 
1970 
1950 DEFPROCvalue 
1990 a-Otmax-0 
2000 FOR I-1TOS0 
2010 a-data(I) 
2020 IF a>max THEN max-atpeak%-I 
2030 NEXT 
2040 FOR Impeak%-5 TO peak'!. -lsmax-max+data(I)sNEXT 
2050 FOR I=peak;: +1 TO peak7.. +5smax max+dataýI)sNEXT 
2060 reading(no%)-maxtr-max 
2070 ENDPROC 
2080 
2090 
2100 DEFPROCsav! 
2110 PRINT"Saving data" 
2120 time%(no%)-TIME-T%tt . time;: (no'l. ) 
211-0 n%. -no': 
2140 PRINT£channel. n`/., t%, r 
2150 ENDF"ROC 
2160 
2170 
2180 DEFPRCCelute 
2190 
22t: 0 REM Elute with 3M NaSCN 
2210 PRINTsPRINT TAB(15)"Regenerating column" 
2220 PROCwrvia(&60, &. 3) 
22,0 PRCCdelay(180) 
2240 
2250 REM Wash with buffer 
2260 PRINTtPRINT TAB(15)"Buffer wash" 
2270 PROCwrvia(w60. &20) 
2280 PROCdelay(600) 
2290 ENDPROC 
2300 
2310 
2320 DEFF"ROCmenu 
23.30 CLOSE£0 
2.3.40 VDU26.12iF"RINT TAB(2,5)"1. Ftle catalogue" 
2350 PRINT TAB(2,6)"2. Recall data" 
2360 PRINT TAB(2,7)"3. Plot data" 
2370 PRINT TAB(2,8)"4. Print graph" 
2380 PRINT TAB(2,9)"S. Restart program" 
2390 PRINT TAB(2,10)"6. Exit program" 
2400 PRINT TAB(2,20)"Current files"; filet 
2410 INPUT TAB(5,15)"Which"IA 
2420 ON A GOTO 24.30,2450,2470,2490,2600,2510 
2470 VDU121*. 
2440 PRINT TAB(5,20)"Press return for menu"sINFUT8IsIF D$-"" THEN 2340 
2450 PROCrecall 
2460 PRINT TAB(6920)"Press return for menu"sINPUTb$1IF 6i "" THEN 2340 
2470 PROCplot 
2480 PRINT TAB(5.1)"Press return for menu" iINPUTBtt IF @ts"" THEN 21.40 
2490 PROCprinttGOTO 2340 
2500 PROCrestartsENDPROC 
2510 VDUI2sPRINT TAB(20,10)"** END OF PROGRAM **"LEND 
2520 ENDF"ROC 
2530 
2540 
2550 DEFF'ROCrecal1 
2560 ON ERROR GOTO 3330 
2570 LOCAL Ill-l 
265 
2580 VDUI2: PRINT TAr(14.10)"Enter filename": INPUT TAB(18.12)stcre$ 
2--90 IF LEN(storeS)>6 THEN VDU7: GOTO2530 
2600 IF stores="" THEN ENDFGOC 
2610 channel=CPENIldstoret 
2620 INF, UT£channel. date$, timei, med1, dil$, cell3 
2630 REPEAT: INPUT£channel, number%(I), time%(I), reading(I): I=I+1: UNTIL EOF£channe 
1 
2640 CLOSE£channel: no'%=number%(I)SPRINT TAE+(10,15)"Data loaded" 
2650 ENDPROC 
2660 
2670 
2680 DEFPROCplot 
2690 PROCaxes 
2700 PROCdraw 
2710 ENDPROC 
2720 
2730 
2740 DEFPROCaxes 
2750 VDU28,0,31; 39,28: GCOL0,128: GCOL0,3: VDU16,12 
2760 MCVE260,31C: DRAW! 260,313: DRAW1260,1013sDRAW260,1013: DRAW260,313 
2770 FOR I=260TO1260STEP200: MOVE I, 313: DRAW I, 3Z0: MOVE I, 996; DRAW I, 1013: NEXT 
2780 FOR I=313TDIOIZSTEP140: MOVE260, I: DR.; W277,1: MOVE1260, I: DRAW124'-, I: NEXT 
2790 tmax%=(time'l. (no'! ))/360000: IF tmax%<25 THEN tmax%-25 
2800 VDU5: AS="0": MOVE2--5,293: PRINT At: Aß=STR$(tmax%): MOVE l2l0.219'-: PRINTA-t: VDU4 
2810 S=tmax%/5: J=395: 0=0 
2820 FOR I=1T04: 0=0+S 
28: 0 @; C=&20103 
2840 VDU5: MOVE J. 2w: PRINT O: J=J+200: NEXT 
2850 MOVE600.200: PRINT"Time"'hrs": VDU4 
2860 @'J. =&20204 
2870 pa=Z 
2880 S=pa/5: J=46Z: 0=0: VDUZ 
281; 0 MOVE110,1009: FRINT pa 
2900 MOVE1IO. 339: PRINT"0.00" 
2910 FOR I=1T04: 0=0+S 
2420 MOVE110, J: J=J+140: PRINTO: NEXT 
2930 @%=10: VDU4: J=800 
2940 FOR I=1T09 
2950 scale="Peak area" 
2960 AS=MID$(scale*. I, 1) 
2970 VDU5: MOVEIO, J: J=J-40: PRINT AS: VDU4: NEXT 
2Q80 ENDPROC 
2990 
3000 
3010 DEFPROCdraw 
3020 X-260: Y=313: PLOT4, X, Y 
3030 FOR I=1T0 no'!. 
3040 X=INT((1000/tmax'%)*(time%(I))/360000+260> 
3050 Y=INT((700/pa)*reading(I)+31v) 
3060 DRAW X, Y: NEXT 
3070 ENDPROC 
3080 
3090 DEFPROCprint 
3100"VDU2: PRINT" Date: "; dates; " Time: "; time$ 
3110 PRINT: PRINT" Details of run: -" 
3120 PRINT" Medium: "imeds 
3120 PRINT" Dilution rate: "; dilt; "/h" 
3140 PRINT" Cell den=sity: "; cell$; " million/mi, ': PRINT: FRINT:. 'CL 
3 
3150 PROCp1ot 
3160 COLOUR128: CLS 
3170 VDU2: CALL &C00: VDU3 
3180 COLOUR131 
3190 ENDF"RCC 
3200 
256 
3210 
32-10 
3240 
3250 
3260 
3270 
3280 
3: QV 
33100 
3310 
3320 
=30 
3340 
3350 
3360 
3270 
3x80 
3390 
3400 
3410 
DEFFR, OCrestart 
no%=ä 
ENDF"ROC 
REM *** Escape routine *** 
IF ERR<>17 THEN 3320 
VDU26,12 
PRCCmenu 
PROCelute 
ON ERROR OFF: GOTO 200 
PRINT TAB(2.10)"Error "; ERR; " at line "; ERL: REPORTzGOTO 3280 
REM *** Disc errors *** 
IF ERR=222 THEN E. $="**FILE NOT ON DISC-": E1$="ENTER 
IF ERR=190 THEN ES="**CATALOGUE FULL-' GOTO 3390 
IF ERR=191 THEN ES="**DISC FULL-'aGOTO 3390 
IF ERR=198 THEN ES '**DISC FULL-" 
IF ERR<>198 THEN REPORT: PRINT ERR: PRINT ERL%GOTOZ41O 
E1*="USE NEW DISC**" 
VDU7: PRINT TAB(2.1O)Et;: PRINT E13 
PROCdelay(5): ON ERROR OFF300TO 3290 
AGAIN**"sGOTO 3400 
4. 
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Appendix III Cross-flow filter 
Medium 
flow 
iý 
i 
ococo 
o- 4==b 
oo c==p 
o co 0o cý 
00ov 
I== 
Filtrate 
Silicone 0-ring 
0.22 pm fitter 
Fitter support 
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Appendix IV. The determination of the volumetric mass transfer 
coefficient (KL a) for oxygen in the Gallenkamp fermenter. 
The volumetric mass transfer coefficient for 02 can be calculated 
by depleting the fermenter of oxygen by flushing with nitrogen and 
observing the rate of oxygen transfer when the oxygen supply is 
restored. 
The relationship between K,. a and the rate of oxygen transfer is 
described by the following equation: 
-KLat = ln(C, at - Ct) 
where Cs at is the oxygen concentration at air saturation and Ct is the 
oxygen concentration at time t. Thus Ki. a can be derived from a plot of 
ln(Cs at - Ct) versus time where -KL a is equal to the slope of the 
resulting graph. 
The graph below shows the determination of KL a for the 
Gallenkamp fermenter at stirrer speeds of 35 and 100 rpm. The fermenter 
contained 500m1 RPMI 1640 and the headspace was gassed with air at 
3litres/h. These determinations were carried out at 370 C using a 
Gallenkamp galvanic oxygen probe. 
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Kea determination in the Gallenkamp fermenter 
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